data_2h9x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2h9x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.56 174.0 11.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 113.854 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 127.262 2.225 . . . . 0.0 111.834 -177.175 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -78.47 -13.5 59.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.123 1.769 . . . . 0.0 109.493 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.35 166.61 32.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 129.057 3.218 . . . . 0.0 106.89 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.5 m -145.82 145.9 30.95 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.194 -1.18 . . . . 0.0 113.347 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -100.23 136.2 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 124.341 2.019 . . . . 0.0 107.122 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -127.59 113.23 15.82 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 130.594 3.558 . . . . 0.0 102.563 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -80.25 163.94 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.265 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -56.85 4.87 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t 177.09 170.04 0.54 Allowed 'General case' 0 N--CA 1.485 1.316 1 C-N-CA 131.922 4.089 . . . . 0.0 112.247 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.45 172.87 0.2 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 129.471 3.108 . . . . 0.0 116.927 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.7 140.81 29.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.547 1.939 . . . . 0.0 110.723 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -44.02 -12.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 1 C-N-CA 132.199 4.2 . . . . 0.0 120.915 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.12 2.87 5.16 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.063 1.316 . . . . 0.0 114.63 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -104.95 177.51 4.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.493 1.117 . . . . 0.0 110.983 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -150.37 169.53 21.21 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.618 -0.676 . . . . 0.0 110.87 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.44 118.16 8.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 113.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.3 p -95.53 7.18 47.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.58 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -159.26 167.1 29.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.502 1.121 . . . . 0.0 111.429 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -76.94 -32.8 57.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 122.13 0.967 . . . . 0.0 112.877 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -96.73 -175.88 3.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.053 1.741 . . . . 0.0 108.059 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.413 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.03 -66.82 0.37 Allowed 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 118.821 -2.424 . . . . 0.0 109.681 -178.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.98 171.7 0.84 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.43 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.3 tp -45.39 -41.72 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 130.514 3.526 . . . . 0.0 114.756 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.43 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -140.42 -49.37 0.45 Allowed 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 129.924 3.29 . . . . 0.0 112.298 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -74.39 -166.67 0.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 130.775 3.63 . . . . 0.0 116.613 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.6 mt-10 -150.63 129.96 12.86 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.979 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 74.6 m -92.71 138.87 31.12 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.102 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.5 m -144.88 170.58 15.86 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 126.77 2.028 . . . . 0.0 108.466 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HE2' ' C ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -134.98 168.03 19.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.245 0.864 0 C-N-CA 127.353 2.261 . . . . 0.0 113.493 177.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.442 -0.856 0 CA-C-O 120.8 0.333 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HB3' HD22 ' A' ' 18' ' ' LEU . 2.2 ptp180 -75.77 -172.7 1.99 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 122.28 1.038 . . . . 0.0 113.463 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.8 m . . . . . 0 CA--C 1.544 0.741 0 C-N-CA 126.58 1.952 . . . . 0.0 112.079 -177.22 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 5' ' ' ARG . 87.2 mt . . . . . 0 CA--C 1.548 0.875 0 CA-C-O 120.628 0.251 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -74.18 52.24 0.45 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.355 2.662 . . . . 0.0 110.355 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.26 -173.99 37.35 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 129.092 3.234 . . . . 0.0 108.464 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.7 m -157.23 137.9 13.16 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.011 -1.876 . . . . 0.0 109.657 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.67 137.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-O 124.414 2.054 . . . . 0.0 107.913 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.19 116.03 22.73 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 130.845 3.658 . . . . 0.0 103.509 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.09 143.38 11.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.463 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.06 -53.45 4.81 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 p -167.54 154.5 8.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.756 2.022 . . . . 0.0 115.179 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -59.63 151.34 25.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.491 1.916 . . . . 0.0 112.534 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.86 136.87 53.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.077 1.351 . . . . 0.0 109.745 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 p -24.53 -68.29 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.919 3.288 . . . . 0.0 117.191 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.42 9.84 75.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.12 1.819 . . . . 0.0 116.319 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 47' ' ' GLN . 7.3 m95 -98.32 177.87 5.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.897 1.348 . . . . 0.0 110.798 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -148.9 161.85 41.03 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.254 -0.904 . . . . 0.0 109.108 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.0 mptm? -62.64 123.05 17.37 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 124.412 1.085 . . . . 0.0 112.399 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 28.4 p -98.27 9.57 42.7 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.764 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -158.8 169.58 24.05 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.277 0.944 . . . . 0.0 112.378 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.56 -52.08 24.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.331 1.052 . . . . 0.0 111.074 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -167.91 1.92 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -147.56 -57.95 0.25 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 119.506 -1.996 . . . . 0.0 110.575 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.91 175.87 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.359 2.664 . . . . 0.0 114.157 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -47.62 -39.43 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 1 C-N-CA 132.588 4.355 . . . . 0.0 115.97 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.47 -47.54 0.26 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 129.121 2.968 . . . . 0.0 112.191 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.25 -167.46 0.91 Allowed 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 131.708 4.003 . . . . 0.0 116.746 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 84.1 mt-10 -149.8 124.01 9.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.5 m -88.46 114.45 25.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.426 1.091 . . . . 0.0 109.967 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.4 m -118.78 170.62 8.84 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.277 0.0 OUTLIER -132.18 168.75 17.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.975 177.882 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' CD2' ' A' ' 31' ' ' TRP . 1.1 tt0 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 125.997 1.719 . . . . 0.0 112.949 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.266 0.555 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 161.34 14.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 123.403 1.573 . . . . 0.0 113.665 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . 0.315 57.2 m . . . . . 0 CA--C 1.553 1.073 0 CA-C-N 111.955 -2.384 . . . . 0.0 107.358 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -69.39 -11.06 60.51 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.292 1.037 . . . . 0.0 111.82 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.64 -179.19 47.88 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -152.77 134.76 14.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 119.202 -2.352 . . . . 0.0 112.502 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.284 2.7 p -95.15 133.51 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 124.428 2.061 . . . . 0.0 105.691 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -121.0 130.22 53.71 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 130.859 3.664 . . . . 0.0 102.215 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.484 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -103.72 155.6 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.014 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.6 -35.32 2.26 Favored Glycine 0 CA--C 1.552 2.366 0 C-N-CA 118.406 -1.854 . . . . 0.0 113.567 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.6 p 175.95 167.71 0.41 Allowed 'General case' 0 CA--C 1.548 0.883 1 C-N-CA 132.073 4.149 . . . . 0.0 112.975 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -75.2 166.45 23.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.284 1.434 . . . . 0.0 110.222 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 136.74 36.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.784 2.034 . . . . 0.0 110.581 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -29.39 -55.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 129.739 3.216 . . . . 0.0 118.557 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.49 7.98 61.91 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -99.73 175.94 5.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.226 1.013 . . . . 0.0 111.298 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -147.86 167.1 25.65 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.756 -1.215 . . . . 0.0 109.229 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.501 ' HZ1' ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -63.36 115.3 4.47 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.404 1.082 . . . . 0.0 110.959 177.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.53 3.51 53.79 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.574 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -159.16 164.62 35.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.379 0.671 . . . . 0.0 112.293 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.58 -32.04 63.92 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -97.91 -176.05 3.33 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.562 1.945 . . . . 0.0 108.125 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.404 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -143.62 -65.43 0.37 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 118.717 -2.49 . . . . 0.0 111.289 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.24 177.39 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.723 1.725 . . . . 0.0 115.59 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -49.44 -40.49 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 131.1 3.76 . . . . 0.0 114.233 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -146.51 -47.1 0.19 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.263 3.425 . . . . 0.0 112.112 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.484 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -72.4 -167.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 131.684 3.994 . . . . 0.0 114.959 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB3' ' HZ1' ' A' ' 33' ' ' LYS . 27.6 mt-10 -151.06 135.16 16.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.467 . . . . 0.0 114.916 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.5 138.99 30.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.348 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.1 m -145.12 168.38 20.48 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.323 2.249 . . . . 0.0 108.179 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 166.37 23.36 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.611 1.164 . . . . 0.0 112.375 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.944 0 C-N-CA 129.09 2.956 . . . . 0.0 113.07 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 CA--C 1.528 0.131 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.297 7.7 ptp180 -79.38 176.41 9.72 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.2 m . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 128.008 2.523 . . . . 0.0 111.532 -176.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -65.78 -30.6 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 110.07 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.22 54.54 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -145.61 143.99 30.19 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 119.809 -1.994 . . . . 0.0 110.768 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.1 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 123.483 1.611 . . . . 0.0 109.309 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.75 102.61 7.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 129.532 3.133 . . . . 0.0 106.73 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.29 133.37 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 109.959 -3.291 . . . . 0.0 107.69 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.13 -9.92 75.0 Favored Glycine 0 CA--C 1.556 2.612 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.849 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 129.41 162.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 1 C-N-CA 135.949 5.7 . . . . 0.0 115.434 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.51 153.98 2.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.843 3.257 . . . . 0.0 118.209 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 131.19 41.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.64 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 m -39.61 -4.78 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 1 C-N-CA 132.945 4.498 . . . . 0.0 120.809 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.29 4.18 2.0 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 125.581 1.562 . . . . 0.0 115.431 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -99.68 -179.39 4.17 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.884 1.274 . . . . 0.0 111.288 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -149.74 159.69 44.15 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.646 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.1 mptm? -59.14 124.31 19.55 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.005 1.322 . . . . 0.0 112.539 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -97.26 6.73 47.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.507 1.754 . . . . 0.0 110.749 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -157.63 171.5 20.21 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 118.953 0.797 . . . . 0.0 110.369 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.61 -48.78 53.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.949 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.52 -177.88 6.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.142 2.977 . . . . 0.0 109.498 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.474 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.65 -68.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 119.405 -2.059 . . . . 0.0 112.431 -177.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.81 174.51 1.77 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.989 1.376 . . . . 0.0 114.55 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 tp -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 1 C-N-CA 131.818 4.047 . . . . 0.0 115.321 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.24 -46.74 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.35 3.06 . . . . 0.0 112.291 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -168.62 1.66 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.639 3.976 . . . . 0.0 115.714 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.1 mt-10 -147.21 126.89 13.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.873 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -89.33 122.13 32.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.024 0.916 . . . . 0.0 109.718 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -128.17 170.3 13.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.144 1.378 . . . . 0.0 107.707 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HE2' ' C ' ' A' ' 46' ' ' LYS 0.274 0.0 OUTLIER -133.65 169.1 17.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.505 -179.78 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 127.618 2.367 . . . . 0.0 111.073 176.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.51 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 10.1 ptp85 -53.41 173.72 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 131.653 3.981 . . . . 0.0 115.847 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.442 -0.838 0 CA-C-N 112.189 -2.278 . . . . 0.0 106.074 176.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 5' ' ' ARG . 5.0 mt . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 p -69.08 -23.13 63.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.42 0.688 . . . . 0.0 110.326 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 163.19 41.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -144.63 142.26 30.0 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.4 -1.647 . . . . 0.0 110.444 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 3.0 p -99.03 138.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 124.394 2.045 . . . . 0.0 108.22 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -130.45 113.8 14.75 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 131.583 3.953 . . . . 0.0 102.34 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG12 ' CE1' ' A' ' 42' ' ' TYR . 1.9 m -79.64 160.84 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.206 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.36 -66.75 3.43 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.58 164.52 12.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.463 2.305 . . . . 0.0 114.187 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.02 154.27 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.972 2.909 . . . . 0.0 116.465 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.04 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.637 1.975 . . . . 0.0 109.452 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -38.81 -30.7 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.01 5.32 30.51 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.719 1.152 . . . . 0.0 115.755 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -106.9 177.39 4.87 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.367 1.084 . . . . 0.0 111.789 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -147.26 167.23 24.77 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HZ3' ' HB3' ' A' ' 43' ' ' GLU . 1.5 mptp? -66.2 114.21 5.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.052 0.93 . . . . 0.0 111.774 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -86.87 2.35 49.42 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.349 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -159.56 170.69 21.11 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.468 -0.77 . . . . 0.0 113.005 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -73.37 -42.05 62.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.577 1.551 . . . . 0.0 112.99 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.87 -178.55 6.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.738 2.015 . . . . 0.0 109.944 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.401 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -142.99 -68.31 0.35 Allowed 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 119.391 -2.068 . . . . 0.0 109.674 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.43 175.71 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.487 1.515 . . . . 0.0 114.685 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -48.92 -39.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 1 C-N-CA 132.338 4.255 . . . . 0.0 114.652 176.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . . . -146.72 -45.73 0.18 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 130.315 3.446 . . . . 0.0 111.959 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -76.5 -167.38 0.79 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 130.083 3.353 . . . . 0.0 115.925 -177.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 20.5 mt-10 -151.08 127.17 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.586 -1.643 . . . . 0.0 113.259 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.7 m -91.47 138.4 31.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.203 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.5 m -141.95 170.22 16.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.406 2.282 . . . . 0.0 107.468 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 169.5 16.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.121 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 127.138 2.175 . . . . 0.0 111.595 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.7 t . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 15.1 mtm180 -67.12 177.21 1.85 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 130.058 3.343 . . . . 0.0 109.72 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 39.9 mt . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -71.97 -24.01 61.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.172 2.189 . . . . 0.0 107.38 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.83 166.65 54.28 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 104.596 -3.402 . . . . 0.0 104.596 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.0 m -149.68 143.51 25.52 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 119.169 -2.371 . . . . 0.0 113.219 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.33 3.1 p -99.78 135.45 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 124.955 2.312 . . . . 0.0 107.992 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -126.79 132.99 50.91 Favored 'General case' 0 C--N 1.305 -1.366 1 C-N-CA 132.901 4.481 . . . . 0.0 102.149 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.1 m -103.99 157.38 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.495 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.11 -42.25 2.52 Favored Glycine 0 CA--C 1.554 2.513 0 C-N-CA 119.291 -1.433 . . . . 0.0 111.064 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -175.32 166.41 3.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 130.13 3.372 . . . . 0.0 110.469 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.74 159.89 32.31 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.37 2.268 . . . . 0.0 113.435 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 134.81 48.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.173 2.189 . . . . 0.0 110.649 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -23.16 -62.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.864 3.265 . . . . 0.0 118.676 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 11.19 65.12 Favored Glycine 0 N--CA 1.463 0.469 0 C-N-CA 125.829 1.68 . . . . 0.0 116.268 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -104.64 173.76 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.191 0.996 . . . . 0.0 111.213 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -153.0 165.32 35.92 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.755 -1.216 . . . . 0.0 111.814 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 2.1 mptp? -58.95 107.28 0.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.877 2.071 . . . . 0.0 113.912 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.0 p -86.64 4.5 40.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.949 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -154.56 176.43 12.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.956 1.702 . . . . 0.0 110.931 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.15 -52.05 8.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.578 1.151 . . . . 0.0 111.566 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.6 -174.14 4.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.538 1.935 . . . . 0.0 109.343 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.72 -70.22 0.36 Allowed 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.467 -2.02 . . . . 0.0 110.219 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.14 176.23 1.41 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.743 1.617 . . . . 0.0 113.936 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -45.13 -37.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 1 C-N-CA 131.815 4.046 . . . . 0.0 115.316 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HB1' ' CD1' ' A' ' 42' ' ' TYR . . . -149.73 -43.37 0.14 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.48 2.712 . . . . 0.0 112.284 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.451 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -78.0 -167.42 1.0 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 131.564 3.946 . . . . 0.0 115.949 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 27.3 mt-10 -150.49 131.21 14.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.157 -1.383 . . . . 0.0 114.013 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.7 m -94.66 130.23 41.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.004 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -135.09 174.81 10.19 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.19 2.196 . . . . 0.0 108.755 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.254 0.0 OUTLIER -135.42 169.21 17.85 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.614 1.166 . . . . 0.0 113.244 178.016 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 115.854 -2.022 . . . . 0.0 114.315 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -98.25 157.4 16.19 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.547 0.845 0 CA-C-N 110.501 -3.045 . . . . 0.0 107.511 177.42 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.252 27.2 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.696 0.76 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.3 p -81.38 -17.42 49.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.43 3.492 . . . . 0.0 112.207 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.3 176.58 25.61 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.262 2.363 . . . . 0.0 111.04 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -141.64 137.88 32.13 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.252 3.2 p -97.2 136.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 124.174 1.94 . . . . 0.0 106.178 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -123.45 128.75 50.26 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 131.012 3.725 . . . . 0.0 103.059 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.3 m -100.27 158.49 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.353 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.44 -36.81 1.57 Allowed Glycine 0 CA--C 1.556 2.653 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.259 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.8 t 177.43 167.92 0.63 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 130.41 3.484 . . . . 0.0 110.607 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.11 156.78 33.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.574 1.95 . . . . 0.0 113.435 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 132.87 48.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.641 1.976 . . . . 0.0 110.257 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -28.18 -50.84 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.841 3.256 . . . . 0.0 118.15 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.79 5.56 54.0 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -101.41 174.61 5.9 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.436 1.118 . . . . 0.0 111.741 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -150.47 167.35 27.4 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.024 -1.048 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -66.25 114.11 5.08 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 125.092 1.357 . . . . 0.0 113.404 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.5 p -94.69 5.54 51.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.663 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -151.85 171.39 17.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.135 -0.978 . . . . 0.0 112.944 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.67 -51.9 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.286 1.434 . . . . 0.0 111.066 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.53 -170.57 3.17 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.531 1.532 . . . . 0.0 108.291 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -144.32 -62.78 0.37 Allowed 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 119.364 -2.085 . . . . 0.0 109.68 177.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.34 175.2 0.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -48.77 -39.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 131.186 3.794 . . . . 0.0 114.166 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -143.89 -49.55 0.3 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.686 3.194 . . . . 0.0 111.846 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -74.57 -166.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 133.426 4.691 . . . . 0.0 115.989 -177.135 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.523 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 25.4 mt-10 -150.89 130.92 13.41 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.25 136.87 33.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.178 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.91 169.22 19.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.521 1.928 . . . . 0.0 107.582 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -135.81 168.17 19.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.739 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 129.231 3.012 . . . . 0.0 110.687 177.449 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.25 2.3 ptp180 -98.89 158.55 15.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 129.589 3.156 . . . . 0.0 112.528 -177.335 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.5 mt . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 t -79.38 5.37 12.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.887 1.675 . . . . 0.0 112.743 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.68 171.3 14.94 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.209 2.337 . . . . 0.0 108.776 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -140.39 138.67 34.97 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 p -96.99 139.25 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 123.943 1.83 . . . . 0.0 106.405 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.65 112.3 16.63 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 129.724 3.21 . . . . 0.0 103.479 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.74 143.56 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.103 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 -51.48 4.11 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 178.33 164.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 128.943 2.897 . . . . 0.0 113.978 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.8 155.51 22.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.287 2.635 . . . . 0.0 116.66 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.21 135.03 47.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.966 1.706 . . . . 0.0 110.354 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 m -39.18 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 1 C-N-CA 132.174 4.19 . . . . 0.0 120.643 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.21 1.27 7.71 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.971 1.272 . . . . 0.0 114.84 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.39 179.04 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.21 1.404 . . . . 0.0 110.303 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -149.24 165.46 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.09 -1.006 . . . . 0.0 109.864 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.73 114.59 3.39 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.422 1.089 . . . . 0.0 112.205 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 26.5 p -92.96 10.31 31.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.19 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -163.11 170.6 17.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.1 -53.47 17.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.621 1.568 . . . . 0.0 111.959 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -80.0 -177.51 6.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.017 2.927 . . . . 0.0 110.129 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.8 -65.67 0.36 Allowed 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 119.484 -2.01 . . . . 0.0 109.945 177.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.46 175.0 0.59 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -49.46 -37.02 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 1 C-N-CA 131.713 4.005 . . . . 0.0 114.426 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.15 -49.52 0.21 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 129.983 3.313 . . . . 0.0 111.501 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -167.3 0.41 Allowed 'General case' 0 N--CA 1.443 -0.814 1 C-N-CA 131.711 4.004 . . . . 0.0 116.475 -177.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.1 mt-10 -148.41 130.8 15.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.06 137.5 32.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.75 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.9 m -149.14 170.26 18.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 108.692 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.89 173.48 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.534 1.534 . . . . 0.0 112.832 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 128.947 2.899 . . . . 0.0 109.896 176.583 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.403 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -72.82 175.8 6.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.305 1.442 . . . . 0.0 113.995 -178.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.448 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD2' ' H ' ' A' ' 5' ' ' ARG 0.269 74.1 mt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -71.85 -27.23 62.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.61 155.61 48.65 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 104.467 -3.453 . . . . 0.0 104.467 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.1 m -140.49 143.55 35.54 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 120.766 -1.432 . . . . 0.0 113.35 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.278 3.5 p -97.17 136.28 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 124.577 2.132 . . . . 0.0 107.984 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -122.33 122.17 38.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 108.867 -3.788 . . . . 0.0 102.851 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.27 139.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.944 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.47 -19.53 10.79 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.544 -1.142 . . . . 0.0 114.402 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 166.35 153.97 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 130.491 3.516 . . . . 0.0 111.884 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -66.49 154.94 38.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.123 2.169 . . . . 0.0 112.198 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 133.54 49.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.358 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -35.7 -28.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 131.185 3.794 . . . . 0.0 120.155 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.32 3.37 12.55 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.17 1.366 . . . . 0.0 114.839 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -99.77 177.64 5.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.976 1.31 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -150.27 163.82 37.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -61.25 120.04 9.6 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.432 1.093 . . . . 0.0 112.443 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.41 2.47 55.77 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.557 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -151.66 165.56 33.96 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 119.705 1.139 . . . . 0.0 110.767 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -43.34 89.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.459 1.123 . . . . 0.0 112.675 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.36 -173.99 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 109.597 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.476 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -142.81 -68.8 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 119.543 -1.973 . . . . 0.0 111.957 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.06 175.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.24 1.816 . . . . 0.0 114.152 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tp -47.95 -37.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 1 C-N-CA 132.109 4.163 . . . . 0.0 115.444 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.99 -42.16 0.15 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.463 3.105 . . . . 0.0 112.896 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -82.39 -169.64 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.909 3.284 . . . . 0.0 116.141 -176.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.4 mt-10 -149.46 124.56 10.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.226 177.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.34 110.77 20.47 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.278 1.431 . . . . 0.0 110.096 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -114.91 171.72 7.48 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.306 1.442 . . . . 0.0 108.531 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 168.17 19.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.674 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 129.938 3.295 . . . . 0.0 110.137 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.226 -0.168 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.25 2.1 ptp180 -73.62 172.55 11.19 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.414 1.886 . . . . 0.0 115.6 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 127.663 2.385 . . . . 0.0 111.703 -177.173 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -73.95 -27.14 60.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.645 2.778 . . . . 0.0 109.375 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.19 165.55 45.22 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -140.72 142.09 34.85 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.301 -1.117 . . . . 0.0 113.527 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.275 3.2 p -100.25 136.12 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 124.465 2.079 . . . . 0.0 106.928 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -126.62 124.93 41.03 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 131.634 3.974 . . . . 0.0 102.422 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.41 HG11 ' CE1' ' A' ' 42' ' ' TYR . 1.5 m -93.16 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.005 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.77 -61.16 3.7 Favored Glycine 0 CA--C 1.554 2.529 0 C-N-CA 119.241 -1.456 . . . . 0.0 110.76 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 t -158.95 158.77 33.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 128.295 2.638 . . . . 0.0 112.234 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -68.45 158.98 32.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.37 1.868 . . . . 0.0 112.688 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.89 42.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.905 2.482 . . . . 0.0 111.146 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 p -20.84 -63.22 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.552 3.541 . . . . 0.0 118.57 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.05 9.9 67.88 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.035 1.574 . . . . 0.0 117.035 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -101.6 174.11 6.12 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.374 1.087 . . . . 0.0 110.825 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -149.99 168.0 25.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.861 -1.149 . . . . 0.0 110.551 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -60.42 111.45 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.918 1.687 . . . . 0.0 112.496 177.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 16.8 p -93.46 10.69 31.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -159.61 165.95 31.7 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.587 1.155 . . . . 0.0 110.556 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.79 -36.28 80.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.04 1.336 . . . . 0.0 112.657 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -102.2 -175.14 2.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.254 2.622 . . . . 0.0 110.191 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.418 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -136.95 -68.16 0.49 Allowed 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 119.538 -1.976 . . . . 0.0 110.137 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.4 174.22 1.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.44 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.4 tp -46.09 -42.42 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 1 C-N-CA 132.122 4.169 . . . . 0.0 114.338 176.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.44 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -144.01 -44.32 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 130.823 3.649 . . . . 0.0 111.951 -176.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -79.04 -166.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 130.54 3.536 . . . . 0.0 116.087 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 15.9 mt-10 -152.11 127.22 9.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.806 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -91.13 136.07 33.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.995 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -142.18 167.78 21.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.738 2.015 . . . . 0.0 108.849 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.265 0.0 OUTLIER -130.04 165.83 21.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.11 179.82 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 C-N-CA 129.456 3.102 . . . . 0.0 112.234 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -95.22 175.61 6.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.851 1.31 . . . . 0.0 113.317 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.316 -0.883 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.09 178.472 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 20' ' ' GLY 0.306 28.4 mt . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -76.93 29.53 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.072 2.149 . . . . 0.0 110.479 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . -142.5 173.05 24.07 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 130.168 3.747 . . . . 0.0 108.381 177.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -148.15 139.67 23.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.482 -1.01 . . . . 0.0 111.448 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.275 2.5 p -98.24 131.04 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 124.338 2.018 . . . . 0.0 105.774 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -115.2 124.29 51.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 109.114 -3.675 . . . . 0.0 103.337 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 42' ' ' TYR . 1.6 m -92.67 161.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.38 -59.67 4.78 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -178.54 166.72 1.8 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.379 3.471 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.85 157.01 35.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.548 2.339 . . . . 0.0 117.258 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 129.66 39.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.96 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -34.71 -31.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 131.28 3.832 . . . . 0.0 119.713 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.14 29.57 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.754 1.169 . . . . 0.0 115.638 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -104.3 174.4 5.89 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.998 1.319 . . . . 0.0 111.463 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -151.56 167.98 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.201 -0.937 . . . . 0.0 111.368 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -69.23 110.54 4.64 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 113.724 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.5 t -84.88 -2.98 58.48 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.196 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -156.72 165.63 35.7 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.863 -1.148 . . . . 0.0 111.205 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -73.97 -26.25 60.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -101.56 175.06 5.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.661 1.584 . . . . 0.0 109.876 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -139.76 -62.62 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.689 -1.882 . . . . 0.0 110.629 -177.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.62 177.27 0.2 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.953 1.701 . . . . 0.0 115.132 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -51.46 -35.73 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 131.658 3.983 . . . . 0.0 114.092 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.55 -44.73 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 130.362 3.465 . . . . 0.0 112.986 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.414 ' CE2' HG13 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -73.85 -169.83 0.8 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.909 3.284 . . . . 0.0 113.9 -177.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 17.3 mt-10 -148.42 129.3 14.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.874 1.321 . . . . 0.0 114.498 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.4 132.06 34.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.76 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.6 m -142.34 173.57 11.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.085 1.754 . . . . 0.0 108.262 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -137.91 166.72 23.34 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 129.715 3.206 . . . . 0.0 113.129 177.444 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.477 ' CB ' HG23 ' A' ' 22' ' ' VAL . 48.0 t . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -89.56 164.07 14.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.97 1.367 . . . . 0.0 112.825 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.546 0.792 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.386 177.184 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.296 18.0 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -75.48 -14.53 60.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.763 2.025 . . . . 0.0 110.451 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.26 174.14 33.57 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.8 m -155.74 148.04 23.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 119.553 -2.145 . . . . 0.0 112.581 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER -92.57 140.66 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 126.79 2.036 . . . . 0.0 109.368 177.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -132.44 109.59 9.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.02 160.42 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.852 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.44 -62.72 4.28 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -177.96 165.0 1.94 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 130.799 3.64 . . . . 0.0 112.089 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -51.7 151.74 3.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 129.607 3.163 . . . . 0.0 117.786 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 135.52 48.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.197 1.799 . . . . 0.0 110.89 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.77 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 131.433 3.893 . . . . 0.0 119.208 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.1 8.63 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 125.954 1.74 . . . . 0.0 116.773 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -101.27 177.26 4.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -151.03 165.48 33.65 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 121.54 -0.725 . . . . 0.0 110.32 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.6 mptm? -64.1 121.7 14.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.26 1.024 . . . . 0.0 113.643 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.35 4.07 53.77 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.403 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -158.48 170.07 23.03 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 120.462 1.483 . . . . 0.0 114.049 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.5 -29.61 56.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -101.85 178.44 4.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 107.942 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.509 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.82 -64.4 0.38 Allowed 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 119.719 -1.863 . . . . 0.0 109.452 -177.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.49 171.41 0.44 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.977 2.111 . . . . 0.0 113.862 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.9 tp -50.7 -38.44 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 131.024 3.73 . . . . 0.0 114.776 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.72 -48.0 0.75 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 129.502 3.121 . . . . 0.0 113.309 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CD2' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -85.78 -168.17 2.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 129.908 3.283 . . . . 0.0 116.25 -177.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 60.1 mt-10 -142.95 135.6 27.7 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.417 -2.174 . . . . 0.0 112.328 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -93.74 129.03 40.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.15 1.38 . . . . 0.0 109.565 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.3 m -135.27 171.82 13.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.92 1.288 . . . . 0.0 108.237 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HE2' ' C ' ' A' ' 46' ' ' LYS 0.253 0.0 OUTLIER -135.05 165.76 24.61 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.53 177.585 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.246 1.818 . . . . 0.0 114.079 177.315 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 C--O 1.225 -0.186 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -83.43 177.84 8.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.065 1.346 . . . . 0.0 113.238 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 126.507 1.923 . . . . 0.0 108.867 177.574 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 t -69.58 -15.11 63.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.785 0.834 . . . . 0.0 111.078 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.3 173.59 55.25 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -153.29 143.66 22.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 118.914 -2.521 . . . . 0.0 113.017 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.291 2.6 p -99.78 132.3 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-O 124.434 2.064 . . . . 0.0 107.265 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -121.26 110.5 16.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 109.134 -3.666 . . . . 0.0 103.739 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 42' ' ' TYR . 1.5 m -80.95 160.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.586 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -55.11 4.8 Favored Glycine 0 CA--C 1.552 2.385 0 C-N-CA 118.234 -1.936 . . . . 0.0 109.337 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.2 t 175.52 164.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.133 3.773 . . . . 0.0 113.265 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.35 151.28 44.36 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 127.922 2.489 . . . . 0.0 116.382 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.79 53.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.487 1.915 . . . . 0.0 111.332 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -32.0 -17.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 1 C-N-CA 134.298 5.039 . . . . 0.0 121.253 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.81 10.2 2.6 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 125.466 1.507 . . . . 0.0 115.274 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -99.71 178.6 4.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.105 0.962 . . . . 0.0 110.735 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -147.98 168.13 23.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.325 -0.859 . . . . 0.0 110.83 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -63.35 109.34 1.56 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.58 177.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 46' ' ' LYS . 8.4 t -86.21 -3.35 58.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.027 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -150.51 165.43 33.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.084 1.354 . . . . 0.0 110.882 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.4 -47.69 69.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.327 1.051 . . . . 0.0 112.923 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.62 -176.37 6.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 128.509 2.723 . . . . 0.0 109.57 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.8 -70.43 0.42 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 119.645 -1.909 . . . . 0.0 108.493 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.98 177.12 2.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 114.438 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -44.55 -38.5 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 131.354 3.862 . . . . 0.0 113.349 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' ' 40' ' ' ILE . . . -148.21 -52.67 0.18 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 130.407 3.483 . . . . 0.0 111.321 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.416 ' CE2' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -65.8 -170.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.888 1 C-N-CA 131.859 4.063 . . . . 0.0 113.889 -177.107 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 13.6 mt-10 -147.6 125.54 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.0 m -89.78 135.17 33.79 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.021 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.3 m -142.86 173.65 11.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.686 2.394 . . . . 0.0 106.829 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -139.11 170.3 16.21 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.218 1.007 . . . . 0.0 110.384 177.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.325 2.25 . . . . 0.0 110.015 176.546 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -96.72 158.52 15.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 122.721 1.248 . . . . 0.0 114.322 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.723 -177.291 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.187 0.517 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -68.19 -25.78 65.4 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.078 1.351 . . . . 0.0 108.73 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.61 160.09 48.72 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.7 m -141.27 141.38 33.96 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.298 -1.119 . . . . 0.0 111.709 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.72 137.29 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 124.399 2.047 . . . . 0.0 107.01 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -121.32 119.75 33.08 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 110.304 -3.135 . . . . 0.0 103.89 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -90.46 144.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.546 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.46 -35.47 2.23 Favored Glycine 0 CA--C 1.555 2.557 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.301 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t 175.77 152.69 0.15 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.067 2.947 . . . . 0.0 112.503 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.73 160.68 11.29 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.593 1.957 . . . . 0.0 111.385 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.79 132.34 38.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.316 1.446 . . . . 0.0 109.393 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -28.12 -50.33 0.07 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 130.045 3.338 . . . . 0.0 117.732 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 3.59 61.49 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.08 1.592 . . . . 0.0 117.08 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -101.62 -179.23 3.96 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.723 1.262 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -151.84 163.81 38.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 121.149 -0.969 . . . . 0.0 109.41 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.7 mptm? -61.06 118.66 7.06 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 112.973 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 46' ' ' LYS . 5.2 t -92.29 5.13 51.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.057 176.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -157.51 168.65 26.69 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-N 120.563 1.529 . . . . 0.0 113.097 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.51 -48.17 73.45 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.489 1.515 . . . . 0.0 112.561 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -88.58 -177.94 5.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.991 2.116 . . . . 0.0 108.14 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.428 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.21 -59.85 0.38 Allowed 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 118.76 -2.462 . . . . 0.0 110.635 -177.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 172.44 175.45 0.09 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.135 2.174 . . . . 0.0 113.959 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.9 tp -49.05 -38.21 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 130.872 3.669 . . . . 0.0 114.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.53 -52.64 0.35 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 129.665 3.186 . . . . 0.0 111.936 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -169.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.744 1 C-N-CA 132.137 4.175 . . . . 0.0 116.347 -177.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 28.1 mt-10 -148.74 128.47 13.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.24 115.39 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.758 1.223 . . . . 0.0 111.112 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.3 m -124.39 167.64 14.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.786 1.279 . . . . 0.0 107.776 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.96 168.88 18.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.098 -179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 128.212 2.605 . . . . 0.0 113.507 177.246 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.455 ' H ' ' CD2' ' A' ' 18' ' ' LEU 0.294 0.0 OUTLIER -91.12 175.0 7.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.851 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 5' ' ' ARG . 1.4 p . . . . . 0 C--N 1.31 -1.134 0 C-N-CA 127.925 2.49 . . . . 0.0 112.632 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 5' ' ' ARG . 25.5 mt . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -68.96 -11.96 61.2 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.231 0.613 . . . . 0.0 111.656 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.92 175.1 41.46 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.353 1.93 . . . . 0.0 110.49 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -149.48 142.72 25.11 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.16 -1.788 . . . . 0.0 113.219 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.32 137.99 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 124.119 1.914 . . . . 0.0 106.291 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -125.16 119.14 27.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 130.88 3.672 . . . . 0.0 103.181 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 m -87.18 161.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.455 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.34 -63.45 3.93 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.076 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 p -162.16 161.04 27.85 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.188 2.595 . . . . 0.0 113.05 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -61.57 160.99 10.35 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.787 1.279 . . . . 0.0 113.653 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 133.08 39.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.945 2.098 . . . . 0.0 110.153 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.7 p -18.87 -65.77 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 130.716 3.607 . . . . 0.0 117.894 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 9.48 70.6 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.802 1.668 . . . . 0.0 116.896 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -99.25 174.8 6.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.433 1.116 . . . . 0.0 111.024 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -149.95 168.72 23.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.805 -1.184 . . . . 0.0 111.034 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -67.77 112.8 5.05 Favored 'General case' 0 CA--C 1.511 -0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 113.053 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 22.2 t -88.02 -1.71 58.16 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.862 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -157.79 167.69 29.31 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.093 -1.004 . . . . 0.0 111.498 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.63 -33.48 68.98 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.6 177.21 5.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 110.627 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.24 -64.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 119.708 -1.87 . . . . 0.0 110.487 -177.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 174.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.154 1.781 . . . . 0.0 115.046 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.1 tp -47.59 -42.35 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 131.026 3.73 . . . . 0.0 113.884 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -141.91 -46.55 0.35 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 130.708 3.603 . . . . 0.0 112.827 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -74.4 -169.16 0.77 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 130.024 3.329 . . . . 0.0 115.447 -177.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.4 mt-10 -148.04 126.34 12.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 123.309 1.528 . . . . 0.0 114.263 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.76 132.25 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.467 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.4 m -143.42 170.79 15.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.517 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -136.0 167.83 20.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.784 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 129.059 2.944 . . . . 0.0 112.328 177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 12.9 mtm180 -69.5 -175.6 0.86 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.922 2.296 . . . . 0.0 111.884 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.437 -1.111 0 C-N-CA 129.69 3.196 . . . . 0.0 110.309 177.788 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 5.5 mt . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -75.8 0.95 16.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.685 0.794 . . . . 0.0 111.448 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.36 162.83 12.27 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.235 2.826 . . . . 0.0 107.818 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.1 m -146.91 141.56 26.68 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.377 -1.661 . . . . 0.0 110.506 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.323 2.5 p -96.34 133.23 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 124.91 2.291 . . . . 0.0 108.541 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -121.46 112.71 18.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 109.343 -3.571 . . . . 0.0 104.213 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 42' ' ' TYR . 1.2 m -86.63 158.11 3.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 112.959 -1.928 . . . . 0.0 107.497 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.72 -50.5 3.28 Favored Glycine 0 CA--C 1.553 2.439 0 C-N-CA 119.127 -1.511 . . . . 0.0 112.071 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -178.32 160.61 1.34 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.294 3.438 . . . . 0.0 111.768 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.07 161.84 7.99 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.909 2.484 . . . . 0.0 114.664 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 145.57 40.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.735 2.014 . . . . 0.0 110.647 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -32.37 -54.72 0.33 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 119.482 3.142 . . . . 0.0 119.482 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.28 14.05 30.8 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 124.692 1.139 . . . . 0.0 115.204 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -96.95 173.31 7.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.66 0.743 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -151.0 166.83 29.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.38 124.97 22.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.613 0.765 . . . . 0.0 111.487 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.8 t -96.59 1.27 51.1 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.838 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.66 168.22 26.55 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 121.238 -0.914 . . . . 0.0 109.724 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -16.59 56.25 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -105.36 175.43 5.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.973 1.309 . . . . 0.0 108.181 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 119.901 -1.749 . . . . 0.0 109.972 -176.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.68 -178.57 0.16 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.707 2.003 . . . . 0.0 113.626 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -52.94 -38.16 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 131.501 3.921 . . . . 0.0 113.341 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' ' 40' ' ' ILE . . . -149.51 -50.93 0.15 Allowed 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 130.505 3.522 . . . . 0.0 111.204 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -69.92 -172.38 0.52 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.33 3.452 . . . . 0.0 112.772 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -146.4 128.67 15.77 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 72.8 m -86.91 123.68 32.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.64 173.94 10.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.799 2.04 . . . . 0.0 107.562 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -138.12 172.67 12.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.871 2.869 . . . . 0.0 110.447 176.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.47 ' HE ' HD23 ' A' ' 18' ' ' LEU . 59.1 mtm180 -69.91 -176.77 1.16 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 113.465 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p . . . . . 0 C--N 1.319 -0.73 0 C-N-CA 129.888 3.275 . . . . 0.0 112.264 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.47 HD23 ' HE ' ' A' ' 5' ' ' ARG 0.252 17.2 mt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.2 t -64.73 -30.68 71.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.426 1.49 . . . . 0.0 109.158 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.33 157.72 38.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.2 m -140.22 138.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 122.003 -0.704 . . . . 0.0 111.915 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.308 3.3 p -96.77 134.27 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-O 124.807 2.241 . . . . 0.0 108.103 176.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -119.64 122.02 40.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 108.994 -3.73 . . . . 0.0 103.73 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.3 m -96.74 156.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.6 -12.6 7.75 Favored Glycine 0 CA--C 1.557 2.695 0 C-N-CA 118.769 -1.681 . . . . 0.0 115.48 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 142.91 162.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 1 C-N-CA 135.985 5.714 . . . . 0.0 113.946 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -70.45 154.46 41.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.894 2.477 . . . . 0.0 115.35 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 131.78 46.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.251 1.82 . . . . 0.0 108.551 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -28.96 -63.62 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.296 2.638 . . . . 0.0 116.87 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.2 5.33 84.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -97.44 177.68 5.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.753 1.277 . . . . 0.0 111.074 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -152.3 166.07 32.97 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.2 mptm? -64.46 121.83 15.31 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.327 1.051 . . . . 0.0 113.103 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.7 t -91.25 0.03 57.6 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.157 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -160.73 166.89 27.94 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 119.83 1.196 . . . . 0.0 109.302 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -22.26 59.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.16 171.48 7.3 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.936 1.695 . . . . 0.0 108.832 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.32 -67.7 0.47 Allowed 'General case' 0 C--O 1.223 -0.32 0 O-C-N 120.187 -1.571 . . . . 0.0 110.161 -177.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.14 174.71 0.71 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 112.906 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 tp -48.13 -35.98 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 130.924 3.69 . . . . 0.0 115.046 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.27 -44.54 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 113.136 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.43 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -76.96 -171.22 1.9 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.07 2.948 . . . . 0.0 113.55 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mt-10 -148.85 120.69 8.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 81.0 m -83.66 104.14 13.54 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.594 1.558 . . . . 0.0 109.445 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.9 m -111.52 175.73 5.31 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.54 1.162 . . . . 0.0 108.937 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -139.46 173.89 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.246 0.904 0 C-N-CA 128.799 2.84 . . . . 0.0 109.622 176.82 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -75.75 154.7 36.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 123.973 1.844 . . . . 0.0 114.369 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 110.047 -3.251 . . . . 0.0 108.995 177.378 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t -66.52 -37.19 84.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.504 1.922 . . . . 0.0 109.57 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.07 46.88 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 m -135.92 134.51 38.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 120.745 -1.444 . . . . 0.0 113.098 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.37 137.37 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 124.316 2.008 . . . . 0.0 106.228 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -122.58 119.73 31.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 109.997 -3.274 . . . . 0.0 103.127 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.2 t -93.3 138.83 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.279 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -48.24 3.68 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -170.18 158.2 6.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.269 1.828 . . . . 0.0 114.251 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.0 161.42 18.72 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.327 1.537 . . . . 0.0 112.688 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 133.89 40.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.488 1.915 . . . . 0.0 109.346 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -34.96 -40.81 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.653 3.181 . . . . 0.0 118.801 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.61 4.14 39.79 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -100.41 177.59 4.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.012 1.325 . . . . 0.0 111.653 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -151.2 166.97 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.294 -0.879 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.75 118.7 7.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.632 1.573 . . . . 0.0 112.882 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.3 p -99.03 11.75 38.06 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.303 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.66 158.36 33.63 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 110.091 -177.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -25.25 59.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.588 0.709 . . . . 0.0 112.321 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.24 -169.86 1.75 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.108 2.563 . . . . 0.0 109.485 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -143.83 -65.26 0.37 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 119.114 -2.241 . . . . 0.0 112.436 177.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.68 176.8 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -51.24 -40.03 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 1 C-N-CA 131.701 4.001 . . . . 0.0 113.977 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.17 -48.4 0.27 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.074 3.35 . . . . 0.0 111.405 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -164.73 0.43 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.014 4.126 . . . . 0.0 116.484 -177.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.2 mt-10 -148.62 129.73 14.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.506 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.55 134.43 34.13 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.981 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.32 169.81 16.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.941 1.696 . . . . 0.0 108.929 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.311 0.0 OUTLIER -134.62 168.27 19.29 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.722 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.084 1 C-N-CA 132.406 4.282 . . . . 0.0 109.447 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 40.0 mtm180 -73.31 -171.83 1.03 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.249 1.82 . . . . 0.0 113.568 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 C--N 1.32 -0.683 0 C-N-CA 127.886 2.474 . . . . 0.0 114.072 -179.821 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 32.2 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 m -69.88 -25.79 63.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.941 1.296 . . . . 0.0 108.373 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.75 170.66 55.04 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.8 m -148.99 142.82 25.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 119.534 -2.156 . . . . 0.0 112.148 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.257 2.8 p -98.33 135.64 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.535 2.112 . . . . 0.0 106.46 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -126.17 127.07 45.14 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.021 4.128 . . . . 0.0 102.403 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.61 159.72 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.46 -49.5 3.03 Favored Glycine 0 CA--C 1.557 2.71 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.3 t -169.33 169.02 9.34 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 129.741 3.216 . . . . 0.0 111.34 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.08 165.94 24.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.404 2.282 . . . . 0.0 113.632 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.7 142.82 35.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.881 1.672 . . . . 0.0 112.544 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -35.07 -8.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 C-N-CA 134.697 5.199 . . . . 0.0 122.236 -177.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.22 9.96 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.005 1.764 . . . . 0.0 114.807 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.75 177.92 5.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.044 1.338 . . . . 0.0 110.863 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -152.81 167.67 28.27 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.12 -0.987 . . . . 0.0 110.787 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -64.16 113.51 3.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.387 1.875 . . . . 0.0 111.557 177.174 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.9 t -87.84 1.7 53.28 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.31 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -158.9 167.25 29.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.622 1.569 . . . . 0.0 110.637 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.28 -42.51 79.44 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -89.37 177.73 6.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.378 2.271 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.27 -68.67 0.45 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 119.879 -1.763 . . . . 0.0 111.191 -177.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.43 170.72 0.78 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.07 1.748 . . . . 0.0 115.164 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.5 tp -44.32 -44.22 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 1 C-N-CA 131.768 4.027 . . . . 0.0 115.214 176.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -136.68 -48.19 0.62 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.989 3.315 . . . . 0.0 111.938 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -76.71 -165.25 0.51 Allowed 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.084 4.154 . . . . 0.0 116.54 -177.337 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 16.5 mt-10 -152.58 127.58 9.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.12 -1.855 . . . . 0.0 113.664 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 71.5 m -91.66 129.02 37.7 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -135.41 175.32 9.69 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.287 1.835 . . . . 0.0 108.303 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' A' ' 46' ' ' LYS 0.273 0.0 OUTLIER -138.96 173.17 11.84 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 177.586 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.101 4.56 . . . . 0.0 109.069 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 43.6 mtm180 -66.49 178.67 1.19 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.325 2.25 . . . . 0.0 111.052 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 126.789 2.036 . . . . 0.0 112.357 -178.332 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 68.4 mt . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -66.77 -29.91 69.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.02 0.928 . . . . 0.0 108.765 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.36 176.3 34.91 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.734 2.112 . . . . 0.0 108.102 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.0 m -151.34 139.24 19.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 119.046 -2.444 . . . . 0.0 112.92 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.1 135.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 124.247 1.975 . . . . 0.0 106.935 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -122.47 108.94 13.75 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 109.97 -3.286 . . . . 0.0 104.15 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG12 ' CE2' ' A' ' 42' ' ' TYR . 1.5 m -79.14 160.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 112.653 -2.067 . . . . 0.0 106.695 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.11 -49.15 4.06 Favored Glycine 0 CA--C 1.567 3.339 0 C-N-CA 118.672 -1.728 . . . . 0.0 109.766 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t 165.29 164.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 1 C-N-CA 134.011 4.924 . . . . 0.0 113.271 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.89 154.87 3.7 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 129.626 3.17 . . . . 0.0 117.119 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.36 43.13 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.864 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -29.91 -44.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.999 3.719 . . . . 0.0 118.571 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.74 8.72 34.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.439 1.495 . . . . 0.0 116.576 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -102.54 179.39 4.31 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.772 1.229 . . . . 0.0 111.048 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -149.1 160.82 42.99 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.069 -1.019 . . . . 0.0 109.777 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -57.77 112.75 1.57 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.471 1.509 . . . . 0.0 112.26 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.2 p -85.1 5.08 31.21 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.246 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.09 165.46 33.81 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.275 0.943 . . . . 0.0 110.416 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.8 -35.85 75.2 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.893 0.746 . . . . 0.0 112.982 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.98 -175.77 4.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.069 2.148 . . . . 0.0 107.527 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.31 -67.2 0.33 Allowed 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 119.091 -2.256 . . . . 0.0 111.168 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.57 174.55 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.392 1.877 . . . . 0.0 112.354 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -47.38 -32.38 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 130.765 3.626 . . . . 0.0 115.589 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.42 -42.45 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 128.797 2.839 . . . . 0.0 113.863 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.409 ' CE2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -78.22 -169.26 1.55 Allowed 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.939 3.296 . . . . 0.0 113.894 -176.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 53.1 mt-10 -150.65 123.45 8.64 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.38 117.41 25.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 123.403 1.573 . . . . 0.0 110.789 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.45 174.69 7.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.231 1.813 . . . . 0.0 109.514 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.334 0.0 OUTLIER -137.28 170.56 15.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 177.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.249 1.031 1 C-N-CA 132.651 4.38 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.331 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.586 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.251 59.1 t -145.49 149.33 16.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.0 t -149.57 128.71 12.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.56 174.0 11.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 113.854 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.1 m -111.65 174.71 5.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.262 2.225 . . . . 0.0 111.834 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.77 -42.73 84.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.384 1.074 . . . . 0.0 111.727 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -108.06 54.65 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.25 1.82 . . . . 0.0 109.155 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -45.63 -42.53 11.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.857 0.863 . . . . 0.0 113.257 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 67.5 0.17 Allowed Glycine 0 N--CA 1.463 0.458 0 C-N-CA 125.713 1.625 . . . . 0.0 114.645 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -57.2 -22.35 47.99 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.444 2.763 . . . . 0.0 117.216 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -148.51 34.11 0.79 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.322 1.449 . . . . 0.0 113.568 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 162.91 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.82 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -71.45 150.76 44.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 113.027 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.97 32.5 84.29 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -73.24 -10.07 59.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.46 2.704 . . . . 0.0 116.477 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -60.92 173.71 0.73 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.637 1.975 . . . . 0.0 112.222 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 36.7 mt -67.49 60.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.86 2.064 . . . . 0.0 114.756 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -78.47 -13.5 59.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.123 1.769 . . . . 0.0 109.493 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.35 166.61 32.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 129.057 3.218 . . . . 0.0 106.89 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.5 m -145.82 145.9 30.95 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.194 -1.18 . . . . 0.0 113.347 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 3.2 p -100.23 136.2 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 124.341 2.019 . . . . 0.0 107.122 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -127.59 113.23 15.82 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 130.594 3.558 . . . . 0.0 102.563 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -80.25 163.94 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.265 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -56.85 4.87 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t 177.09 170.04 0.54 Allowed 'General case' 0 N--CA 1.485 1.316 1 C-N-CA 131.922 4.089 . . . . 0.0 112.247 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.45 172.87 0.2 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 129.471 3.108 . . . . 0.0 116.927 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.7 140.81 29.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.547 1.939 . . . . 0.0 110.723 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -44.02 -12.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 1 C-N-CA 132.199 4.2 . . . . 0.0 120.915 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.12 2.87 5.16 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.063 1.316 . . . . 0.0 114.63 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -104.95 177.51 4.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.493 1.117 . . . . 0.0 110.983 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -150.37 169.53 21.21 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.618 -0.676 . . . . 0.0 110.87 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.44 118.16 8.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 113.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.3 p -95.53 7.18 47.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.58 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -159.26 167.1 29.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.502 1.121 . . . . 0.0 111.429 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -76.94 -32.8 57.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 122.13 0.967 . . . . 0.0 112.877 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -96.73 -175.88 3.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.053 1.741 . . . . 0.0 108.059 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.413 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.03 -66.82 0.37 Allowed 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 118.821 -2.424 . . . . 0.0 109.681 -178.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.98 171.7 0.84 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.43 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.3 tp -45.39 -41.72 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 130.514 3.526 . . . . 0.0 114.756 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.43 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -140.42 -49.37 0.45 Allowed 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 129.924 3.29 . . . . 0.0 112.298 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -74.39 -166.67 0.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 130.775 3.63 . . . . 0.0 116.613 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.6 mt-10 -150.63 129.96 12.86 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.979 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 74.6 m -92.71 138.87 31.12 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.102 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.5 m -144.88 170.58 15.86 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 126.77 2.028 . . . . 0.0 108.466 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HE2' ' C ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -134.98 168.03 19.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.245 0.864 0 C-N-CA 127.353 2.261 . . . . 0.0 113.493 177.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.258 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.32 72.3 t -149.24 153.62 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.937 0.895 . . . . 0.0 111.792 -177.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.6 t -152.56 128.67 10.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.077 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HB3' HD22 ' A' ' 18' ' ' LEU . 2.2 ptp180 -75.77 -172.7 1.99 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 122.28 1.038 . . . . 0.0 113.463 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.8 m -124.07 -177.87 3.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.58 1.952 . . . . 0.0 112.079 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -54.87 -64.52 0.81 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.963 1.305 . . . . 0.0 109.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -88.11 50.92 2.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.156 2.582 . . . . 0.0 110.843 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -59.27 -13.95 9.52 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.8 59.71 8.3 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 118.225 2.05 . . . . 0.0 118.225 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.64 -0.32 2.41 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 124.289 3.326 . . . . 0.0 115.526 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.3 m -135.33 7.68 3.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.243 1.817 . . . . 0.0 115.054 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.81 -163.81 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.077 0.951 . . . . 0.0 112.784 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -60.69 135.74 57.86 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.68 1.592 . . . . 0.0 114.239 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.2 26.85 71.78 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.424 2.13 . . . . 0.0 118.424 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -47.8 49.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 135.261 5.424 . . . . 0.0 117.523 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 p -144.81 -170.23 3.36 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 128.041 2.536 . . . . 0.0 113.746 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 5' ' ' ARG . 87.2 mt -69.76 52.73 0.11 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.828 2.851 . . . . 0.0 111.429 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -74.18 52.24 0.45 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.355 2.662 . . . . 0.0 110.355 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.26 -173.99 37.35 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 129.092 3.234 . . . . 0.0 108.464 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.7 m -157.23 137.9 13.16 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.011 -1.876 . . . . 0.0 109.657 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 4.4 p -93.67 137.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-O 124.414 2.054 . . . . 0.0 107.913 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.19 116.03 22.73 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 130.845 3.658 . . . . 0.0 103.509 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.09 143.38 11.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.463 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.06 -53.45 4.81 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 p -167.54 154.5 8.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.756 2.022 . . . . 0.0 115.179 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -59.63 151.34 25.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.491 1.916 . . . . 0.0 112.534 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.86 136.87 53.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.077 1.351 . . . . 0.0 109.745 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 p -24.53 -68.29 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.919 3.288 . . . . 0.0 117.191 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.42 9.84 75.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.12 1.819 . . . . 0.0 116.319 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 47' ' ' GLN . 7.3 m95 -98.32 177.87 5.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.897 1.348 . . . . 0.0 110.798 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -148.9 161.85 41.03 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.254 -0.904 . . . . 0.0 109.108 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.0 mptm? -62.64 123.05 17.37 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 124.412 1.085 . . . . 0.0 112.399 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 28.4 p -98.27 9.57 42.7 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.764 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -158.8 169.58 24.05 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.277 0.944 . . . . 0.0 112.378 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.56 -52.08 24.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.331 1.052 . . . . 0.0 111.074 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -167.91 1.92 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -147.56 -57.95 0.25 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 119.506 -1.996 . . . . 0.0 110.575 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.91 175.87 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.359 2.664 . . . . 0.0 114.157 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -47.62 -39.43 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 1 C-N-CA 132.588 4.355 . . . . 0.0 115.97 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.47 -47.54 0.26 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 129.121 2.968 . . . . 0.0 112.191 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.25 -167.46 0.91 Allowed 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 131.708 4.003 . . . . 0.0 116.746 -177.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 84.1 mt-10 -149.8 124.01 9.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.5 m -88.46 114.45 25.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.426 1.091 . . . . 0.0 109.967 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.4 m -118.78 170.62 8.84 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.277 0.0 OUTLIER -132.18 168.75 17.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.975 177.882 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' CD2' ' A' ' 31' ' ' TRP . 1.1 tt0 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 125.997 1.719 . . . . 0.0 112.949 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.217 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.305 59.6 t -143.77 152.67 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 110.133 -177.416 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.1 t -153.39 135.67 14.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.236 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 161.34 14.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 123.403 1.573 . . . . 0.0 113.665 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . 0.315 57.2 m -87.06 169.66 12.21 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 111.955 -2.384 . . . . 0.0 107.358 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 35' ' ' ASN . 17.1 p30 -66.64 -37.23 84.39 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.318 -1.489 . . . . 0.0 112.517 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -105.5 47.7 0.87 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.528 2.331 . . . . 0.0 110.071 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.13 -30.7 2.02 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.96 -84.62 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 125.119 1.342 . . . . 0.0 116.282 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -57.08 -2.2 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.851 3.701 . . . . 0.0 115.085 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 t -85.96 -28.67 24.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.875 1.27 . . . . 0.0 111.659 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.58 -172.91 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.25 -1.23 1.52 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.62 15.28 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.23 16.3 1.61 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 129.678 3.191 . . . . 0.0 116.692 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.8 p -135.98 134.51 38.67 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.0 mt -73.17 61.34 0.61 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.633 3.173 . . . . 0.0 112.475 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -69.39 -11.06 60.51 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.292 1.037 . . . . 0.0 111.82 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.64 -179.19 47.88 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -152.77 134.76 14.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 119.202 -2.352 . . . . 0.0 112.502 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.284 2.7 p -95.15 133.51 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 124.428 2.061 . . . . 0.0 105.691 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -121.0 130.22 53.71 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 130.859 3.664 . . . . 0.0 102.215 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.484 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -103.72 155.6 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.014 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.6 -35.32 2.26 Favored Glycine 0 CA--C 1.552 2.366 0 C-N-CA 118.406 -1.854 . . . . 0.0 113.567 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.6 p 175.95 167.71 0.41 Allowed 'General case' 0 CA--C 1.548 0.883 1 C-N-CA 132.073 4.149 . . . . 0.0 112.975 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -75.2 166.45 23.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.284 1.434 . . . . 0.0 110.222 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 136.74 36.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.784 2.034 . . . . 0.0 110.581 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -29.39 -55.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 129.739 3.216 . . . . 0.0 118.557 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.49 7.98 61.91 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -99.73 175.94 5.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.226 1.013 . . . . 0.0 111.298 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -147.86 167.1 25.65 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.756 -1.215 . . . . 0.0 109.229 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.501 ' HZ1' ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -63.36 115.3 4.47 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.404 1.082 . . . . 0.0 110.959 177.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.53 3.51 53.79 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.574 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 7' ' ' ASP . 19.7 p-10 -159.16 164.62 35.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.379 0.671 . . . . 0.0 112.293 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.58 -32.04 63.92 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -97.91 -176.05 3.33 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.562 1.945 . . . . 0.0 108.125 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.404 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -143.62 -65.43 0.37 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 118.717 -2.49 . . . . 0.0 111.289 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.24 177.39 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.723 1.725 . . . . 0.0 115.59 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -49.44 -40.49 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 131.1 3.76 . . . . 0.0 114.233 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -146.51 -47.1 0.19 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.263 3.425 . . . . 0.0 112.112 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.484 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -72.4 -167.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 131.684 3.994 . . . . 0.0 114.959 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB3' ' HZ1' ' A' ' 33' ' ' LYS . 27.6 mt-10 -151.06 135.16 16.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.467 . . . . 0.0 114.916 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.5 138.99 30.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.348 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.1 m -145.12 168.38 20.48 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.323 2.249 . . . . 0.0 108.179 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 166.37 23.36 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.611 1.164 . . . . 0.0 112.375 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.944 0 C-N-CA 129.09 2.956 . . . . 0.0 113.07 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.59 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 24.5 t -113.69 141.85 28.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -148.31 127.57 12.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.297 7.7 ptp180 -79.38 176.41 9.72 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.2 m -118.46 173.66 6.7 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.008 2.523 . . . . 0.0 111.532 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.87 -57.76 6.78 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.162 1.385 . . . . 0.0 110.917 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.9 t -99.04 55.06 1.0 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 109.935 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -48.02 -40.9 24.12 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.09 62.48 0.06 OUTLIER Glycine 0 C--N 1.33 0.216 0 N-CA-C 117.463 1.745 . . . . 0.0 117.463 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.32 -16.9 57.59 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.965 2.443 . . . . 0.0 116.548 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -130.88 34.27 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 123.516 1.627 . . . . 0.0 114.849 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.51 164.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.185 -1.37 . . . . 0.0 114.644 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.58 65.91 1.35 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.146 1.778 . . . . 0.0 113.149 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.35 55.96 0.2 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.89 -4.77 17.71 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -96.99 146.73 24.69 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.53 2.332 . . . . 0.0 117.04 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.36 66.4 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 129.511 3.124 . . . . 0.0 115.797 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -65.78 -30.6 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 110.07 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.22 54.54 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -145.61 143.99 30.19 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 119.809 -1.994 . . . . 0.0 110.768 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.5 p -95.1 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 123.483 1.611 . . . . 0.0 109.309 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.75 102.61 7.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 129.532 3.133 . . . . 0.0 106.73 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.29 133.37 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 109.959 -3.291 . . . . 0.0 107.69 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.13 -9.92 75.0 Favored Glycine 0 CA--C 1.556 2.612 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.849 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 129.41 162.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 1 C-N-CA 135.949 5.7 . . . . 0.0 115.434 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.51 153.98 2.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.843 3.257 . . . . 0.0 118.209 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 131.19 41.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.64 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 m -39.61 -4.78 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 1 C-N-CA 132.945 4.498 . . . . 0.0 120.809 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.29 4.18 2.0 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 125.581 1.562 . . . . 0.0 115.431 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -99.68 -179.39 4.17 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.884 1.274 . . . . 0.0 111.288 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -149.74 159.69 44.15 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.646 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.1 mptm? -59.14 124.31 19.55 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.005 1.322 . . . . 0.0 112.539 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -97.26 6.73 47.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.507 1.754 . . . . 0.0 110.749 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -157.63 171.5 20.21 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 118.953 0.797 . . . . 0.0 110.369 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.61 -48.78 53.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.949 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.52 -177.88 6.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.142 2.977 . . . . 0.0 109.498 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.474 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.65 -68.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 119.405 -2.059 . . . . 0.0 112.431 -177.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.81 174.51 1.77 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.989 1.376 . . . . 0.0 114.55 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 tp -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 1 C-N-CA 131.818 4.047 . . . . 0.0 115.321 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.24 -46.74 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.35 3.06 . . . . 0.0 112.291 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.82 -168.62 1.66 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.639 3.976 . . . . 0.0 115.714 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.1 mt-10 -147.21 126.89 13.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.873 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -89.33 122.13 32.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.024 0.916 . . . . 0.0 109.718 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -128.17 170.3 13.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.144 1.378 . . . . 0.0 107.707 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HE2' ' C ' ' A' ' 46' ' ' LYS 0.274 0.0 OUTLIER -133.65 169.1 17.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.505 -179.78 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 127.618 2.367 . . . . 0.0 111.073 176.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.545 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.266 59.5 t -112.91 149.17 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 123.793 0.837 . . . . 0.0 108.868 178.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.8 t -155.88 108.83 2.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.51 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 10.1 ptp85 -53.41 173.72 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 131.653 3.981 . . . . 0.0 115.847 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.9 -174.25 2.82 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 112.189 -2.278 . . . . 0.0 106.074 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -72.99 -55.09 7.03 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.304 -1.498 . . . . 0.0 107.546 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -78.26 32.04 0.18 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.412 2.285 . . . . 0.0 113.306 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 27.5 t70 -53.85 -10.83 0.34 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 -89.3 1.11 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.592 1.091 . . . . 0.0 113.742 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -54.78 -7.13 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 125.266 3.977 . . . . 0.0 115.963 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -92.48 -7.82 46.35 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -176.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.507 1.123 . . . . 0.0 112.14 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -71.16 -11.56 61.01 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.306 -1.496 . . . . 0.0 112.655 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.94 69.94 1.18 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.36 1.304 . . . . 0.0 116.36 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -133.55 -54.56 0.89 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.569 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.4 p -140.42 151.24 44.75 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 5' ' ' ARG . 5.0 mt -52.97 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.778 1 C-N-CA 131.756 4.022 . . . . 0.0 114.426 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 p -69.08 -23.13 63.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.42 0.688 . . . . 0.0 110.326 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 163.19 41.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -144.63 142.26 30.0 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.4 -1.647 . . . . 0.0 110.444 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.267 3.0 p -99.03 138.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 124.394 2.045 . . . . 0.0 108.22 176.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -130.45 113.8 14.75 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 131.583 3.953 . . . . 0.0 102.34 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG12 ' CE1' ' A' ' 42' ' ' TYR . 1.9 m -79.64 160.84 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.206 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.36 -66.75 3.43 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.58 164.52 12.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.463 2.305 . . . . 0.0 114.187 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.02 154.27 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.972 2.909 . . . . 0.0 116.465 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.04 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.637 1.975 . . . . 0.0 109.452 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -38.81 -30.7 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.01 5.32 30.51 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.719 1.152 . . . . 0.0 115.755 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -106.9 177.39 4.87 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.367 1.084 . . . . 0.0 111.789 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -147.26 167.23 24.77 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HZ3' ' HB3' ' A' ' 43' ' ' GLU . 1.5 mptp? -66.2 114.21 5.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.052 0.93 . . . . 0.0 111.774 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -86.87 2.35 49.42 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.349 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -159.56 170.69 21.11 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.468 -0.77 . . . . 0.0 113.005 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -73.37 -42.05 62.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.577 1.551 . . . . 0.0 112.99 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -87.87 -178.55 6.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.738 2.015 . . . . 0.0 109.944 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.401 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -142.99 -68.31 0.35 Allowed 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 119.391 -2.068 . . . . 0.0 109.674 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.43 175.71 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.487 1.515 . . . . 0.0 114.685 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -48.92 -39.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 1 C-N-CA 132.338 4.255 . . . . 0.0 114.652 176.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 42' ' ' TYR . . . -146.72 -45.73 0.18 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 130.315 3.446 . . . . 0.0 111.959 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -76.5 -167.38 0.79 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 130.083 3.353 . . . . 0.0 115.925 -177.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 20.5 mt-10 -151.08 127.17 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.586 -1.643 . . . . 0.0 113.259 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.7 m -91.47 138.4 31.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.203 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.5 m -141.95 170.22 16.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.406 2.282 . . . . 0.0 107.468 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 169.5 16.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.121 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 127.138 2.175 . . . . 0.0 111.595 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.433 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.278 46.5 t -100.03 148.36 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.921 0.888 . . . . 0.0 110.011 -177.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.7 t -155.84 131.49 9.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 9' ' ' ASP . 15.1 mtm180 -67.12 177.21 1.85 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.1 m -122.95 165.27 17.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 130.058 3.343 . . . . 0.0 109.72 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -48.89 -47.13 43.4 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 127.529 2.332 . . . . 0.0 113.156 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -79.35 -18.37 52.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.53 1.932 . . . . 0.0 116.086 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HB2' ' CD ' ' A' ' 5' ' ' ARG 0.464 0.0 OUTLIER 30.08 46.59 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 131.455 3.902 . . . . 0.0 113.837 -177.235 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.85 71.81 0.04 OUTLIER Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.906 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -61.4 -7.82 9.38 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.591 3.528 . . . . 0.0 117.294 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t 72.05 32.41 1.81 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 127.8 2.44 . . . . 0.0 116.532 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.8 -162.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.407 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -64.21 87.59 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.773 2.029 . . . . 0.0 113.717 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.69 93.22 2.19 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.888 1.709 . . . . 0.0 115.366 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -67.16 -26.79 66.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -54.69 -171.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 130.67 3.588 . . . . 0.0 113.255 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 39.9 mt -60.76 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 129.295 3.038 . . . . 0.0 116.207 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -71.97 -24.01 61.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.172 2.189 . . . . 0.0 107.38 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.83 166.65 54.28 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 104.596 -3.402 . . . . 0.0 104.596 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.0 m -149.68 143.51 25.52 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 119.169 -2.371 . . . . 0.0 113.219 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.33 3.1 p -99.78 135.45 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 124.955 2.312 . . . . 0.0 107.992 176.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -126.79 132.99 50.91 Favored 'General case' 0 C--N 1.305 -1.366 1 C-N-CA 132.901 4.481 . . . . 0.0 102.149 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.1 m -103.99 157.38 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.495 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.11 -42.25 2.52 Favored Glycine 0 CA--C 1.554 2.513 0 C-N-CA 119.291 -1.433 . . . . 0.0 111.064 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -175.32 166.41 3.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 130.13 3.372 . . . . 0.0 110.469 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.74 159.89 32.31 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.37 2.268 . . . . 0.0 113.435 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 134.81 48.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.173 2.189 . . . . 0.0 110.649 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -23.16 -62.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.864 3.265 . . . . 0.0 118.676 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 11.19 65.12 Favored Glycine 0 N--CA 1.463 0.469 0 C-N-CA 125.829 1.68 . . . . 0.0 116.268 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -104.64 173.76 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.191 0.996 . . . . 0.0 111.213 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -153.0 165.32 35.92 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.755 -1.216 . . . . 0.0 111.814 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 2.1 mptp? -58.95 107.28 0.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.877 2.071 . . . . 0.0 113.912 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.0 p -86.64 4.5 40.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.949 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -154.56 176.43 12.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.956 1.702 . . . . 0.0 110.931 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.15 -52.05 8.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.578 1.151 . . . . 0.0 111.566 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.6 -174.14 4.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.538 1.935 . . . . 0.0 109.343 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.72 -70.22 0.36 Allowed 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.467 -2.02 . . . . 0.0 110.219 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.14 176.23 1.41 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.743 1.617 . . . . 0.0 113.936 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -45.13 -37.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 1 C-N-CA 131.815 4.046 . . . . 0.0 115.316 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HB1' ' CD1' ' A' ' 42' ' ' TYR . . . -149.73 -43.37 0.14 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.48 2.712 . . . . 0.0 112.284 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -78.0 -167.42 1.0 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 131.564 3.946 . . . . 0.0 115.949 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 27.3 mt-10 -150.49 131.21 14.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.157 -1.383 . . . . 0.0 114.013 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.7 m -94.66 130.23 41.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.004 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -135.09 174.81 10.19 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.19 2.196 . . . . 0.0 108.755 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.254 0.0 OUTLIER -135.42 169.21 17.85 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.614 1.166 . . . . 0.0 113.244 178.016 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 115.854 -2.022 . . . . 0.0 114.315 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.989 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.292 51.5 t -101.98 148.74 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.237 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.3 t -151.63 130.62 12.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -98.25 157.4 16.19 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m -82.17 155.82 24.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 110.501 -3.045 . . . . 0.0 107.511 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.18 -21.36 47.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.745 1.157 . . . . 0.0 113.168 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.2 p -106.96 -10.04 16.08 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.693 2.797 . . . . 0.0 115.519 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.458 1.0 OUTLIER 40.92 2.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 1 C-N-CA 134.705 5.202 . . . . 0.0 119.17 -177.425 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 67.31 0.14 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 126.84 2.162 . . . . 0.0 112.012 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.37 -16.05 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 124.484 3.456 . . . . 0.0 116.743 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -115.57 -20.69 10.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 119.366 0.985 . . . . 0.0 113.444 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.91 147.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.83 1.252 . . . . 0.0 110.921 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.4 111.49 1.25 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.441 1.496 . . . . 0.0 113.179 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -156.96 70.33 0.27 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.84 0.733 . . . . 0.0 113.25 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -49.45 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 1 C-N-CA 134.16 4.984 . . . . 0.0 120.432 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.5 p -131.32 174.0 10.5 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 128.884 2.874 . . . . 0.0 113.905 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.252 27.2 mt -73.0 75.78 1.19 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.775 1.23 . . . . 0.0 112.26 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.3 p -81.38 -17.42 49.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.43 3.492 . . . . 0.0 112.207 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.3 176.58 25.61 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.262 2.363 . . . . 0.0 111.04 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -141.64 137.88 32.13 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.252 3.2 p -97.2 136.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 124.174 1.94 . . . . 0.0 106.178 176.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -123.45 128.75 50.26 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 131.012 3.725 . . . . 0.0 103.059 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.3 m -100.27 158.49 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.353 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.44 -36.81 1.57 Allowed Glycine 0 CA--C 1.556 2.653 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.259 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.8 t 177.43 167.92 0.63 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 130.41 3.484 . . . . 0.0 110.607 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.11 156.78 33.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.574 1.95 . . . . 0.0 113.435 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 132.87 48.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.641 1.976 . . . . 0.0 110.257 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -28.18 -50.84 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.841 3.256 . . . . 0.0 118.15 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.79 5.56 54.0 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -101.41 174.61 5.9 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.436 1.118 . . . . 0.0 111.741 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -150.47 167.35 27.4 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.024 -1.048 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -66.25 114.11 5.08 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 125.092 1.357 . . . . 0.0 113.404 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.5 p -94.69 5.54 51.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.663 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -151.85 171.39 17.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.135 -0.978 . . . . 0.0 112.944 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.67 -51.9 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.286 1.434 . . . . 0.0 111.066 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.53 -170.57 3.17 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.531 1.532 . . . . 0.0 108.291 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -144.32 -62.78 0.37 Allowed 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 119.364 -2.085 . . . . 0.0 109.68 177.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.34 175.2 0.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -48.77 -39.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 131.186 3.794 . . . . 0.0 114.166 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -143.89 -49.55 0.3 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.686 3.194 . . . . 0.0 111.846 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -74.57 -166.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 133.426 4.691 . . . . 0.0 115.989 -177.135 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.523 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 25.4 mt-10 -150.89 130.92 13.41 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.25 136.87 33.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.178 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.91 169.22 19.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.521 1.928 . . . . 0.0 107.582 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -135.81 168.17 19.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.739 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 129.231 3.012 . . . . 0.0 110.687 177.449 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 46.5 t -128.96 148.5 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 118.696 -0.669 . . . . 0.0 109.921 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.1 t -152.18 132.68 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.25 2.3 ptp180 -98.89 158.55 15.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -85.22 169.58 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.589 3.156 . . . . 0.0 112.528 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -60.01 -18.82 48.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -123.33 -18.29 6.3 Favored 'General case' 0 C--N 1.32 -0.682 1 C-N-CA 132.162 4.185 . . . . 0.0 114.463 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.503 5.2 p-10 46.23 17.86 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 130.44 3.496 . . . . 0.0 116.105 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.49 66.91 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 129.687 3.517 . . . . 0.0 111.423 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.31 -2.13 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.518 3.479 . . . . 0.0 116.959 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -135.38 -32.75 0.92 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -153.26 -170.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.19 1.796 . . . . 0.0 111.201 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.62 114.89 1.39 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.669 1.988 . . . . 0.0 111.903 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.73 6.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.631 1.586 . . . . 0.0 111.751 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.92 -25.65 1.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.658 1.983 . . . . 0.0 113.255 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.7 p -134.0 167.16 21.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.879 2.072 . . . . 0.0 112.107 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.5 mt -56.1 66.01 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.244 3.018 . . . . 0.0 117.642 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 t -79.38 5.37 12.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.887 1.675 . . . . 0.0 112.743 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.68 171.3 14.94 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.209 2.337 . . . . 0.0 108.776 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -140.39 138.67 34.97 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.9 p -96.99 139.25 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 123.943 1.83 . . . . 0.0 106.405 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.65 112.3 16.63 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 129.724 3.21 . . . . 0.0 103.479 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.74 143.56 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.103 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 -51.48 4.11 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 178.33 164.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 128.943 2.897 . . . . 0.0 113.978 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.8 155.51 22.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.287 2.635 . . . . 0.0 116.66 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.21 135.03 47.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.966 1.706 . . . . 0.0 110.354 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 m -39.18 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 1 C-N-CA 132.174 4.19 . . . . 0.0 120.643 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.21 1.27 7.71 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.971 1.272 . . . . 0.0 114.84 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.39 179.04 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.21 1.404 . . . . 0.0 110.303 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -149.24 165.46 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.09 -1.006 . . . . 0.0 109.864 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.73 114.59 3.39 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.422 1.089 . . . . 0.0 112.205 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 26.5 p -92.96 10.31 31.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.19 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -163.11 170.6 17.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.1 -53.47 17.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.621 1.568 . . . . 0.0 111.959 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -80.0 -177.51 6.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.017 2.927 . . . . 0.0 110.129 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.8 -65.67 0.36 Allowed 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 119.484 -2.01 . . . . 0.0 109.945 177.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.46 175.0 0.59 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -49.46 -37.02 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 1 C-N-CA 131.713 4.005 . . . . 0.0 114.426 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.15 -49.52 0.21 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 129.983 3.313 . . . . 0.0 111.501 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -167.3 0.41 Allowed 'General case' 0 N--CA 1.443 -0.814 1 C-N-CA 131.711 4.004 . . . . 0.0 116.475 -177.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.1 mt-10 -148.41 130.8 15.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.06 137.5 32.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.75 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.9 m -149.14 170.26 18.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 108.692 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.89 173.48 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.534 1.534 . . . . 0.0 112.832 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 128.947 2.899 . . . . 0.0 109.896 176.583 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.272 48.5 t -103.94 147.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.36 0.664 . . . . 0.0 109.468 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.9 t -157.1 111.89 2.76 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -72.82 175.8 6.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.305 1.442 . . . . 0.0 113.995 -178.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.21 174.32 7.46 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.448 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.57 -47.71 66.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 10' ' ' GLY . 45.7 t -99.01 -28.2 13.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.832 0.853 . . . . 0.0 112.88 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.368 0.7 OUTLIER 58.2 -23.84 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 130.975 3.71 . . . . 0.0 117.118 -176.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 8' ' ' SER . . . -58.78 -72.59 0.58 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 127.487 2.47 . . . . 0.0 117.088 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.61 -3.21 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.179 3.253 . . . . 0.0 114.288 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -93.84 -21.54 19.21 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 p -175.07 152.2 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.327 1.051 . . . . 0.0 111.781 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -73.03 79.18 1.2 Allowed 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.584 -1.323 . . . . 0.0 113.312 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 17' ' ' THR . . . 124.22 143.31 6.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.444 1.973 . . . . 0.0 113.565 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -51.07 8.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 1 C-N-CA 132.632 4.373 . . . . 0.0 120.37 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' H ' ' C ' ' A' ' 15' ' ' GLY . 68.3 p -66.82 146.79 54.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 131.008 3.723 . . . . 0.0 115.352 -177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD2' ' H ' ' A' ' 5' ' ' ARG 0.269 74.1 mt -78.66 54.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.548 -2.115 . . . . 0.0 114.116 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -71.85 -27.23 62.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.61 155.61 48.65 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 104.467 -3.453 . . . . 0.0 104.467 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.1 m -140.49 143.55 35.54 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 120.766 -1.432 . . . . 0.0 113.35 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.278 3.5 p -97.17 136.28 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 124.577 2.132 . . . . 0.0 107.984 176.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -122.33 122.17 38.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 108.867 -3.788 . . . . 0.0 102.851 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.27 139.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.944 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.47 -19.53 10.79 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.544 -1.142 . . . . 0.0 114.402 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 166.35 153.97 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 130.491 3.516 . . . . 0.0 111.884 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -66.49 154.94 38.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.123 2.169 . . . . 0.0 112.198 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 133.54 49.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.358 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -35.7 -28.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 131.185 3.794 . . . . 0.0 120.155 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.32 3.37 12.55 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.17 1.366 . . . . 0.0 114.839 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -99.77 177.64 5.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.976 1.31 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -150.27 163.82 37.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -61.25 120.04 9.6 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.432 1.093 . . . . 0.0 112.443 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.41 2.47 55.77 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.557 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -151.66 165.56 33.96 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 119.705 1.139 . . . . 0.0 110.767 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -43.34 89.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.459 1.123 . . . . 0.0 112.675 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.36 -173.99 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 109.597 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.476 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -142.81 -68.8 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 119.543 -1.973 . . . . 0.0 111.957 -177.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.06 175.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.24 1.816 . . . . 0.0 114.152 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tp -47.95 -37.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 1 C-N-CA 132.109 4.163 . . . . 0.0 115.444 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.99 -42.16 0.15 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.463 3.105 . . . . 0.0 112.896 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -82.39 -169.64 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.909 3.284 . . . . 0.0 116.141 -176.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.4 mt-10 -149.46 124.56 10.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.226 177.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.34 110.77 20.47 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.278 1.431 . . . . 0.0 110.096 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -114.91 171.72 7.48 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.306 1.442 . . . . 0.0 108.531 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 168.17 19.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.674 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 129.938 3.295 . . . . 0.0 110.137 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.539 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.274 47.3 t -107.36 150.57 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.923 0.889 . . . . 0.0 109.274 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.1 t -152.89 121.07 6.21 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.25 2.1 ptp180 -73.62 172.55 11.19 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.414 1.886 . . . . 0.0 115.6 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.0 m -109.41 169.81 8.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.663 2.385 . . . . 0.0 111.703 -177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -52.86 -33.7 50.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.768 1.627 . . . . 0.0 114.908 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -127.55 64.24 1.35 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.492 2.717 . . . . 0.0 109.196 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.73 -24.01 0.5 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.622 1.969 . . . . 0.0 115.586 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 69.49 0.9 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 122.168 3.627 . . . . 0.0 122.168 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.03 -30.28 47.83 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.512 2.808 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 t -87.95 2.81 50.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.87 168.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -51.63 -37.19 49.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.121 2.168 . . . . 0.0 114.802 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.49 35.41 3.02 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -65.17 24.48 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 129.944 3.298 . . . . 0.0 117.164 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -134.09 178.0 7.3 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.419 2.288 . . . . 0.0 112.673 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.51 65.3 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.108 2.163 . . . . 0.0 114.249 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -73.95 -27.14 60.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.645 2.778 . . . . 0.0 109.375 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.19 165.55 45.22 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -140.72 142.09 34.85 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.301 -1.117 . . . . 0.0 113.527 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.539 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.275 3.2 p -100.25 136.12 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 124.465 2.079 . . . . 0.0 106.928 176.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -126.62 124.93 41.03 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 131.634 3.974 . . . . 0.0 102.422 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.41 HG11 ' CE1' ' A' ' 42' ' ' TYR . 1.5 m -93.16 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.005 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.77 -61.16 3.7 Favored Glycine 0 CA--C 1.554 2.529 0 C-N-CA 119.241 -1.456 . . . . 0.0 110.76 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 t -158.95 158.77 33.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 128.295 2.638 . . . . 0.0 112.234 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -68.45 158.98 32.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.37 1.868 . . . . 0.0 112.688 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.89 42.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.905 2.482 . . . . 0.0 111.146 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 p -20.84 -63.22 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.552 3.541 . . . . 0.0 118.57 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.05 9.9 67.88 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.035 1.574 . . . . 0.0 117.035 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -101.6 174.11 6.12 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.374 1.087 . . . . 0.0 110.825 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -149.99 168.0 25.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.861 -1.149 . . . . 0.0 110.551 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -60.42 111.45 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.918 1.687 . . . . 0.0 112.496 177.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 16.8 p -93.46 10.69 31.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -159.61 165.95 31.7 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.587 1.155 . . . . 0.0 110.556 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.79 -36.28 80.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.04 1.336 . . . . 0.0 112.657 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -102.2 -175.14 2.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.254 2.622 . . . . 0.0 110.191 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.418 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -136.95 -68.16 0.49 Allowed 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 119.538 -1.976 . . . . 0.0 110.137 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.4 174.22 1.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.44 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.4 tp -46.09 -42.42 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 1 C-N-CA 132.122 4.169 . . . . 0.0 114.338 176.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.44 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -144.01 -44.32 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 130.823 3.649 . . . . 0.0 111.951 -176.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -79.04 -166.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 130.54 3.536 . . . . 0.0 116.087 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 15.9 mt-10 -152.11 127.22 9.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.806 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -91.13 136.07 33.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.995 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -142.18 167.78 21.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.738 2.015 . . . . 0.0 108.849 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.265 0.0 OUTLIER -130.04 165.83 21.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.11 179.82 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 C-N-CA 129.456 3.102 . . . . 0.0 112.234 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.537 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.259 56.4 t -121.08 147.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.392 0.596 . . . . 0.0 110.386 -177.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.9 t -151.74 125.8 9.2 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -95.22 175.61 6.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.851 1.31 . . . . 0.0 113.317 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.4 p -123.67 174.84 7.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.09 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.73 -30.9 46.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.495 1.918 . . . . 0.0 115.182 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -96.5 -18.56 19.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.048 2.139 . . . . 0.0 113.709 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.306 0.9 OUTLIER 39.7 27.19 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.247 3.419 . . . . 0.0 115.7 -177.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.83 70.75 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.31 -20.68 26.15 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.289 3.326 . . . . 0.0 115.866 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.1 p -114.33 -34.05 5.42 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.99 2.116 . . . . 0.0 110.835 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -174.43 138.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 127.929 2.492 . . . . 0.0 107.153 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 14' ' ' HIS . 19.0 p80 -84.25 161.29 20.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.87 2.468 . . . . 0.0 114.966 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 28.66 0.02 OUTLIER Glycine 0 N--CA 1.473 1.103 0 N-CA-C 117.341 1.696 . . . . 0.0 117.341 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 52.88 48.65 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 129.257 3.023 . . . . 0.0 115.058 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.0 p -121.29 156.53 32.34 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.784 1.754 . . . . 0.0 113.994 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 20' ' ' GLY 0.306 28.4 mt -81.59 53.8 2.21 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.386 1.474 . . . . 0.0 112.918 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -76.93 29.53 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.072 2.149 . . . . 0.0 110.479 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . -142.5 173.05 24.07 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 130.168 3.747 . . . . 0.0 108.381 177.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -148.15 139.67 23.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.482 -1.01 . . . . 0.0 111.448 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.275 2.5 p -98.24 131.04 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 124.338 2.018 . . . . 0.0 105.774 176.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -115.2 124.29 51.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 109.114 -3.675 . . . . 0.0 103.337 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 42' ' ' TYR . 1.6 m -92.67 161.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.38 -59.67 4.78 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -178.54 166.72 1.8 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.379 3.471 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.85 157.01 35.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.548 2.339 . . . . 0.0 117.258 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 129.66 39.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.96 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -34.71 -31.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 131.28 3.832 . . . . 0.0 119.713 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.14 29.57 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.754 1.169 . . . . 0.0 115.638 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -104.3 174.4 5.89 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.998 1.319 . . . . 0.0 111.463 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -151.56 167.98 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.201 -0.937 . . . . 0.0 111.368 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -69.23 110.54 4.64 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 113.724 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.5 t -84.88 -2.98 58.48 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.196 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -156.72 165.63 35.7 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.863 -1.148 . . . . 0.0 111.205 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -73.97 -26.25 60.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -101.56 175.06 5.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.661 1.584 . . . . 0.0 109.876 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -139.76 -62.62 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.689 -1.882 . . . . 0.0 110.629 -177.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.62 177.27 0.2 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.953 1.701 . . . . 0.0 115.132 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -51.46 -35.73 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 131.658 3.983 . . . . 0.0 114.092 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.55 -44.73 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 130.362 3.465 . . . . 0.0 112.986 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.414 ' CE2' HG13 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -73.85 -169.83 0.8 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.909 3.284 . . . . 0.0 113.9 -177.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 17.3 mt-10 -148.42 129.3 14.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.874 1.321 . . . . 0.0 114.498 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.4 132.06 34.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.76 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.6 m -142.34 173.57 11.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.085 1.754 . . . . 0.0 108.262 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -137.91 166.72 23.34 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 129.715 3.206 . . . . 0.0 113.129 177.444 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 22' ' ' VAL . 87.5 t -130.41 132.14 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.477 ' CB ' HG23 ' A' ' 22' ' ' VAL . 48.0 t -153.78 125.55 7.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -89.56 164.07 14.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.97 1.367 . . . . 0.0 112.825 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.92 159.64 26.28 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.386 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.4 -12.15 13.19 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.0 p -113.62 -14.09 12.67 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.744 2.018 . . . . 0.0 114.451 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.344 0.5 OUTLIER 43.29 -8.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 1 C-N-CA 135.881 5.672 . . . . 0.0 118.466 -177.474 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.89 70.97 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.97 0 O-C-N 121.155 -0.966 . . . . 0.0 112.9 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.27 -20.03 53.23 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.418 3.412 . . . . 0.0 116.478 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -105.23 -38.08 6.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 127.866 2.466 . . . . 0.0 110.015 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.72 131.97 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.874 1.269 . . . . 0.0 110.093 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -41.16 125.37 2.45 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.318 2.247 . . . . 0.0 114.13 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.53 70.59 0.41 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 117.463 1.745 . . . . 0.0 117.463 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -27.84 62.12 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.676 1.226 . . . . 0.0 112.12 177.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -71.08 118.75 14.24 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 129.049 2.939 . . . . 0.0 111.209 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.296 18.0 mt -60.77 66.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.945 2.898 . . . . 0.0 115.487 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -75.48 -14.53 60.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.763 2.025 . . . . 0.0 110.451 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.26 174.14 33.57 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.8 m -155.74 148.04 23.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 119.553 -2.145 . . . . 0.0 112.581 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER -92.57 140.66 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 126.79 2.036 . . . . 0.0 109.368 177.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -132.44 109.59 9.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.02 160.42 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.852 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.44 -62.72 4.28 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -177.96 165.0 1.94 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 130.799 3.64 . . . . 0.0 112.089 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -51.7 151.74 3.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 129.607 3.163 . . . . 0.0 117.786 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 135.52 48.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.197 1.799 . . . . 0.0 110.89 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.77 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 131.433 3.893 . . . . 0.0 119.208 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.1 8.63 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 125.954 1.74 . . . . 0.0 116.773 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -101.27 177.26 4.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -151.03 165.48 33.65 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 121.54 -0.725 . . . . 0.0 110.32 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.6 mptm? -64.1 121.7 14.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.26 1.024 . . . . 0.0 113.643 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.35 4.07 53.77 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.403 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -158.48 170.07 23.03 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 120.462 1.483 . . . . 0.0 114.049 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.5 -29.61 56.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -101.85 178.44 4.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 107.942 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.509 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.82 -64.4 0.38 Allowed 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 119.719 -1.863 . . . . 0.0 109.452 -177.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.49 171.41 0.44 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.977 2.111 . . . . 0.0 113.862 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.9 tp -50.7 -38.44 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 131.024 3.73 . . . . 0.0 114.776 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.72 -48.0 0.75 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 129.502 3.121 . . . . 0.0 113.309 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CD2' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -85.78 -168.17 2.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 129.908 3.283 . . . . 0.0 116.25 -177.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 60.1 mt-10 -142.95 135.6 27.7 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.417 -2.174 . . . . 0.0 112.328 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -93.74 129.03 40.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.15 1.38 . . . . 0.0 109.565 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.3 m -135.27 171.82 13.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.92 1.288 . . . . 0.0 108.237 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HE2' ' C ' ' A' ' 46' ' ' LYS 0.253 0.0 OUTLIER -135.05 165.76 24.61 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.53 177.585 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.246 1.818 . . . . 0.0 114.079 177.315 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.301 57.5 t -145.99 152.64 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.066 1.346 . . . . 0.0 110.593 -177.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t -151.38 133.51 15.21 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -83.43 177.84 8.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.065 1.346 . . . . 0.0 113.238 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.5 m -106.88 169.99 8.21 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.507 1.923 . . . . 0.0 108.867 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.75 -54.38 15.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 t -87.08 1.51 52.71 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.4 2.5 p-10 36.27 34.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 130.544 3.538 . . . . 0.0 116.696 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.95 59.56 0.25 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 116.962 1.545 . . . . 0.0 116.962 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.72 -17.32 13.08 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.075 3.183 . . . . 0.0 116.211 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 m 60.68 64.37 1.18 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 131.81 4.044 . . . . 0.0 119.181 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.92 -47.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -75.98 -54.97 6.07 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 131.65 3.98 . . . . 0.0 116.29 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.72 -169.34 42.01 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 127.023 2.249 . . . . 0.0 111.834 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.92 4.28 44.92 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -136.4 -172.09 3.06 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.11 2.564 . . . . 0.0 112.149 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt -55.18 53.98 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.65 3.58 . . . . 0.0 116.824 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 t -69.58 -15.11 63.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.785 0.834 . . . . 0.0 111.078 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.3 173.59 55.25 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -153.29 143.66 22.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 118.914 -2.521 . . . . 0.0 113.017 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.291 2.6 p -99.78 132.3 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-O 124.434 2.064 . . . . 0.0 107.265 176.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -121.26 110.5 16.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 109.134 -3.666 . . . . 0.0 103.739 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 42' ' ' TYR . 1.5 m -80.95 160.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.586 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -55.11 4.8 Favored Glycine 0 CA--C 1.552 2.385 0 C-N-CA 118.234 -1.936 . . . . 0.0 109.337 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.2 t 175.52 164.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.133 3.773 . . . . 0.0 113.265 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.35 151.28 44.36 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 127.922 2.489 . . . . 0.0 116.382 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.79 53.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.487 1.915 . . . . 0.0 111.332 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -32.0 -17.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 1 C-N-CA 134.298 5.039 . . . . 0.0 121.253 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.81 10.2 2.6 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 125.466 1.507 . . . . 0.0 115.274 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -99.71 178.6 4.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.105 0.962 . . . . 0.0 110.735 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -147.98 168.13 23.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.325 -0.859 . . . . 0.0 110.83 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -63.35 109.34 1.56 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.58 177.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 46' ' ' LYS . 8.4 t -86.21 -3.35 58.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.027 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -150.51 165.43 33.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.084 1.354 . . . . 0.0 110.882 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.4 -47.69 69.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.327 1.051 . . . . 0.0 112.923 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.62 -176.37 6.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 128.509 2.723 . . . . 0.0 109.57 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.8 -70.43 0.42 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 119.645 -1.909 . . . . 0.0 108.493 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.98 177.12 2.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 114.438 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -44.55 -38.5 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 131.354 3.862 . . . . 0.0 113.349 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' ' 40' ' ' ILE . . . -148.21 -52.67 0.18 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 130.407 3.483 . . . . 0.0 111.321 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.416 ' CE2' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -65.8 -170.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.888 1 C-N-CA 131.859 4.063 . . . . 0.0 113.889 -177.107 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 13.6 mt-10 -147.6 125.54 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 87.0 m -89.78 135.17 33.79 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.021 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.3 m -142.86 173.65 11.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.686 2.394 . . . . 0.0 106.829 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -139.11 170.3 16.21 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.218 1.007 . . . . 0.0 110.384 177.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.325 2.25 . . . . 0.0 110.015 176.546 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.471 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.569 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 38.2 t -113.01 142.99 23.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.672 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -149.63 132.2 15.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -96.72 158.52 15.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 122.721 1.248 . . . . 0.0 114.322 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m -82.25 -179.83 7.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.723 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -35.16 76.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.053 2.141 . . . . 0.0 111.626 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.2 t -116.2 53.63 0.86 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.011 1.724 . . . . 0.0 109.519 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -57.42 -29.33 64.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.1 66.38 0.03 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.841 1.686 . . . . 0.0 115.328 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.75 -10.53 27.95 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.756 2.971 . . . . 0.0 117.752 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -146.15 22.42 1.37 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 p -161.39 168.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 127.153 2.181 . . . . 0.0 108.304 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -71.47 119.45 15.63 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.536 -1.352 . . . . 0.0 112.787 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.55 138.14 27.0 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 17' ' ' THR . 5.9 p-10 -98.0 -74.47 0.58 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.096 0.959 . . . . 0.0 112.752 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 74.5 p -152.33 170.37 20.22 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.5 mt -73.79 63.93 0.92 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.294 2.638 . . . . 0.0 111.393 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -68.19 -25.78 65.4 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.078 1.351 . . . . 0.0 108.73 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.61 160.09 48.72 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.7 m -141.27 141.38 33.96 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.298 -1.119 . . . . 0.0 111.709 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.569 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.4 p -94.72 137.29 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 124.399 2.047 . . . . 0.0 107.01 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -121.32 119.75 33.08 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 110.304 -3.135 . . . . 0.0 103.89 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -90.46 144.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.546 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.46 -35.47 2.23 Favored Glycine 0 CA--C 1.555 2.557 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.301 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t 175.77 152.69 0.15 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.067 2.947 . . . . 0.0 112.503 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.73 160.68 11.29 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.593 1.957 . . . . 0.0 111.385 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.79 132.34 38.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.316 1.446 . . . . 0.0 109.393 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -28.12 -50.33 0.07 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 130.045 3.338 . . . . 0.0 117.732 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 3.59 61.49 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.08 1.592 . . . . 0.0 117.08 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -101.62 -179.23 3.96 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.723 1.262 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -151.84 163.81 38.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 121.149 -0.969 . . . . 0.0 109.41 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.7 mptm? -61.06 118.66 7.06 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 112.973 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 46' ' ' LYS . 5.2 t -92.29 5.13 51.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.057 176.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -157.51 168.65 26.69 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-N 120.563 1.529 . . . . 0.0 113.097 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.51 -48.17 73.45 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.489 1.515 . . . . 0.0 112.561 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -88.58 -177.94 5.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.991 2.116 . . . . 0.0 108.14 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.428 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.21 -59.85 0.38 Allowed 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 118.76 -2.462 . . . . 0.0 110.635 -177.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 172.44 175.45 0.09 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.135 2.174 . . . . 0.0 113.959 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.9 tp -49.05 -38.21 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 130.872 3.669 . . . . 0.0 114.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.53 -52.64 0.35 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 129.665 3.186 . . . . 0.0 111.936 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -169.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.744 1 C-N-CA 132.137 4.175 . . . . 0.0 116.347 -177.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 28.1 mt-10 -148.74 128.47 13.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.24 115.39 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.758 1.223 . . . . 0.0 111.112 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.3 m -124.39 167.64 14.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.786 1.279 . . . . 0.0 107.776 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.96 168.88 18.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.098 -179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 128.212 2.605 . . . . 0.0 113.507 177.246 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 48.5 t -135.05 148.26 29.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.9 t -152.64 116.9 4.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.455 ' H ' ' CD2' ' A' ' 18' ' ' LEU 0.294 0.0 OUTLIER -91.12 175.0 7.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.851 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 5' ' ' ARG . 1.4 p -115.98 -179.28 3.61 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.925 2.49 . . . . 0.0 112.632 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.11 -53.86 46.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.802 0.811 . . . . 0.0 109.225 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 t -88.63 43.55 1.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.591 1.157 . . . . 0.0 111.142 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -41.71 -41.83 2.39 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.795 1.638 . . . . 0.0 112.681 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.1 60.46 0.03 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 125.61 1.576 . . . . 0.0 116.739 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -63.28 -16.04 52.02 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.386 3.391 . . . . 0.0 117.695 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -69.73 -22.56 63.37 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.99 -157.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.113 2.165 . . . . 0.0 111.02 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.88 82.22 2.16 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 112.1 177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 109.05 2.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.81 -15.14 0.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 117.003 2.224 . . . . 0.0 117.003 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.4 p -130.79 154.14 48.32 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 124.228 1.966 . . . . 0.0 115.652 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 5' ' ' ARG . 25.5 mt -70.82 63.11 0.29 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.558 2.743 . . . . 0.0 116.629 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -68.96 -11.96 61.2 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.231 0.613 . . . . 0.0 111.656 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.92 175.1 41.46 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.353 1.93 . . . . 0.0 110.49 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -149.48 142.72 25.11 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.16 -1.788 . . . . 0.0 113.219 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.6 p -101.32 137.99 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 124.119 1.914 . . . . 0.0 106.291 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -125.16 119.14 27.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 130.88 3.672 . . . . 0.0 103.181 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 m -87.18 161.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.455 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.34 -63.45 3.93 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.076 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 p -162.16 161.04 27.85 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.188 2.595 . . . . 0.0 113.05 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -61.57 160.99 10.35 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.787 1.279 . . . . 0.0 113.653 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.07 133.08 39.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.945 2.098 . . . . 0.0 110.153 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.7 p -18.87 -65.77 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 130.716 3.607 . . . . 0.0 117.894 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 9.48 70.6 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.802 1.668 . . . . 0.0 116.896 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -99.25 174.8 6.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.433 1.116 . . . . 0.0 111.024 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -149.95 168.72 23.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.805 -1.184 . . . . 0.0 111.034 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -67.77 112.8 5.05 Favored 'General case' 0 CA--C 1.511 -0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 113.053 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 22.2 t -88.02 -1.71 58.16 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.862 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -157.79 167.69 29.31 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.093 -1.004 . . . . 0.0 111.498 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.63 -33.48 68.98 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.6 177.21 5.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 110.627 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.24 -64.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 119.708 -1.87 . . . . 0.0 110.487 -177.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 174.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.154 1.781 . . . . 0.0 115.046 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.1 tp -47.59 -42.35 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 131.026 3.73 . . . . 0.0 113.884 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -141.91 -46.55 0.35 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 130.708 3.603 . . . . 0.0 112.827 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -74.4 -169.16 0.77 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 130.024 3.329 . . . . 0.0 115.447 -177.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.4 mt-10 -148.04 126.34 12.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 123.309 1.528 . . . . 0.0 114.263 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.76 132.25 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.467 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.4 m -143.42 170.79 15.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.517 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -136.0 167.83 20.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.784 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 129.059 2.944 . . . . 0.0 112.328 177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.317 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.297 66.2 t -148.32 151.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 110.471 -177.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.1 t -155.42 116.13 3.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 12.9 mtm180 -69.5 -175.6 0.86 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.922 2.296 . . . . 0.0 111.884 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 p -142.31 170.32 15.93 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 129.69 3.196 . . . . 0.0 110.309 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.14 -38.81 91.78 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.338 1.055 . . . . 0.0 109.064 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -93.35 25.53 3.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.617 2.767 . . . . 0.0 112.153 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -53.71 -20.15 5.1 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 121.036 1.744 . . . . 0.0 113.609 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.07 71.68 0.01 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.1 -16.87 48.71 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.114 2.543 . . . . 0.0 117.651 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.3 m -87.24 -16.94 33.75 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.85 137.42 5.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -38.01 106.23 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.888 1.675 . . . . 0.0 115.472 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.99 67.74 2.04 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.746 1.641 . . . . 0.0 114.091 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -61.5 -33.64 74.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.653 2.781 . . . . 0.0 112.296 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.1 p -140.16 155.75 46.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 124.03 1.871 . . . . 0.0 113.428 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 5.5 mt -61.87 83.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.749 3.62 . . . . 0.0 114.716 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -75.8 0.95 16.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.685 0.794 . . . . 0.0 111.448 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.36 162.83 12.27 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.235 2.826 . . . . 0.0 107.818 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.1 m -146.91 141.56 26.68 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.377 -1.661 . . . . 0.0 110.506 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.323 2.5 p -96.34 133.23 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 124.91 2.291 . . . . 0.0 108.541 176.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -121.46 112.71 18.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 109.343 -3.571 . . . . 0.0 104.213 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 42' ' ' TYR . 1.2 m -86.63 158.11 3.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 112.959 -1.928 . . . . 0.0 107.497 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.72 -50.5 3.28 Favored Glycine 0 CA--C 1.553 2.439 0 C-N-CA 119.127 -1.511 . . . . 0.0 112.071 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -178.32 160.61 1.34 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.294 3.438 . . . . 0.0 111.768 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.07 161.84 7.99 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.909 2.484 . . . . 0.0 114.664 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 145.57 40.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.735 2.014 . . . . 0.0 110.647 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -32.37 -54.72 0.33 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 119.482 3.142 . . . . 0.0 119.482 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.28 14.05 30.8 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 124.692 1.139 . . . . 0.0 115.204 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -96.95 173.31 7.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.66 0.743 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -151.0 166.83 29.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.38 124.97 22.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.613 0.765 . . . . 0.0 111.487 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.8 t -96.59 1.27 51.1 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.838 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.66 168.22 26.55 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 121.238 -0.914 . . . . 0.0 109.724 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -16.59 56.25 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -105.36 175.43 5.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.973 1.309 . . . . 0.0 108.181 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 119.901 -1.749 . . . . 0.0 109.972 -176.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.68 -178.57 0.16 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.707 2.003 . . . . 0.0 113.626 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -52.94 -38.16 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 131.501 3.921 . . . . 0.0 113.341 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' N ' ' CG2' ' A' ' 40' ' ' ILE . . . -149.51 -50.93 0.15 Allowed 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 130.505 3.522 . . . . 0.0 111.204 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -69.92 -172.38 0.52 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.33 3.452 . . . . 0.0 112.772 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -146.4 128.67 15.77 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 72.8 m -86.91 123.68 32.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.64 173.94 10.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.799 2.04 . . . . 0.0 107.562 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -138.12 172.67 12.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.871 2.869 . . . . 0.0 110.447 176.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.302 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.281 56.0 t -100.41 150.09 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.728 1.211 . . . . 0.0 109.73 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.4 t -159.16 112.69 2.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.47 ' HE ' HD23 ' A' ' 18' ' ' LEU . 59.1 mtm180 -69.91 -176.77 1.16 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 113.465 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p -133.87 177.29 7.84 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 129.888 3.275 . . . . 0.0 112.264 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.22 -48.77 77.96 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.689 1.196 . . . . 0.0 111.623 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -70.65 -30.43 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.38 1.472 . . . . 0.0 114.907 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 43.0 -11.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 1 C-N-CA 136.66 5.984 . . . . 0.0 119.685 -177.447 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.87 67.26 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 127.232 2.349 . . . . 0.0 112.623 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.93 -29.32 41.32 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.362 2.708 . . . . 0.0 114.86 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -130.39 10.96 5.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -159.1 155.76 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 126.472 1.909 . . . . 0.0 109.914 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -58.36 109.68 0.82 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.524 2.33 . . . . 0.0 113.56 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.53 89.79 1.03 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.04 0.828 . . . . 0.0 114.162 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -110.68 -34.3 6.32 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.68 1.192 . . . . 0.0 112.719 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.6 p -146.84 -177.92 5.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.45 2.7 . . . . 0.0 111.995 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.47 HD23 ' HE ' ' A' ' 5' ' ' ARG 0.252 17.2 mt -63.54 69.97 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 128.58 2.752 . . . . 0.0 117.216 -177.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.2 t -64.73 -30.68 71.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.426 1.49 . . . . 0.0 109.158 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.33 157.72 38.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.2 m -140.22 138.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 122.003 -0.704 . . . . 0.0 111.915 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.308 3.3 p -96.77 134.27 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-O 124.807 2.241 . . . . 0.0 108.103 176.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -119.64 122.02 40.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 108.994 -3.73 . . . . 0.0 103.73 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.3 m -96.74 156.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.6 -12.6 7.75 Favored Glycine 0 CA--C 1.557 2.695 0 C-N-CA 118.769 -1.681 . . . . 0.0 115.48 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 142.91 162.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 1 C-N-CA 135.985 5.714 . . . . 0.0 113.946 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -70.45 154.46 41.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.894 2.477 . . . . 0.0 115.35 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 131.78 46.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.251 1.82 . . . . 0.0 108.551 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -28.96 -63.62 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.296 2.638 . . . . 0.0 116.87 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.2 5.33 84.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -97.44 177.68 5.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.753 1.277 . . . . 0.0 111.074 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -152.3 166.07 32.97 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.2 mptm? -64.46 121.83 15.31 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.327 1.051 . . . . 0.0 113.103 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.7 t -91.25 0.03 57.6 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.157 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -160.73 166.89 27.94 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 119.83 1.196 . . . . 0.0 109.302 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -22.26 59.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.16 171.48 7.3 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.936 1.695 . . . . 0.0 108.832 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.32 -67.7 0.47 Allowed 'General case' 0 C--O 1.223 -0.32 0 O-C-N 120.187 -1.571 . . . . 0.0 110.161 -177.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.14 174.71 0.71 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 112.906 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.2 tp -48.13 -35.98 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 130.924 3.69 . . . . 0.0 115.046 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.27 -44.54 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 113.136 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.43 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -76.96 -171.22 1.9 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.07 2.948 . . . . 0.0 113.55 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mt-10 -148.85 120.69 8.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 81.0 m -83.66 104.14 13.54 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.594 1.558 . . . . 0.0 109.445 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.9 m -111.52 175.73 5.31 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.54 1.162 . . . . 0.0 108.937 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -139.46 173.89 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.246 0.904 0 C-N-CA 128.799 2.84 . . . . 0.0 109.622 176.82 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.533 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.302 55.1 t -125.9 151.81 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.052 1.341 . . . . 0.0 111.128 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -157.15 127.75 6.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -75.75 154.7 36.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 123.973 1.844 . . . . 0.0 114.369 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.1 m -89.13 166.53 13.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 110.047 -3.251 . . . . 0.0 108.995 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.0 -46.1 92.14 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.609 -1.307 . . . . 0.0 112.228 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -95.79 43.75 1.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.94 1.696 . . . . 0.0 110.529 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -38.34 -35.68 0.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.677 2.791 . . . . 0.0 116.511 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.34 -84.63 0.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.39 -7.4 0.78 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.149 3.233 . . . . 0.0 115.041 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.98 -24.92 52.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.124 0.874 . . . . 0.0 111.293 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.08 143.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 122.992 1.377 . . . . 0.0 113.059 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -2.42 0.41 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 128.069 2.548 . . . . 0.0 116.486 -177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.89 117.83 0.91 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.08 2.752 . . . . 0.0 109.629 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -53.98 -11.53 0.45 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.8 t -58.5 162.62 3.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.488 1.515 . . . . 0.0 113.092 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.6 mt -66.73 61.2 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.819 2.447 . . . . 0.0 116.972 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t -66.52 -37.19 84.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.504 1.922 . . . . 0.0 109.57 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.07 46.88 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 m -135.92 134.51 38.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 120.745 -1.444 . . . . 0.0 113.098 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 3.5 p -93.37 137.37 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 124.316 2.008 . . . . 0.0 106.228 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -122.58 119.73 31.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 109.997 -3.274 . . . . 0.0 103.127 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.2 t -93.3 138.83 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.279 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -48.24 3.68 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -170.18 158.2 6.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.269 1.828 . . . . 0.0 114.251 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.0 161.42 18.72 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.327 1.537 . . . . 0.0 112.688 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 133.89 40.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.488 1.915 . . . . 0.0 109.346 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -34.96 -40.81 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.653 3.181 . . . . 0.0 118.801 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.61 4.14 39.79 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -100.41 177.59 4.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.012 1.325 . . . . 0.0 111.653 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -151.2 166.97 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.294 -0.879 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.75 118.7 7.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.632 1.573 . . . . 0.0 112.882 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.3 p -99.03 11.75 38.06 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.303 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.66 158.36 33.63 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 110.091 -177.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -25.25 59.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.588 0.709 . . . . 0.0 112.321 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.24 -169.86 1.75 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.108 2.563 . . . . 0.0 109.485 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -143.83 -65.26 0.37 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 119.114 -2.241 . . . . 0.0 112.436 177.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.68 176.8 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.1 tp -51.24 -40.03 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 1 C-N-CA 131.701 4.001 . . . . 0.0 113.977 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.17 -48.4 0.27 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.074 3.35 . . . . 0.0 111.405 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -164.73 0.43 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.014 4.126 . . . . 0.0 116.484 -177.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.2 mt-10 -148.62 129.73 14.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.506 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.55 134.43 34.13 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.981 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.32 169.81 16.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.941 1.696 . . . . 0.0 108.929 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.311 0.0 OUTLIER -134.62 168.27 19.29 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.722 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.084 1 C-N-CA 132.406 4.282 . . . . 0.0 109.447 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.293 67.4 t -142.61 151.19 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.947 1.699 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.92 122.1 5.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 40.0 mtm180 -73.31 -171.83 1.03 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.249 1.82 . . . . 0.0 113.568 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.2 p -151.35 -178.87 6.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.886 2.474 . . . . 0.0 114.072 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.72 -47.24 67.45 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.383 2.273 . . . . 0.0 112.451 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -91.69 -6.36 52.17 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.897 1.279 . . . . 0.0 113.908 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.484 0.2 OUTLIER 46.52 -14.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 136.149 5.78 . . . . 0.0 119.974 -177.436 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.67 65.35 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 127.221 2.343 . . . . 0.0 110.989 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -53.31 -16.2 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.594 4.196 . . . . 0.0 118.159 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 m -77.68 -21.87 51.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 125.488 1.515 . . . . 0.0 113.942 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.45 -151.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.468 1.507 . . . . 0.0 112.85 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -119.1 -11.48 9.62 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 129.231 3.012 . . . . 0.0 114.707 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.22 90.22 1.11 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.592 1.568 . . . . 0.0 116.445 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -56.76 69.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.522 3.529 . . . . 0.0 114.752 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.7 p -134.85 170.67 15.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.168 2.187 . . . . 0.0 115.175 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 32.2 mt -71.42 52.73 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.459 1.904 . . . . 0.0 114.152 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 m -69.88 -25.79 63.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.941 1.296 . . . . 0.0 108.373 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.75 170.66 55.04 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.8 m -148.99 142.82 25.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 119.534 -2.156 . . . . 0.0 112.148 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.257 2.8 p -98.33 135.64 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.535 2.112 . . . . 0.0 106.46 176.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -126.17 127.07 45.14 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.021 4.128 . . . . 0.0 102.403 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 m -97.61 159.72 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.46 -49.5 3.03 Favored Glycine 0 CA--C 1.557 2.71 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.3 t -169.33 169.02 9.34 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 129.741 3.216 . . . . 0.0 111.34 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.08 165.94 24.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.404 2.282 . . . . 0.0 113.632 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.7 142.82 35.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.881 1.672 . . . . 0.0 112.544 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -35.07 -8.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 C-N-CA 134.697 5.199 . . . . 0.0 122.236 -177.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.22 9.96 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.005 1.764 . . . . 0.0 114.807 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.75 177.92 5.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.044 1.338 . . . . 0.0 110.863 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -152.81 167.67 28.27 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.12 -0.987 . . . . 0.0 110.787 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -64.16 113.51 3.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.387 1.875 . . . . 0.0 111.557 177.174 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.9 t -87.84 1.7 53.28 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.31 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -158.9 167.25 29.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.622 1.569 . . . . 0.0 110.637 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.28 -42.51 79.44 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -89.37 177.73 6.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.378 2.271 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.27 -68.67 0.45 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 119.879 -1.763 . . . . 0.0 111.191 -177.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.43 170.72 0.78 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.07 1.748 . . . . 0.0 115.164 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' CG2' ' H ' ' A' ' 41' ' ' ALA . 6.5 tp -44.32 -44.22 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 1 C-N-CA 131.768 4.027 . . . . 0.0 115.214 176.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' H ' ' CG2' ' A' ' 40' ' ' ILE . . . -136.68 -48.19 0.62 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.989 3.315 . . . . 0.0 111.938 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -76.71 -165.25 0.51 Allowed 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.084 4.154 . . . . 0.0 116.54 -177.337 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 16.5 mt-10 -152.58 127.58 9.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.12 -1.855 . . . . 0.0 113.664 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 71.5 m -91.66 129.02 37.7 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -135.41 175.32 9.69 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.287 1.835 . . . . 0.0 108.303 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' A' ' 46' ' ' LYS 0.273 0.0 OUTLIER -138.96 173.17 11.84 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 177.586 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.101 4.56 . . . . 0.0 109.069 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.303 57.2 t -93.16 151.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.776 1.63 . . . . 0.0 110.07 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.2 t -148.83 137.36 21.18 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 43.6 mtm180 -66.49 178.67 1.19 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.325 2.25 . . . . 0.0 111.052 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.72 178.57 7.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.789 2.036 . . . . 0.0 112.357 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.65 -32.94 73.13 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 126.074 1.75 . . . . 0.0 113.113 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 t -118.05 48.01 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.156 1.782 . . . . 0.0 108.392 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.57 -27.19 57.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.99 64.91 0.03 OUTLIER Glycine 0 C--N 1.338 0.672 0 C-N-CA 124.919 1.247 . . . . 0.0 115.876 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.96 -24.33 53.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.321 2.681 . . . . 0.0 117.425 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -94.83 -22.95 17.71 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 119.781 1.173 . . . . 0.0 113.683 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.28 138.31 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.05 0.94 . . . . 0.0 111.944 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -57.75 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.813 2.045 . . . . 0.0 114.349 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.0 103.59 0.27 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.098 0.856 . . . . 0.0 113.267 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 54.37 2.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 124.462 2.077 . . . . 0.0 110.889 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 p -82.67 101.7 11.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 68.4 mt -77.15 44.89 0.42 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.278 2.231 . . . . 0.0 113.779 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -66.77 -29.91 69.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.02 0.928 . . . . 0.0 108.765 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.36 176.3 34.91 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.734 2.112 . . . . 0.0 108.102 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.0 m -151.34 139.24 19.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 119.046 -2.444 . . . . 0.0 112.92 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 5.0 p -96.1 135.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 124.247 1.975 . . . . 0.0 106.935 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -122.47 108.94 13.75 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 109.97 -3.286 . . . . 0.0 104.15 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG12 ' CE2' ' A' ' 42' ' ' TYR . 1.5 m -79.14 160.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 112.653 -2.067 . . . . 0.0 106.695 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.11 -49.15 4.06 Favored Glycine 0 CA--C 1.567 3.339 0 C-N-CA 118.672 -1.728 . . . . 0.0 109.766 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t 165.29 164.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 1 C-N-CA 134.011 4.924 . . . . 0.0 113.271 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.89 154.87 3.7 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 129.626 3.17 . . . . 0.0 117.119 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.36 43.13 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.864 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -29.91 -44.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.999 3.719 . . . . 0.0 118.571 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.74 8.72 34.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.439 1.495 . . . . 0.0 116.576 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -102.54 179.39 4.31 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.772 1.229 . . . . 0.0 111.048 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -149.1 160.82 42.99 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.069 -1.019 . . . . 0.0 109.777 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' NZ ' ' CD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -57.77 112.75 1.57 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.471 1.509 . . . . 0.0 112.26 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.2 p -85.1 5.08 31.21 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.246 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.09 165.46 33.81 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.275 0.943 . . . . 0.0 110.416 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.8 -35.85 75.2 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.893 0.746 . . . . 0.0 112.982 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.98 -175.77 4.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.069 2.148 . . . . 0.0 107.527 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.31 -67.2 0.33 Allowed 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 119.091 -2.256 . . . . 0.0 111.168 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.57 174.55 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.392 1.877 . . . . 0.0 112.354 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.0 tp -47.38 -32.38 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 130.765 3.626 . . . . 0.0 115.589 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.42 -42.45 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 128.797 2.839 . . . . 0.0 113.863 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.409 ' CE2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -78.22 -169.26 1.55 Allowed 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.939 3.296 . . . . 0.0 113.894 -176.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 53.1 mt-10 -150.65 123.45 8.64 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.38 117.41 25.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 123.403 1.573 . . . . 0.0 110.789 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.45 174.69 7.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.231 1.813 . . . . 0.0 109.514 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.334 0.0 OUTLIER -137.28 170.56 15.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 177.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.249 1.031 1 C-N-CA 132.651 4.38 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.0 t . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.56 174.0 11.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 113.854 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 127.262 2.225 . . . . 0.0 111.834 -177.175 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 4' ' ' CYS . 36.7 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -78.47 -13.5 59.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.123 1.769 . . . . 0.0 109.493 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.35 166.61 32.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 129.057 3.218 . . . . 0.0 106.89 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.5 m -145.82 145.9 30.95 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.194 -1.18 . . . . 0.0 113.347 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG21 ' HD2' ' A' ' 42' ' ' TYR . 3.2 p -100.23 136.2 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 124.341 2.019 . . . . 0.0 107.122 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -127.59 113.23 15.82 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 130.594 3.558 . . . . 0.0 102.563 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 42' ' ' TYR . 2.4 m -80.25 163.94 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.265 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -56.85 4.87 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t 177.09 170.04 0.54 Allowed 'General case' 0 N--CA 1.485 1.316 1 C-N-CA 131.922 4.089 . . . . 0.0 112.247 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.45 172.87 0.2 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 129.471 3.108 . . . . 0.0 116.927 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.7 140.81 29.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.547 1.939 . . . . 0.0 110.723 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -44.02 -12.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 1 C-N-CA 132.199 4.2 . . . . 0.0 120.915 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.12 2.87 5.16 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.063 1.316 . . . . 0.0 114.63 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -104.95 177.51 4.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.493 1.117 . . . . 0.0 110.983 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -150.37 169.53 21.21 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.618 -0.676 . . . . 0.0 110.87 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -64.44 118.16 8.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 113.461 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 30.3 p -95.53 7.18 47.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.58 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -159.26 167.1 29.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.502 1.121 . . . . 0.0 111.429 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -76.94 -32.8 57.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 122.13 0.967 . . . . 0.0 112.877 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -96.73 -175.88 3.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.053 1.741 . . . . 0.0 108.059 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.548 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.03 -66.82 0.37 Allowed 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 118.821 -2.424 . . . . 0.0 109.681 -178.239 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.98 171.7 0.84 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -45.39 -41.72 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 130.514 3.526 . . . . 0.0 114.756 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -140.42 -49.37 0.45 Allowed 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 129.924 3.29 . . . . 0.0 112.298 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.586 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.39 -166.67 0.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 130.775 3.63 . . . . 0.0 116.613 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.6 mt-10 -150.63 129.96 12.86 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.979 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 74.6 m -92.71 138.87 31.12 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.102 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.5 m -144.88 170.58 15.86 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 126.77 2.028 . . . . 0.0 108.466 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.98 168.03 19.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.245 0.864 0 C-N-CA 127.353 2.261 . . . . 0.0 113.493 177.767 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.6 t . . . . . 0 N--CA 1.442 -0.856 0 CA-C-O 120.8 0.333 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -75.77 -172.7 1.99 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 122.28 1.038 . . . . 0.0 113.463 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.8 m . . . . . 0 CA--C 1.544 0.741 0 C-N-CA 126.58 1.952 . . . . 0.0 112.079 -177.22 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 4' ' ' CYS . 87.2 mt . . . . . 0 CA--C 1.548 0.875 0 CA-C-O 120.628 0.251 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -74.18 52.24 0.45 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.355 2.662 . . . . 0.0 110.355 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.26 -173.99 37.35 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 129.092 3.234 . . . . 0.0 108.464 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.7 m -157.23 137.9 13.16 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.011 -1.876 . . . . 0.0 109.657 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 42' ' ' TYR . 4.4 p -93.67 137.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-O 124.414 2.054 . . . . 0.0 107.913 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.19 116.03 22.73 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 130.845 3.658 . . . . 0.0 103.509 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.682 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.9 t -87.09 143.38 11.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.463 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.06 -53.45 4.81 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 p -167.54 154.5 8.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.756 2.022 . . . . 0.0 115.179 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -59.63 151.34 25.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.491 1.916 . . . . 0.0 112.534 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.86 136.87 53.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.077 1.351 . . . . 0.0 109.745 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 p -24.53 -68.29 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.919 3.288 . . . . 0.0 117.191 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.42 9.84 75.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.12 1.819 . . . . 0.0 116.319 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.416 ' CD2' ' HB2' ' A' ' 47' ' ' GLN . 7.3 m95 -98.32 177.87 5.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.897 1.348 . . . . 0.0 110.798 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -148.9 161.85 41.03 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.254 -0.904 . . . . 0.0 109.108 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.0 mptm? -62.64 123.05 17.37 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 124.412 1.085 . . . . 0.0 112.399 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 28.4 p -98.27 9.57 42.7 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.764 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -158.8 169.58 24.05 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.277 0.944 . . . . 0.0 112.378 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.56 -52.08 24.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.331 1.052 . . . . 0.0 111.074 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -167.91 1.92 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -147.56 -57.95 0.25 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 119.506 -1.996 . . . . 0.0 110.575 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.91 175.87 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.359 2.664 . . . . 0.0 114.157 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.62 -39.43 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 1 C-N-CA 132.588 4.355 . . . . 0.0 115.97 176.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.47 -47.54 0.26 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 129.121 2.968 . . . . 0.0 112.191 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.682 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -77.25 -167.46 0.91 Allowed 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 131.708 4.003 . . . . 0.0 116.746 -177.034 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 84.1 mt-10 -149.8 124.01 9.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 65.5 m -88.46 114.45 25.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.426 1.091 . . . . 0.0 109.967 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.4 m -118.78 170.62 8.84 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.277 0.0 OUTLIER -132.18 168.75 17.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.975 177.882 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 31' ' ' TRP . 1.1 tt0 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 125.997 1.719 . . . . 0.0 112.949 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.266 0.555 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.541 ' HB3' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -94.28 161.34 14.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 123.403 1.573 . . . . 0.0 113.665 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . 0.315 57.2 m . . . . . 0 CA--C 1.553 1.073 0 CA-C-N 111.955 -2.384 . . . . 0.0 107.358 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.0 mt . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -69.39 -11.06 60.51 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.292 1.037 . . . . 0.0 111.82 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.64 -179.19 47.88 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -152.77 134.76 14.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 119.202 -2.352 . . . . 0.0 112.502 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.284 2.7 p -95.15 133.51 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 124.428 2.061 . . . . 0.0 105.691 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -121.0 130.22 53.71 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 130.859 3.664 . . . . 0.0 102.215 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -103.72 155.6 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.014 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.6 -35.32 2.26 Favored Glycine 0 CA--C 1.552 2.366 0 C-N-CA 118.406 -1.854 . . . . 0.0 113.567 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.6 p 175.95 167.71 0.41 Allowed 'General case' 0 CA--C 1.548 0.883 1 C-N-CA 132.073 4.149 . . . . 0.0 112.975 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -75.2 166.45 23.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.284 1.434 . . . . 0.0 110.222 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 136.74 36.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.784 2.034 . . . . 0.0 110.581 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -29.39 -55.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 129.739 3.216 . . . . 0.0 118.557 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.49 7.98 61.91 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -99.73 175.94 5.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.226 1.013 . . . . 0.0 111.298 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -147.86 167.1 25.65 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.756 -1.215 . . . . 0.0 109.229 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -63.36 115.3 4.47 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.404 1.082 . . . . 0.0 110.959 177.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.436 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 21.1 p -90.53 3.51 53.79 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.574 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -159.16 164.62 35.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.379 0.671 . . . . 0.0 112.293 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.58 -32.04 63.92 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -97.91 -176.05 3.33 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.562 1.945 . . . . 0.0 108.125 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.479 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.62 -65.43 0.37 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 118.717 -2.49 . . . . 0.0 111.289 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.24 177.39 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.723 1.725 . . . . 0.0 115.59 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -49.44 -40.49 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 131.1 3.76 . . . . 0.0 114.233 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.51 -47.1 0.19 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.263 3.425 . . . . 0.0 112.112 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -72.4 -167.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 131.684 3.994 . . . . 0.0 114.959 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -151.06 135.16 16.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.467 . . . . 0.0 114.916 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.5 138.99 30.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.348 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.1 m -145.12 168.38 20.48 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.323 2.249 . . . . 0.0 108.179 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.436 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.53 166.37 23.36 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.611 1.164 . . . . 0.0 112.375 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.944 0 C-N-CA 129.09 2.956 . . . . 0.0 113.07 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 CA--C 1.528 0.131 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.297 7.7 ptp180 -79.38 176.41 9.72 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.2 m . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 128.008 2.523 . . . . 0.0 111.532 -176.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 5' ' ' ARG . 15.2 mt . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -65.78 -30.6 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 110.07 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.22 54.54 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -145.61 143.99 30.19 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 119.809 -1.994 . . . . 0.0 110.768 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.5 p -95.1 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 123.483 1.611 . . . . 0.0 109.309 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.75 102.61 7.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 129.532 3.133 . . . . 0.0 106.73 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 42' ' ' TYR . 47.6 t -76.29 133.37 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 109.959 -3.291 . . . . 0.0 107.69 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.13 -9.92 75.0 Favored Glycine 0 CA--C 1.556 2.612 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.849 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 129.41 162.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 1 C-N-CA 135.949 5.7 . . . . 0.0 115.434 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.51 153.98 2.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.843 3.257 . . . . 0.0 118.209 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 131.19 41.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.64 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 m -39.61 -4.78 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 1 C-N-CA 132.945 4.498 . . . . 0.0 120.809 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.29 4.18 2.0 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 125.581 1.562 . . . . 0.0 115.431 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -99.68 -179.39 4.17 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.884 1.274 . . . . 0.0 111.288 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -149.74 159.69 44.15 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.646 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.1 mptm? -59.14 124.31 19.55 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.005 1.322 . . . . 0.0 112.539 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 31.0 p -97.26 6.73 47.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.507 1.754 . . . . 0.0 110.749 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -157.63 171.5 20.21 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 118.953 0.797 . . . . 0.0 110.369 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.61 -48.78 53.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.949 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.52 -177.88 6.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.142 2.977 . . . . 0.0 109.498 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.65 -68.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 119.405 -2.059 . . . . 0.0 112.431 -177.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.81 174.51 1.77 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.989 1.376 . . . . 0.0 114.55 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 1 C-N-CA 131.818 4.047 . . . . 0.0 115.321 176.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.24 -46.74 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.35 3.06 . . . . 0.0 112.291 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -79.82 -168.62 1.66 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.639 3.976 . . . . 0.0 115.714 -176.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.1 mt-10 -147.21 126.89 13.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.873 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -89.33 122.13 32.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.024 0.916 . . . . 0.0 109.718 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -128.17 170.3 13.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.144 1.378 . . . . 0.0 107.707 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.274 0.0 OUTLIER -133.65 169.1 17.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.505 -179.78 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 127.618 2.367 . . . . 0.0 111.073 176.608 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HB3' HD23 ' A' ' 18' ' ' LEU . 10.1 ptp85 -53.41 173.72 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 131.653 3.981 . . . . 0.0 115.847 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.442 -0.838 0 CA-C-N 112.189 -2.278 . . . . 0.0 106.074 176.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 5' ' ' ARG . 5.0 mt . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 p -69.08 -23.13 63.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.42 0.688 . . . . 0.0 110.326 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 163.19 41.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -144.63 142.26 30.0 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.4 -1.647 . . . . 0.0 110.444 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.456 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.267 3.0 p -99.03 138.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 124.394 2.045 . . . . 0.0 108.22 176.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -130.45 113.8 14.75 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 131.583 3.953 . . . . 0.0 102.34 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.9 m -79.64 160.84 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.206 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.36 -66.75 3.43 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.58 164.52 12.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.463 2.305 . . . . 0.0 114.187 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.02 154.27 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.972 2.909 . . . . 0.0 116.465 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.04 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.637 1.975 . . . . 0.0 109.452 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -38.81 -30.7 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.01 5.32 30.51 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.719 1.152 . . . . 0.0 115.755 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -106.9 177.39 4.87 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.367 1.084 . . . . 0.0 111.789 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -147.26 167.23 24.77 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.5 mptp? -66.2 114.21 5.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.052 0.93 . . . . 0.0 111.774 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -86.87 2.35 49.42 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.349 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -159.56 170.69 21.11 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.468 -0.77 . . . . 0.0 113.005 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -73.37 -42.05 62.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.577 1.551 . . . . 0.0 112.99 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 11.8 pt-20 -87.87 -178.55 6.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.738 2.015 . . . . 0.0 109.944 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -142.99 -68.31 0.35 Allowed 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 119.391 -2.068 . . . . 0.0 109.674 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.43 175.71 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.487 1.515 . . . . 0.0 114.685 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -48.92 -39.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 1 C-N-CA 132.338 4.255 . . . . 0.0 114.652 176.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.72 -45.73 0.18 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 130.315 3.446 . . . . 0.0 111.959 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.554 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -76.5 -167.38 0.79 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 130.083 3.353 . . . . 0.0 115.925 -177.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -151.08 127.17 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.586 -1.643 . . . . 0.0 113.259 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 66.7 m -91.47 138.4 31.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.203 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.5 m -141.95 170.22 16.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.406 2.282 . . . . 0.0 107.468 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 169.5 16.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.121 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 127.138 2.175 . . . . 0.0 111.595 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB2' HG12 ' A' ' 22' ' ' VAL . 45.7 t . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HG3' HD23 ' A' ' 18' ' ' LEU . 15.1 mtm180 -67.12 177.21 1.85 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 130.058 3.343 . . . . 0.0 109.72 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.664 HD23 ' HG3' ' A' ' 5' ' ' ARG . 39.9 mt . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -71.97 -24.01 61.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.172 2.189 . . . . 0.0 107.38 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.83 166.65 54.28 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 104.596 -3.402 . . . . 0.0 104.596 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.0 m -149.68 143.51 25.52 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 119.169 -2.371 . . . . 0.0 113.219 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 4' ' ' CYS 0.33 3.1 p -99.78 135.45 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 124.955 2.312 . . . . 0.0 107.992 176.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 5.9 m95 -126.79 132.99 50.91 Favored 'General case' 0 C--N 1.305 -1.366 1 C-N-CA 132.901 4.481 . . . . 0.0 102.149 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.1 m -103.99 157.38 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.495 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.11 -42.25 2.52 Favored Glycine 0 CA--C 1.554 2.513 0 C-N-CA 119.291 -1.433 . . . . 0.0 111.064 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -175.32 166.41 3.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 130.13 3.372 . . . . 0.0 110.469 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.74 159.89 32.31 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.37 2.268 . . . . 0.0 113.435 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.31 134.81 48.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.173 2.189 . . . . 0.0 110.649 177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -23.16 -62.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.864 3.265 . . . . 0.0 118.676 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 11.19 65.12 Favored Glycine 0 N--CA 1.463 0.469 0 C-N-CA 125.829 1.68 . . . . 0.0 116.268 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -104.64 173.76 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.191 0.996 . . . . 0.0 111.213 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -153.0 165.32 35.92 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.755 -1.216 . . . . 0.0 111.814 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 2.1 mptp? -58.95 107.28 0.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.877 2.071 . . . . 0.0 113.912 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.0 p -86.64 4.5 40.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.949 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -154.56 176.43 12.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.956 1.702 . . . . 0.0 110.931 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.15 -52.05 8.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.578 1.151 . . . . 0.0 111.566 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.6 -174.14 4.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.538 1.935 . . . . 0.0 109.343 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.72 -70.22 0.36 Allowed 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.467 -2.02 . . . . 0.0 110.219 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.14 176.23 1.41 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.743 1.617 . . . . 0.0 113.936 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -45.13 -37.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 1 C-N-CA 131.815 4.046 . . . . 0.0 115.316 176.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -149.73 -43.37 0.14 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.48 2.712 . . . . 0.0 112.284 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -78.0 -167.42 1.0 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 131.564 3.946 . . . . 0.0 115.949 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 27.3 mt-10 -150.49 131.21 14.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.157 -1.383 . . . . 0.0 114.013 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 61.7 m -94.66 130.23 41.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.004 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -135.09 174.81 10.19 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.19 2.196 . . . . 0.0 108.755 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.254 0.0 OUTLIER -135.42 169.21 17.85 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.614 1.166 . . . . 0.0 113.244 178.016 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 115.854 -2.022 . . . . 0.0 114.315 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.704 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -98.25 157.4 16.19 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.547 0.845 0 CA-C-N 110.501 -3.045 . . . . 0.0 107.511 177.42 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.252 27.2 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.696 0.76 . . . . 0.0 112.26 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.3 p -81.38 -17.42 49.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.43 3.492 . . . . 0.0 112.207 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.3 176.58 25.61 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.262 2.363 . . . . 0.0 111.04 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -141.64 137.88 32.13 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.252 3.2 p -97.2 136.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 124.174 1.94 . . . . 0.0 106.178 176.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -123.45 128.75 50.26 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 131.012 3.725 . . . . 0.0 103.059 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.3 m -100.27 158.49 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.353 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.44 -36.81 1.57 Allowed Glycine 0 CA--C 1.556 2.653 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.259 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.8 t 177.43 167.92 0.63 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 130.41 3.484 . . . . 0.0 110.607 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.11 156.78 33.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.574 1.95 . . . . 0.0 113.435 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 132.87 48.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.641 1.976 . . . . 0.0 110.257 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -28.18 -50.84 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.841 3.256 . . . . 0.0 118.15 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.79 5.56 54.0 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -101.41 174.61 5.9 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.436 1.118 . . . . 0.0 111.741 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -150.47 167.35 27.4 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.024 -1.048 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -66.25 114.11 5.08 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 125.092 1.357 . . . . 0.0 113.404 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 23.5 p -94.69 5.54 51.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.663 176.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -151.85 171.39 17.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.135 -0.978 . . . . 0.0 112.944 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.67 -51.9 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.286 1.434 . . . . 0.0 111.066 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.53 -170.57 3.17 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.531 1.532 . . . . 0.0 108.291 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.522 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.32 -62.78 0.37 Allowed 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 119.364 -2.085 . . . . 0.0 109.68 177.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.34 175.2 0.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -48.77 -39.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 131.186 3.794 . . . . 0.0 114.166 176.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -143.89 -49.55 0.3 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.686 3.194 . . . . 0.0 111.846 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.57 -166.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 133.426 4.691 . . . . 0.0 115.989 -177.135 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 25.4 mt-10 -150.89 130.92 13.41 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.25 136.87 33.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.178 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.91 169.22 19.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.521 1.928 . . . . 0.0 107.582 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.257 0.0 OUTLIER -135.81 168.17 19.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.739 -178.901 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 129.231 3.012 . . . . 0.0 110.687 177.449 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.402 ' CA ' HD22 ' A' ' 18' ' ' LEU . 44.1 t . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.714 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.3 ptp180 -98.89 158.55 15.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -177.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 129.589 3.156 . . . . 0.0 112.528 -177.335 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 5' ' ' ARG . 23.5 mt . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 t -79.38 5.37 12.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.887 1.675 . . . . 0.0 112.743 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.68 171.3 14.94 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.209 2.337 . . . . 0.0 108.776 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -140.39 138.67 34.97 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.9 p -96.99 139.25 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 123.943 1.83 . . . . 0.0 106.405 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.65 112.3 16.63 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 129.724 3.21 . . . . 0.0 103.479 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.711 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.2 t -79.74 143.56 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.103 -177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 -51.48 4.11 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 178.33 164.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 128.943 2.897 . . . . 0.0 113.978 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.8 155.51 22.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.287 2.635 . . . . 0.0 116.66 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.21 135.03 47.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.966 1.706 . . . . 0.0 110.354 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 m -39.18 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 1 C-N-CA 132.174 4.19 . . . . 0.0 120.643 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.21 1.27 7.71 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.971 1.272 . . . . 0.0 114.84 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.39 179.04 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.21 1.404 . . . . 0.0 110.303 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -149.24 165.46 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.09 -1.006 . . . . 0.0 109.864 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.73 114.59 3.39 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.422 1.089 . . . . 0.0 112.205 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 26.5 p -92.96 10.31 31.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.19 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -163.11 170.6 17.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.1 -53.47 17.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.621 1.568 . . . . 0.0 111.959 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -80.0 -177.51 6.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.017 2.927 . . . . 0.0 110.129 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.51 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.8 -65.67 0.36 Allowed 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 119.484 -2.01 . . . . 0.0 109.945 177.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.46 175.0 0.59 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -49.46 -37.02 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 1 C-N-CA 131.713 4.005 . . . . 0.0 114.426 176.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.15 -49.52 0.21 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 129.983 3.313 . . . . 0.0 111.501 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.711 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -73.35 -167.3 0.41 Allowed 'General case' 0 N--CA 1.443 -0.814 1 C-N-CA 131.711 4.004 . . . . 0.0 116.475 -177.193 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.1 mt-10 -148.41 130.8 15.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.06 137.5 32.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.75 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.9 m -149.14 170.26 18.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 108.692 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.89 173.48 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.534 1.534 . . . . 0.0 112.832 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 128.947 2.899 . . . . 0.0 109.896 176.583 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' HD22 ' A' ' 18' ' ' LEU . 35.9 t . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.402 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -72.82 175.8 6.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.305 1.442 . . . . 0.0 113.995 -178.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.448 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 4' ' ' CYS 0.269 74.1 mt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -71.85 -27.23 62.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.61 155.61 48.65 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 104.467 -3.453 . . . . 0.0 104.467 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.1 m -140.49 143.55 35.54 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 120.766 -1.432 . . . . 0.0 113.35 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 42' ' ' TYR 0.278 3.5 p -97.17 136.28 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 124.577 2.132 . . . . 0.0 107.984 176.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -122.33 122.17 38.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 108.867 -3.788 . . . . 0.0 102.851 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.713 HG22 ' CG ' ' A' ' 42' ' ' TYR . 42.3 t -93.27 139.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.944 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.47 -19.53 10.79 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.544 -1.142 . . . . 0.0 114.402 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 166.35 153.97 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 130.491 3.516 . . . . 0.0 111.884 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -66.49 154.94 38.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.123 2.169 . . . . 0.0 112.198 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 133.54 49.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.358 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -35.7 -28.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 131.185 3.794 . . . . 0.0 120.155 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.32 3.37 12.55 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.17 1.366 . . . . 0.0 114.839 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -99.77 177.64 5.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.976 1.31 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -150.27 163.82 37.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.5 mptm? -61.25 120.04 9.6 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.432 1.093 . . . . 0.0 112.443 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.41 2.47 55.77 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.557 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -151.66 165.56 33.96 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 119.705 1.139 . . . . 0.0 110.767 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -43.34 89.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.459 1.123 . . . . 0.0 112.675 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.36 -173.99 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 109.597 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -68.8 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 119.543 -1.973 . . . . 0.0 111.957 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.06 175.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.24 1.816 . . . . 0.0 114.152 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -47.95 -37.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 1 C-N-CA 132.109 4.163 . . . . 0.0 115.444 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.99 -42.16 0.15 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.463 3.105 . . . . 0.0 112.896 -176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.713 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -82.39 -169.64 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.909 3.284 . . . . 0.0 116.141 -176.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.4 mt-10 -149.46 124.56 10.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.226 177.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.34 110.77 20.47 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.278 1.431 . . . . 0.0 110.096 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -114.91 171.72 7.48 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.306 1.442 . . . . 0.0 108.531 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 168.17 19.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.674 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 129.938 3.295 . . . . 0.0 110.137 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.226 -0.168 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.1 ptp180 -73.62 172.55 11.19 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.414 1.886 . . . . 0.0 115.6 -177.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 127.663 2.385 . . . . 0.0 111.703 -177.173 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 5' ' ' ARG . 19.7 mt . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -73.95 -27.14 60.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.645 2.778 . . . . 0.0 109.375 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.19 165.55 45.22 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -140.72 142.09 34.85 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.301 -1.117 . . . . 0.0 113.527 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.275 3.2 p -100.25 136.12 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 124.465 2.079 . . . . 0.0 106.928 176.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -126.62 124.93 41.03 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 131.634 3.974 . . . . 0.0 102.422 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.534 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.5 m -93.16 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.005 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.77 -61.16 3.7 Favored Glycine 0 CA--C 1.554 2.529 0 C-N-CA 119.241 -1.456 . . . . 0.0 110.76 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 t -158.95 158.77 33.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 128.295 2.638 . . . . 0.0 112.234 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -68.45 158.98 32.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.37 1.868 . . . . 0.0 112.688 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.89 42.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.905 2.482 . . . . 0.0 111.146 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 p -20.84 -63.22 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.552 3.541 . . . . 0.0 118.57 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.05 9.9 67.88 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.035 1.574 . . . . 0.0 117.035 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -101.6 174.11 6.12 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.374 1.087 . . . . 0.0 110.825 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -149.99 168.0 25.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.861 -1.149 . . . . 0.0 110.551 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -60.42 111.45 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.918 1.687 . . . . 0.0 112.496 177.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 16.8 p -93.46 10.69 31.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -159.61 165.95 31.7 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.587 1.155 . . . . 0.0 110.556 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.79 -36.28 80.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.04 1.336 . . . . 0.0 112.657 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -102.2 -175.14 2.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.254 2.622 . . . . 0.0 110.191 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.527 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -136.95 -68.16 0.49 Allowed 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 119.538 -1.976 . . . . 0.0 110.137 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.4 174.22 1.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -46.09 -42.42 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 1 C-N-CA 132.122 4.169 . . . . 0.0 114.338 176.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.01 -44.32 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 130.823 3.649 . . . . 0.0 111.951 -176.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -79.04 -166.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 130.54 3.536 . . . . 0.0 116.087 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 15.9 mt-10 -152.11 127.22 9.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.806 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -91.13 136.07 33.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.995 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -142.18 167.78 21.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.738 2.015 . . . . 0.0 108.849 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.443 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.265 0.0 OUTLIER -130.04 165.83 21.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.11 179.82 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 C-N-CA 129.456 3.102 . . . . 0.0 112.234 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.546 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.1 ptt180 -95.22 175.61 6.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.851 1.31 . . . . 0.0 113.317 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 26.4 p . . . . . 0 C--N 1.316 -0.883 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.09 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.306 28.4 mt . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -76.93 29.53 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.072 2.149 . . . . 0.0 110.479 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . -142.5 173.05 24.07 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 130.168 3.747 . . . . 0.0 108.381 177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -148.15 139.67 23.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.482 -1.01 . . . . 0.0 111.448 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.275 2.5 p -98.24 131.04 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 124.338 2.018 . . . . 0.0 105.774 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -115.2 124.29 51.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 109.114 -3.675 . . . . 0.0 103.337 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.624 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.6 m -92.67 161.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.38 -59.67 4.78 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -178.54 166.72 1.8 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.379 3.471 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.85 157.01 35.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.548 2.339 . . . . 0.0 117.258 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 129.66 39.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.96 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -34.71 -31.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 131.28 3.832 . . . . 0.0 119.713 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.14 29.57 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.754 1.169 . . . . 0.0 115.638 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -104.3 174.4 5.89 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.998 1.319 . . . . 0.0 111.463 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -151.56 167.98 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.201 -0.937 . . . . 0.0 111.368 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -69.23 110.54 4.64 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 113.724 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.5 t -84.88 -2.98 58.48 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.196 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -156.72 165.63 35.7 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.863 -1.148 . . . . 0.0 111.205 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -73.97 -26.25 60.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -101.56 175.06 5.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.661 1.584 . . . . 0.0 109.876 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.518 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -139.76 -62.62 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.689 -1.882 . . . . 0.0 110.629 -177.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.62 177.27 0.2 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.953 1.701 . . . . 0.0 115.132 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -51.46 -35.73 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 131.658 3.983 . . . . 0.0 114.092 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -152.55 -44.73 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 130.362 3.465 . . . . 0.0 112.986 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.624 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -73.85 -169.83 0.8 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.909 3.284 . . . . 0.0 113.9 -177.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 17.3 mt-10 -148.42 129.3 14.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.874 1.321 . . . . 0.0 114.498 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.4 132.06 34.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.76 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.6 m -142.34 173.57 11.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.085 1.754 . . . . 0.0 108.262 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -137.91 166.72 23.34 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 129.715 3.206 . . . . 0.0 113.129 177.444 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' CB ' HG23 ' A' ' 22' ' ' VAL . 48.0 t . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.5 ptp85 -89.56 164.07 14.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.97 1.367 . . . . 0.0 112.825 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.546 0.792 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.386 177.184 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.296 18.0 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -75.48 -14.53 60.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.763 2.025 . . . . 0.0 110.451 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.26 174.14 33.57 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.8 m -155.74 148.04 23.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 119.553 -2.145 . . . . 0.0 112.581 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -92.57 140.66 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 126.79 2.036 . . . . 0.0 109.368 177.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 11.9 m95 -132.44 109.59 9.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG12 ' CD1' ' A' ' 42' ' ' TYR . 2.4 m -75.02 160.42 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.852 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.44 -62.72 4.28 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -177.96 165.0 1.94 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 130.799 3.64 . . . . 0.0 112.089 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -51.7 151.74 3.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 129.607 3.163 . . . . 0.0 117.786 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.58 135.52 48.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.197 1.799 . . . . 0.0 110.89 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.77 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 131.433 3.893 . . . . 0.0 119.208 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.1 8.63 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 125.954 1.74 . . . . 0.0 116.773 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -101.27 177.26 4.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -151.03 165.48 33.65 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 121.54 -0.725 . . . . 0.0 110.32 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.6 mptm? -64.1 121.7 14.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.26 1.024 . . . . 0.0 113.643 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.35 4.07 53.77 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.403 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -158.48 170.07 23.03 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 120.462 1.483 . . . . 0.0 114.049 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.5 -29.61 56.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -101.85 178.44 4.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 107.942 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.82 -64.4 0.38 Allowed 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 119.719 -1.863 . . . . 0.0 109.452 -177.458 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.49 171.41 0.44 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.977 2.111 . . . . 0.0 113.862 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -50.7 -38.44 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 131.024 3.73 . . . . 0.0 114.776 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -134.72 -48.0 0.75 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 129.502 3.121 . . . . 0.0 113.309 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.535 ' CD1' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -85.78 -168.17 2.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 129.908 3.283 . . . . 0.0 116.25 -177.169 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 60.1 mt-10 -142.95 135.6 27.7 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.417 -2.174 . . . . 0.0 112.328 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -93.74 129.03 40.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.15 1.38 . . . . 0.0 109.565 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.3 m -135.27 171.82 13.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.92 1.288 . . . . 0.0 108.237 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -135.05 165.76 24.61 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.53 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.246 1.818 . . . . 0.0 114.079 177.315 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 C--O 1.225 -0.186 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -83.43 177.84 8.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.065 1.346 . . . . 0.0 113.238 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 126.507 1.923 . . . . 0.0 108.867 177.574 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 t -69.58 -15.11 63.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.785 0.834 . . . . 0.0 111.078 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.3 173.59 55.25 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -153.29 143.66 22.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 118.914 -2.521 . . . . 0.0 113.017 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.291 2.6 p -99.78 132.3 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-O 124.434 2.064 . . . . 0.0 107.265 176.53 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -121.26 110.5 16.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 109.134 -3.666 . . . . 0.0 103.739 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.652 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -80.95 160.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.586 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -55.11 4.8 Favored Glycine 0 CA--C 1.552 2.385 0 C-N-CA 118.234 -1.936 . . . . 0.0 109.337 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.2 t 175.52 164.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.133 3.773 . . . . 0.0 113.265 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.35 151.28 44.36 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 127.922 2.489 . . . . 0.0 116.382 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.79 53.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.487 1.915 . . . . 0.0 111.332 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -32.0 -17.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 1 C-N-CA 134.298 5.039 . . . . 0.0 121.253 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.81 10.2 2.6 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 125.466 1.507 . . . . 0.0 115.274 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -99.71 178.6 4.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.105 0.962 . . . . 0.0 110.735 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -147.98 168.13 23.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.325 -0.859 . . . . 0.0 110.83 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -63.35 109.34 1.56 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.58 177.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.21 -3.35 58.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.027 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -150.51 165.43 33.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.084 1.354 . . . . 0.0 110.882 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.4 -47.69 69.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.327 1.051 . . . . 0.0 112.923 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.62 -176.37 6.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 128.509 2.723 . . . . 0.0 109.57 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.496 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.8 -70.43 0.42 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 119.645 -1.909 . . . . 0.0 108.493 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.98 177.12 2.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 114.438 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -44.55 -38.5 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 131.354 3.862 . . . . 0.0 113.349 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.21 -52.67 0.18 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 130.407 3.483 . . . . 0.0 111.321 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.652 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -65.8 -170.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.888 1 C-N-CA 131.859 4.063 . . . . 0.0 113.889 -177.107 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 38' ' ' TYR . 13.6 mt-10 -147.6 125.54 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 87.0 m -89.78 135.17 33.79 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.021 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.3 m -142.86 173.65 11.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.686 2.394 . . . . 0.0 106.829 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 170.3 16.21 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.218 1.007 . . . . 0.0 110.384 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.325 2.25 . . . . 0.0 110.015 176.546 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 18' ' ' LEU . 1.7 ptp180 -96.72 158.52 15.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 122.721 1.248 . . . . 0.0 114.322 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.723 -177.291 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.5 mt . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.187 0.517 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -68.19 -25.78 65.4 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.078 1.351 . . . . 0.0 108.73 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.61 160.09 48.72 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.7 m -141.27 141.38 33.96 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.298 -1.119 . . . . 0.0 111.709 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.4 p -94.72 137.29 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 124.399 2.047 . . . . 0.0 107.01 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -121.32 119.75 33.08 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 110.304 -3.135 . . . . 0.0 103.89 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CG ' ' A' ' 42' ' ' TYR . 41.7 t -90.46 144.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.546 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.46 -35.47 2.23 Favored Glycine 0 CA--C 1.555 2.557 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.301 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t 175.77 152.69 0.15 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.067 2.947 . . . . 0.0 112.503 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.73 160.68 11.29 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.593 1.957 . . . . 0.0 111.385 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.79 132.34 38.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.316 1.446 . . . . 0.0 109.393 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -28.12 -50.33 0.07 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 130.045 3.338 . . . . 0.0 117.732 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 3.59 61.49 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.08 1.592 . . . . 0.0 117.08 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -101.62 -179.23 3.96 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.723 1.262 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -151.84 163.81 38.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 121.149 -0.969 . . . . 0.0 109.41 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.7 mptm? -61.06 118.66 7.06 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 112.973 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -92.29 5.13 51.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.057 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -157.51 168.65 26.69 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-N 120.563 1.529 . . . . 0.0 113.097 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.51 -48.17 73.45 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.489 1.515 . . . . 0.0 112.561 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -88.58 -177.94 5.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.991 2.116 . . . . 0.0 108.14 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.436 ' HD2' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.21 -59.85 0.38 Allowed 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 118.76 -2.462 . . . . 0.0 110.635 -177.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 172.44 175.45 0.09 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.135 2.174 . . . . 0.0 113.959 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -49.05 -38.21 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 130.872 3.669 . . . . 0.0 114.122 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -143.53 -52.64 0.35 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 129.665 3.186 . . . . 0.0 111.936 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -69.85 -169.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.744 1 C-N-CA 132.137 4.175 . . . . 0.0 116.347 -177.223 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 28.1 mt-10 -148.74 128.47 13.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.24 115.39 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.758 1.223 . . . . 0.0 111.112 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.3 m -124.39 167.64 14.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.786 1.279 . . . . 0.0 107.776 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.96 168.88 18.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.098 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 128.212 2.605 . . . . 0.0 113.507 177.246 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' HD22 ' A' ' 18' ' ' LEU . 53.9 t . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.422 ' H ' ' CD2' ' A' ' 18' ' ' LEU 0.294 0.0 OUTLIER -91.12 175.0 7.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.851 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.4 p . . . . . 0 C--N 1.31 -1.134 0 C-N-CA 127.925 2.49 . . . . 0.0 112.632 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 4' ' ' CYS . 25.5 mt . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -68.96 -11.96 61.2 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.231 0.613 . . . . 0.0 111.656 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.92 175.1 41.46 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.353 1.93 . . . . 0.0 110.49 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -149.48 142.72 25.11 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.16 -1.788 . . . . 0.0 113.219 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.6 p -101.32 137.99 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 124.119 1.914 . . . . 0.0 106.291 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.423 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 7.7 m95 -125.16 119.14 27.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 130.88 3.672 . . . . 0.0 103.181 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -87.18 161.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.455 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.34 -63.45 3.93 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.076 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 p -162.16 161.04 27.85 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.188 2.595 . . . . 0.0 113.05 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -61.57 160.99 10.35 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.787 1.279 . . . . 0.0 113.653 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -77.07 133.08 39.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.945 2.098 . . . . 0.0 110.153 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.7 p -18.87 -65.77 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 130.716 3.607 . . . . 0.0 117.894 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 9.48 70.6 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.802 1.668 . . . . 0.0 116.896 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -99.25 174.8 6.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.433 1.116 . . . . 0.0 111.024 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -149.95 168.72 23.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.805 -1.184 . . . . 0.0 111.034 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -67.77 112.8 5.05 Favored 'General case' 0 CA--C 1.511 -0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 113.053 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 22.2 t -88.02 -1.71 58.16 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.862 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -157.79 167.69 29.31 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.093 -1.004 . . . . 0.0 111.498 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.63 -33.48 68.98 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.6 177.21 5.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 110.627 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.541 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.24 -64.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 119.708 -1.87 . . . . 0.0 110.487 -177.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 174.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.154 1.781 . . . . 0.0 115.046 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.59 -42.35 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 131.026 3.73 . . . . 0.0 113.884 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -141.91 -46.55 0.35 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 130.708 3.603 . . . . 0.0 112.827 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.585 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -74.4 -169.16 0.77 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 130.024 3.329 . . . . 0.0 115.447 -177.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.4 mt-10 -148.04 126.34 12.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 123.309 1.528 . . . . 0.0 114.263 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.76 132.25 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.467 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.4 m -143.42 170.79 15.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.517 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -136.0 167.83 20.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.784 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 129.059 2.944 . . . . 0.0 112.328 177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.1 t . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.872 ' HG3' HD23 ' A' ' 18' ' ' LEU . 12.9 mtm180 -69.5 -175.6 0.86 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.922 2.296 . . . . 0.0 111.884 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 8.5 p . . . . . 0 N--CA 1.437 -1.111 0 C-N-CA 129.69 3.196 . . . . 0.0 110.309 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' A' ' 5' ' ' ARG . 5.5 mt . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -75.8 0.95 16.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.685 0.794 . . . . 0.0 111.448 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.36 162.83 12.27 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.235 2.826 . . . . 0.0 107.818 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.1 m -146.91 141.56 26.68 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.377 -1.661 . . . . 0.0 110.506 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.323 2.5 p -96.34 133.23 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 124.91 2.291 . . . . 0.0 108.541 176.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -121.46 112.71 18.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 109.343 -3.571 . . . . 0.0 104.213 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.2 m -86.63 158.11 3.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 112.959 -1.928 . . . . 0.0 107.497 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.72 -50.5 3.28 Favored Glycine 0 CA--C 1.553 2.439 0 C-N-CA 119.127 -1.511 . . . . 0.0 112.071 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -178.32 160.61 1.34 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.294 3.438 . . . . 0.0 111.768 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.07 161.84 7.99 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.909 2.484 . . . . 0.0 114.664 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 145.57 40.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.735 2.014 . . . . 0.0 110.647 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -32.37 -54.72 0.33 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 119.482 3.142 . . . . 0.0 119.482 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.28 14.05 30.8 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 124.692 1.139 . . . . 0.0 115.204 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -96.95 173.31 7.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.66 0.743 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -151.0 166.83 29.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 43' ' ' GLU . 4.3 mptp? -63.38 124.97 22.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.613 0.765 . . . . 0.0 111.487 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 37.8 t -96.59 1.27 51.1 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.838 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.66 168.22 26.55 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 121.238 -0.914 . . . . 0.0 109.724 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -16.59 56.25 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -105.36 175.43 5.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.973 1.309 . . . . 0.0 108.181 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 119.901 -1.749 . . . . 0.0 109.972 -176.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.68 -178.57 0.16 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.707 2.003 . . . . 0.0 113.626 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -52.94 -38.16 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 131.501 3.921 . . . . 0.0 113.341 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -149.51 -50.93 0.15 Allowed 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 130.505 3.522 . . . . 0.0 111.204 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.612 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -69.92 -172.38 0.52 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.33 3.452 . . . . 0.0 112.772 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 7.2 mm-40 -146.4 128.67 15.77 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 72.8 m -86.91 123.68 32.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.64 173.94 10.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.799 2.04 . . . . 0.0 107.562 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.287 0.0 OUTLIER -138.12 172.67 12.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.793 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.871 2.869 . . . . 0.0 110.447 176.922 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.4 t . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.886 ' HG3' HD23 ' A' ' 18' ' ' LEU . 59.1 mtm180 -69.91 -176.77 1.16 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 113.465 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p . . . . . 0 C--N 1.319 -0.73 0 C-N-CA 129.888 3.275 . . . . 0.0 112.264 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' A' ' 5' ' ' ARG 0.252 17.2 mt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.2 t -64.73 -30.68 71.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.426 1.49 . . . . 0.0 109.158 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.33 157.72 38.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.2 m -140.22 138.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 122.003 -0.704 . . . . 0.0 111.915 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.428 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.308 3.3 p -96.77 134.27 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-O 124.807 2.241 . . . . 0.0 108.103 176.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -119.64 122.02 40.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 108.994 -3.73 . . . . 0.0 103.73 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.3 m -96.74 156.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.6 -12.6 7.75 Favored Glycine 0 CA--C 1.557 2.695 0 C-N-CA 118.769 -1.681 . . . . 0.0 115.48 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 142.91 162.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 1 C-N-CA 135.985 5.714 . . . . 0.0 113.946 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -70.45 154.46 41.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.894 2.477 . . . . 0.0 115.35 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 131.78 46.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.251 1.82 . . . . 0.0 108.551 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -28.96 -63.62 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.296 2.638 . . . . 0.0 116.87 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.2 5.33 84.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -97.44 177.68 5.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.753 1.277 . . . . 0.0 111.074 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -152.3 166.07 32.97 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.2 mptm? -64.46 121.83 15.31 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.327 1.051 . . . . 0.0 113.103 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.7 t -91.25 0.03 57.6 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.157 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -160.73 166.89 27.94 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 119.83 1.196 . . . . 0.0 109.302 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -22.26 59.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.16 171.48 7.3 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.936 1.695 . . . . 0.0 108.832 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.32 -67.7 0.47 Allowed 'General case' 0 C--O 1.223 -0.32 0 O-C-N 120.187 -1.571 . . . . 0.0 110.161 -177.215 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.14 174.71 0.71 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 112.906 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -48.13 -35.98 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 130.924 3.69 . . . . 0.0 115.046 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -150.27 -44.54 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 113.136 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.562 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -76.96 -171.22 1.9 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.07 2.948 . . . . 0.0 113.55 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mt-10 -148.85 120.69 8.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 81.0 m -83.66 104.14 13.54 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.594 1.558 . . . . 0.0 109.445 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.9 m -111.52 175.73 5.31 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.54 1.162 . . . . 0.0 108.937 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -139.46 173.89 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.246 0.904 0 C-N-CA 128.799 2.84 . . . . 0.0 109.622 176.82 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.758 ' HG3' HD23 ' A' ' 18' ' ' LEU . 44.6 mtm180 -75.75 154.7 36.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 123.973 1.844 . . . . 0.0 114.369 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 110.047 -3.251 . . . . 0.0 108.995 177.378 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.758 HD23 ' HG3' ' A' ' 5' ' ' ARG . 37.6 mt . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t -66.52 -37.19 84.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.504 1.922 . . . . 0.0 109.57 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.07 46.88 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 m -135.92 134.51 38.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 120.745 -1.444 . . . . 0.0 113.098 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.45 HG21 ' HD2' ' A' ' 42' ' ' TYR . 3.5 p -93.37 137.37 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 124.316 2.008 . . . . 0.0 106.228 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -122.58 119.73 31.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 109.997 -3.274 . . . . 0.0 103.127 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 ' CG ' ' A' ' 42' ' ' TYR . 51.2 t -93.3 138.83 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.279 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -48.24 3.68 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -170.18 158.2 6.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.269 1.828 . . . . 0.0 114.251 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.0 161.42 18.72 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.327 1.537 . . . . 0.0 112.688 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 133.89 40.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.488 1.915 . . . . 0.0 109.346 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -34.96 -40.81 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.653 3.181 . . . . 0.0 118.801 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.61 4.14 39.79 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -100.41 177.59 4.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.012 1.325 . . . . 0.0 111.653 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -151.2 166.97 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.294 -0.879 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.75 118.7 7.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.632 1.573 . . . . 0.0 112.882 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.3 p -99.03 11.75 38.06 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.303 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -158.66 158.36 33.63 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 110.091 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -25.25 59.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.588 0.709 . . . . 0.0 112.321 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.24 -169.86 1.75 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.108 2.563 . . . . 0.0 109.485 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.83 -65.26 0.37 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 119.114 -2.241 . . . . 0.0 112.436 177.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.68 176.8 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -51.24 -40.03 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 1 C-N-CA 131.701 4.001 . . . . 0.0 113.977 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.17 -48.4 0.27 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.074 3.35 . . . . 0.0 111.405 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.674 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.52 -164.73 0.43 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.014 4.126 . . . . 0.0 116.484 -177.027 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.2 mt-10 -148.62 129.73 14.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.506 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.55 134.43 34.13 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.981 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.32 169.81 16.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.941 1.696 . . . . 0.0 108.929 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.311 0.0 OUTLIER -134.62 168.27 19.29 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.722 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.084 1 C-N-CA 132.406 4.282 . . . . 0.0 109.447 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.1 t . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.882 ' HG3' HD23 ' A' ' 18' ' ' LEU . 40.0 mtm180 -73.31 -171.83 1.03 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.249 1.82 . . . . 0.0 113.568 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 C--N 1.32 -0.683 0 C-N-CA 127.886 2.474 . . . . 0.0 114.072 -179.821 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.882 HD23 ' HG3' ' A' ' 5' ' ' ARG . 32.2 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 m -69.88 -25.79 63.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.941 1.296 . . . . 0.0 108.373 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.75 170.66 55.04 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.8 m -148.99 142.82 25.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 119.534 -2.156 . . . . 0.0 112.148 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.257 2.8 p -98.33 135.64 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.535 2.112 . . . . 0.0 106.46 176.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -126.17 127.07 45.14 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.021 4.128 . . . . 0.0 102.403 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.479 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -97.61 159.72 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.46 -49.5 3.03 Favored Glycine 0 CA--C 1.557 2.71 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.3 t -169.33 169.02 9.34 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 129.741 3.216 . . . . 0.0 111.34 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.08 165.94 24.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.404 2.282 . . . . 0.0 113.632 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.7 142.82 35.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.881 1.672 . . . . 0.0 112.544 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -35.07 -8.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 C-N-CA 134.697 5.199 . . . . 0.0 122.236 -177.227 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.22 9.96 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.005 1.764 . . . . 0.0 114.807 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.75 177.92 5.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.044 1.338 . . . . 0.0 110.863 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -152.81 167.67 28.27 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.12 -0.987 . . . . 0.0 110.787 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -64.16 113.51 3.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.387 1.875 . . . . 0.0 111.557 177.174 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 38.9 t -87.84 1.7 53.28 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.31 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -158.9 167.25 29.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.622 1.569 . . . . 0.0 110.637 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.28 -42.51 79.44 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -89.37 177.73 6.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.378 2.271 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.27 -68.67 0.45 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 119.879 -1.763 . . . . 0.0 111.191 -177.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.43 170.72 0.78 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.07 1.748 . . . . 0.0 115.164 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.5 tp -44.32 -44.22 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 1 C-N-CA 131.768 4.027 . . . . 0.0 115.214 176.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -136.68 -48.19 0.62 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.989 3.315 . . . . 0.0 111.938 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -76.71 -165.25 0.51 Allowed 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.084 4.154 . . . . 0.0 116.54 -177.337 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 16.5 mt-10 -152.58 127.58 9.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.12 -1.855 . . . . 0.0 113.664 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.41 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.5 m -91.66 129.02 37.7 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -135.41 175.32 9.69 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.287 1.835 . . . . 0.0 108.303 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.273 0.0 OUTLIER -138.96 173.17 11.84 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 177.586 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.101 4.56 . . . . 0.0 109.069 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.2 t . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.474 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 43.6 mtm180 -66.49 178.67 1.19 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.325 2.25 . . . . 0.0 111.052 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 126.789 2.036 . . . . 0.0 112.357 -178.332 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 68.4 mt . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -66.77 -29.91 69.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.02 0.928 . . . . 0.0 108.765 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.36 176.3 34.91 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.734 2.112 . . . . 0.0 108.102 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.0 m -151.34 139.24 19.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 119.046 -2.444 . . . . 0.0 112.92 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' SG ' ' A' ' 44' ' ' CYS . 5.0 p -96.1 135.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 124.247 1.975 . . . . 0.0 106.935 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -122.47 108.94 13.75 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 109.97 -3.286 . . . . 0.0 104.15 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -79.14 160.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 112.653 -2.067 . . . . 0.0 106.695 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.11 -49.15 4.06 Favored Glycine 0 CA--C 1.567 3.339 0 C-N-CA 118.672 -1.728 . . . . 0.0 109.766 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t 165.29 164.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 1 C-N-CA 134.011 4.924 . . . . 0.0 113.271 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.89 154.87 3.7 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 129.626 3.17 . . . . 0.0 117.119 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.36 43.13 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.864 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -29.91 -44.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.999 3.719 . . . . 0.0 118.571 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.74 8.72 34.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.439 1.495 . . . . 0.0 116.576 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -102.54 179.39 4.31 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.772 1.229 . . . . 0.0 111.048 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -149.1 160.82 42.99 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.069 -1.019 . . . . 0.0 109.777 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -57.77 112.75 1.57 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.471 1.509 . . . . 0.0 112.26 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.2 p -85.1 5.08 31.21 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.246 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -159.09 165.46 33.81 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.275 0.943 . . . . 0.0 110.416 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.8 -35.85 75.2 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.893 0.746 . . . . 0.0 112.982 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.98 -175.77 4.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.069 2.148 . . . . 0.0 107.527 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.532 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.31 -67.2 0.33 Allowed 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 119.091 -2.256 . . . . 0.0 111.168 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.57 174.55 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.392 1.877 . . . . 0.0 112.354 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -47.38 -32.38 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 130.765 3.626 . . . . 0.0 115.589 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -155.42 -42.45 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 128.797 2.839 . . . . 0.0 113.863 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.646 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -78.22 -169.26 1.55 Allowed 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.939 3.296 . . . . 0.0 113.894 -176.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 53.1 mt-10 -150.65 123.45 8.64 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.3 m -86.38 117.41 25.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 123.403 1.573 . . . . 0.0 110.789 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.45 174.69 7.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.231 1.813 . . . . 0.0 109.514 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.334 0.0 OUTLIER -137.28 170.56 15.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 177.404 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.249 1.031 1 C-N-CA 132.651 4.38 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.331 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.251 59.1 t -145.49 149.33 16.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.0 t -149.57 128.71 12.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.56 174.0 11.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 113.854 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.1 m -111.65 174.71 5.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.262 2.225 . . . . 0.0 111.834 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.77 -42.73 84.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.384 1.074 . . . . 0.0 111.727 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -108.06 54.65 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.25 1.82 . . . . 0.0 109.155 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -45.63 -42.53 11.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.857 0.863 . . . . 0.0 113.257 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 67.5 0.17 Allowed Glycine 0 N--CA 1.463 0.458 0 C-N-CA 125.713 1.625 . . . . 0.0 114.645 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -57.2 -22.35 47.99 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.444 2.763 . . . . 0.0 117.216 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -148.51 34.11 0.79 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.322 1.449 . . . . 0.0 113.568 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 162.91 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.82 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -71.45 150.76 44.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 113.027 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.97 32.5 84.29 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -73.24 -10.07 59.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.46 2.704 . . . . 0.0 116.477 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -60.92 173.71 0.73 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.637 1.975 . . . . 0.0 112.222 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 4' ' ' CYS . 36.7 mt -67.49 60.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.86 2.064 . . . . 0.0 114.756 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -78.47 -13.5 59.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.123 1.769 . . . . 0.0 109.493 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.35 166.61 32.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 129.057 3.218 . . . . 0.0 106.89 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.5 m -145.82 145.9 30.95 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.194 -1.18 . . . . 0.0 113.347 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 3.2 p -100.23 136.2 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 124.341 2.019 . . . . 0.0 107.122 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -127.59 113.23 15.82 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 130.594 3.558 . . . . 0.0 102.563 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 42' ' ' TYR . 2.4 m -80.25 163.94 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.265 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -56.85 4.87 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t 177.09 170.04 0.54 Allowed 'General case' 0 N--CA 1.485 1.316 1 C-N-CA 131.922 4.089 . . . . 0.0 112.247 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.45 172.87 0.2 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 129.471 3.108 . . . . 0.0 116.927 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.7 140.81 29.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.547 1.939 . . . . 0.0 110.723 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -44.02 -12.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 1 C-N-CA 132.199 4.2 . . . . 0.0 120.915 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.12 2.87 5.16 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.063 1.316 . . . . 0.0 114.63 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -104.95 177.51 4.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.493 1.117 . . . . 0.0 110.983 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -150.37 169.53 21.21 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.618 -0.676 . . . . 0.0 110.87 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -64.44 118.16 8.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 113.461 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 30.3 p -95.53 7.18 47.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.58 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -159.26 167.1 29.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.502 1.121 . . . . 0.0 111.429 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -76.94 -32.8 57.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 122.13 0.967 . . . . 0.0 112.877 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -96.73 -175.88 3.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.053 1.741 . . . . 0.0 108.059 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.548 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.03 -66.82 0.37 Allowed 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 118.821 -2.424 . . . . 0.0 109.681 -178.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.98 171.7 0.84 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -45.39 -41.72 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 130.514 3.526 . . . . 0.0 114.756 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -140.42 -49.37 0.45 Allowed 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 129.924 3.29 . . . . 0.0 112.298 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.586 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.39 -166.67 0.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 130.775 3.63 . . . . 0.0 116.613 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.6 mt-10 -150.63 129.96 12.86 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.979 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 74.6 m -92.71 138.87 31.12 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.102 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.5 m -144.88 170.58 15.86 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 126.77 2.028 . . . . 0.0 108.466 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.98 168.03 19.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.245 0.864 0 C-N-CA 127.353 2.261 . . . . 0.0 113.493 177.767 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.258 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.504 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.32 72.3 t -149.24 153.62 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.937 0.895 . . . . 0.0 111.792 -177.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.505 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.6 t -152.56 128.67 10.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.077 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -75.77 -172.7 1.99 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 122.28 1.038 . . . . 0.0 113.463 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.8 m -124.07 -177.87 3.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.58 1.952 . . . . 0.0 112.079 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -54.87 -64.52 0.81 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.963 1.305 . . . . 0.0 109.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -88.11 50.92 2.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.156 2.582 . . . . 0.0 110.843 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -59.27 -13.95 9.52 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.8 59.71 8.3 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 118.225 2.05 . . . . 0.0 118.225 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.64 -0.32 2.41 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 124.289 3.326 . . . . 0.0 115.526 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.3 m -135.33 7.68 3.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.243 1.817 . . . . 0.0 115.054 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.81 -163.81 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.077 0.951 . . . . 0.0 112.784 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -60.69 135.74 57.86 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.68 1.592 . . . . 0.0 114.239 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.2 26.85 71.78 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.424 2.13 . . . . 0.0 118.424 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -47.8 49.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 135.261 5.424 . . . . 0.0 117.523 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 p -144.81 -170.23 3.36 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 128.041 2.536 . . . . 0.0 113.746 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 3' ' ' HYP . 87.2 mt -69.76 52.73 0.11 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.828 2.851 . . . . 0.0 111.429 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -74.18 52.24 0.45 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.355 2.662 . . . . 0.0 110.355 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.26 -173.99 37.35 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 129.092 3.234 . . . . 0.0 108.464 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.7 m -157.23 137.9 13.16 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.011 -1.876 . . . . 0.0 109.657 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 4.4 p -93.67 137.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-O 124.414 2.054 . . . . 0.0 107.913 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.19 116.03 22.73 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 130.845 3.658 . . . . 0.0 103.509 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.682 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.9 t -87.09 143.38 11.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.463 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.06 -53.45 4.81 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 p -167.54 154.5 8.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.756 2.022 . . . . 0.0 115.179 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -59.63 151.34 25.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.491 1.916 . . . . 0.0 112.534 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.86 136.87 53.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.077 1.351 . . . . 0.0 109.745 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 p -24.53 -68.29 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.919 3.288 . . . . 0.0 117.191 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.42 9.84 75.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.12 1.819 . . . . 0.0 116.319 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.416 ' CD2' ' HB2' ' A' ' 47' ' ' GLN . 7.3 m95 -98.32 177.87 5.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.897 1.348 . . . . 0.0 110.798 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -148.9 161.85 41.03 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.254 -0.904 . . . . 0.0 109.108 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.0 mptm? -62.64 123.05 17.37 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 124.412 1.085 . . . . 0.0 112.399 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 28.4 p -98.27 9.57 42.7 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.764 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -158.8 169.58 24.05 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.277 0.944 . . . . 0.0 112.378 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.56 -52.08 24.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.331 1.052 . . . . 0.0 111.074 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -167.91 1.92 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -147.56 -57.95 0.25 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 119.506 -1.996 . . . . 0.0 110.575 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.91 175.87 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.359 2.664 . . . . 0.0 114.157 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.62 -39.43 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 1 C-N-CA 132.588 4.355 . . . . 0.0 115.97 176.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.47 -47.54 0.26 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 129.121 2.968 . . . . 0.0 112.191 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.682 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -77.25 -167.46 0.91 Allowed 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 131.708 4.003 . . . . 0.0 116.746 -177.034 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 84.1 mt-10 -149.8 124.01 9.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 65.5 m -88.46 114.45 25.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.426 1.091 . . . . 0.0 109.967 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.4 m -118.78 170.62 8.84 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.277 0.0 OUTLIER -132.18 168.75 17.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.975 177.882 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 31' ' ' TRP . 1.1 tt0 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 125.997 1.719 . . . . 0.0 112.949 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.217 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.305 59.6 t -143.77 152.67 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 110.133 -177.416 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.1 t -153.39 135.67 14.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.236 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.541 ' HB3' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -94.28 161.34 14.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 123.403 1.573 . . . . 0.0 113.665 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . 0.315 57.2 m -87.06 169.66 12.21 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 111.955 -2.384 . . . . 0.0 107.358 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' A' ' 35' ' ' ASN . 17.1 p30 -66.64 -37.23 84.39 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.318 -1.489 . . . . 0.0 112.517 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -105.5 47.7 0.87 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.528 2.331 . . . . 0.0 110.071 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.13 -30.7 2.02 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.96 -84.62 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 125.119 1.342 . . . . 0.0 116.282 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -57.08 -2.2 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.851 3.701 . . . . 0.0 115.085 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 t -85.96 -28.67 24.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.875 1.27 . . . . 0.0 111.659 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.58 -172.91 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.25 -1.23 1.52 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.62 15.28 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.23 16.3 1.61 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 129.678 3.191 . . . . 0.0 116.692 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.8 p -135.98 134.51 38.67 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.0 mt -73.17 61.34 0.61 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.633 3.173 . . . . 0.0 112.475 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -69.39 -11.06 60.51 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.292 1.037 . . . . 0.0 111.82 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.64 -179.19 47.88 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -152.77 134.76 14.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 119.202 -2.352 . . . . 0.0 112.502 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.284 2.7 p -95.15 133.51 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 124.428 2.061 . . . . 0.0 105.691 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -121.0 130.22 53.71 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 130.859 3.664 . . . . 0.0 102.215 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -103.72 155.6 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.014 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.6 -35.32 2.26 Favored Glycine 0 CA--C 1.552 2.366 0 C-N-CA 118.406 -1.854 . . . . 0.0 113.567 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.6 p 175.95 167.71 0.41 Allowed 'General case' 0 CA--C 1.548 0.883 1 C-N-CA 132.073 4.149 . . . . 0.0 112.975 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -75.2 166.45 23.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.284 1.434 . . . . 0.0 110.222 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 136.74 36.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.784 2.034 . . . . 0.0 110.581 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -29.39 -55.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 129.739 3.216 . . . . 0.0 118.557 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.49 7.98 61.91 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -99.73 175.94 5.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.226 1.013 . . . . 0.0 111.298 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -147.86 167.1 25.65 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.756 -1.215 . . . . 0.0 109.229 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -63.36 115.3 4.47 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.404 1.082 . . . . 0.0 110.959 177.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.436 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 21.1 p -90.53 3.51 53.79 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.574 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 7' ' ' ASP . 19.7 p-10 -159.16 164.62 35.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.379 0.671 . . . . 0.0 112.293 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.58 -32.04 63.92 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -97.91 -176.05 3.33 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.562 1.945 . . . . 0.0 108.125 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.479 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.62 -65.43 0.37 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 118.717 -2.49 . . . . 0.0 111.289 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.24 177.39 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.723 1.725 . . . . 0.0 115.59 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -49.44 -40.49 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 131.1 3.76 . . . . 0.0 114.233 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.51 -47.1 0.19 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.263 3.425 . . . . 0.0 112.112 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -72.4 -167.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 131.684 3.994 . . . . 0.0 114.959 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -151.06 135.16 16.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.467 . . . . 0.0 114.916 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.5 138.99 30.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.348 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.1 m -145.12 168.38 20.48 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.323 2.249 . . . . 0.0 108.179 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.436 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.53 166.37 23.36 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.611 1.164 . . . . 0.0 112.375 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.944 0 C-N-CA 129.09 2.956 . . . . 0.0 113.07 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.572 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 24.5 t -113.69 141.85 28.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -148.31 127.57 12.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.297 7.7 ptp180 -79.38 176.41 9.72 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.2 m -118.46 173.66 6.7 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.008 2.523 . . . . 0.0 111.532 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.87 -57.76 6.78 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.162 1.385 . . . . 0.0 110.917 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.9 t -99.04 55.06 1.0 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 109.935 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -48.02 -40.9 24.12 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.09 62.48 0.06 OUTLIER Glycine 0 C--N 1.33 0.216 0 N-CA-C 117.463 1.745 . . . . 0.0 117.463 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.32 -16.9 57.59 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.965 2.443 . . . . 0.0 116.548 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -130.88 34.27 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 123.516 1.627 . . . . 0.0 114.849 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.51 164.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.185 -1.37 . . . . 0.0 114.644 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.58 65.91 1.35 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.146 1.778 . . . . 0.0 113.149 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.35 55.96 0.2 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.89 -4.77 17.71 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -96.99 146.73 24.69 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.53 2.332 . . . . 0.0 117.04 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 5' ' ' ARG . 15.2 mt -65.36 66.4 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 129.511 3.124 . . . . 0.0 115.797 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -65.78 -30.6 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 110.07 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.22 54.54 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -145.61 143.99 30.19 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 119.809 -1.994 . . . . 0.0 110.768 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.5 p -95.1 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 123.483 1.611 . . . . 0.0 109.309 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.75 102.61 7.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 129.532 3.133 . . . . 0.0 106.73 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 42' ' ' TYR . 47.6 t -76.29 133.37 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 109.959 -3.291 . . . . 0.0 107.69 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.13 -9.92 75.0 Favored Glycine 0 CA--C 1.556 2.612 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.849 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 129.41 162.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 1 C-N-CA 135.949 5.7 . . . . 0.0 115.434 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.51 153.98 2.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.843 3.257 . . . . 0.0 118.209 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 131.19 41.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.64 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 m -39.61 -4.78 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 1 C-N-CA 132.945 4.498 . . . . 0.0 120.809 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.29 4.18 2.0 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 125.581 1.562 . . . . 0.0 115.431 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -99.68 -179.39 4.17 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.884 1.274 . . . . 0.0 111.288 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -149.74 159.69 44.15 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.646 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.1 mptm? -59.14 124.31 19.55 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.005 1.322 . . . . 0.0 112.539 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 31.0 p -97.26 6.73 47.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.507 1.754 . . . . 0.0 110.749 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -157.63 171.5 20.21 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 118.953 0.797 . . . . 0.0 110.369 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.61 -48.78 53.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.949 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.52 -177.88 6.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.142 2.977 . . . . 0.0 109.498 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.65 -68.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 119.405 -2.059 . . . . 0.0 112.431 -177.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.81 174.51 1.77 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.989 1.376 . . . . 0.0 114.55 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 1 C-N-CA 131.818 4.047 . . . . 0.0 115.321 176.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.24 -46.74 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.35 3.06 . . . . 0.0 112.291 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -79.82 -168.62 1.66 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.639 3.976 . . . . 0.0 115.714 -176.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.1 mt-10 -147.21 126.89 13.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.873 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -89.33 122.13 32.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.024 0.916 . . . . 0.0 109.718 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -128.17 170.3 13.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.144 1.378 . . . . 0.0 107.707 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.274 0.0 OUTLIER -133.65 169.1 17.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.505 -179.78 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 127.618 2.367 . . . . 0.0 111.073 176.608 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.266 59.5 t -112.91 149.17 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 123.793 0.837 . . . . 0.0 108.868 178.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.8 t -155.88 108.83 2.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HB3' HD23 ' A' ' 18' ' ' LEU . 10.1 ptp85 -53.41 173.72 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 131.653 3.981 . . . . 0.0 115.847 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.9 -174.25 2.82 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 112.189 -2.278 . . . . 0.0 106.074 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -72.99 -55.09 7.03 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.304 -1.498 . . . . 0.0 107.546 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -78.26 32.04 0.18 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.412 2.285 . . . . 0.0 113.306 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 27.5 t70 -53.85 -10.83 0.34 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 -89.3 1.11 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.592 1.091 . . . . 0.0 113.742 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -54.78 -7.13 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 125.266 3.977 . . . . 0.0 115.963 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -92.48 -7.82 46.35 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -176.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.507 1.123 . . . . 0.0 112.14 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -71.16 -11.56 61.01 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.306 -1.496 . . . . 0.0 112.655 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.94 69.94 1.18 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.36 1.304 . . . . 0.0 116.36 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -133.55 -54.56 0.89 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.569 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.4 p -140.42 151.24 44.75 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 5' ' ' ARG . 5.0 mt -52.97 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.778 1 C-N-CA 131.756 4.022 . . . . 0.0 114.426 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 p -69.08 -23.13 63.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.42 0.688 . . . . 0.0 110.326 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 163.19 41.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -144.63 142.26 30.0 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.4 -1.647 . . . . 0.0 110.444 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.267 3.0 p -99.03 138.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 124.394 2.045 . . . . 0.0 108.22 176.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -130.45 113.8 14.75 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 131.583 3.953 . . . . 0.0 102.34 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.9 m -79.64 160.84 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.206 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.36 -66.75 3.43 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.58 164.52 12.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.463 2.305 . . . . 0.0 114.187 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.02 154.27 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.972 2.909 . . . . 0.0 116.465 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.04 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.637 1.975 . . . . 0.0 109.452 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -38.81 -30.7 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.01 5.32 30.51 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.719 1.152 . . . . 0.0 115.755 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -106.9 177.39 4.87 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.367 1.084 . . . . 0.0 111.789 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -147.26 167.23 24.77 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.5 mptp? -66.2 114.21 5.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.052 0.93 . . . . 0.0 111.774 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -86.87 2.35 49.42 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.349 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -159.56 170.69 21.11 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.468 -0.77 . . . . 0.0 113.005 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -73.37 -42.05 62.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.577 1.551 . . . . 0.0 112.99 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 11.8 pt-20 -87.87 -178.55 6.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.738 2.015 . . . . 0.0 109.944 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -142.99 -68.31 0.35 Allowed 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 119.391 -2.068 . . . . 0.0 109.674 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.43 175.71 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.487 1.515 . . . . 0.0 114.685 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -48.92 -39.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 1 C-N-CA 132.338 4.255 . . . . 0.0 114.652 176.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.72 -45.73 0.18 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 130.315 3.446 . . . . 0.0 111.959 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.554 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -76.5 -167.38 0.79 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 130.083 3.353 . . . . 0.0 115.925 -177.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -151.08 127.17 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.586 -1.643 . . . . 0.0 113.259 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 66.7 m -91.47 138.4 31.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.203 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.5 m -141.95 170.22 16.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.406 2.282 . . . . 0.0 107.468 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 169.5 16.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.121 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 127.138 2.175 . . . . 0.0 111.595 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.433 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.571 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.278 46.5 t -100.03 148.36 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.921 0.888 . . . . 0.0 110.011 -177.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB2' HG12 ' A' ' 22' ' ' VAL . 45.7 t -155.84 131.49 9.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HG3' HD23 ' A' ' 18' ' ' LEU . 15.1 mtm180 -67.12 177.21 1.85 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.1 m -122.95 165.27 17.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 130.058 3.343 . . . . 0.0 109.72 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -48.89 -47.13 43.4 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 127.529 2.332 . . . . 0.0 113.156 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -79.35 -18.37 52.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.53 1.932 . . . . 0.0 116.086 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CD ' ' A' ' 5' ' ' ARG 0.464 0.0 OUTLIER 30.08 46.59 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 131.455 3.902 . . . . 0.0 113.837 -177.235 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.85 71.81 0.04 OUTLIER Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.906 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -61.4 -7.82 9.38 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.591 3.528 . . . . 0.0 117.294 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t 72.05 32.41 1.81 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 127.8 2.44 . . . . 0.0 116.532 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.8 -162.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.407 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -64.21 87.59 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.773 2.029 . . . . 0.0 113.717 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.69 93.22 2.19 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.888 1.709 . . . . 0.0 115.366 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -67.16 -26.79 66.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -54.69 -171.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 130.67 3.588 . . . . 0.0 113.255 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.664 HD23 ' HG3' ' A' ' 5' ' ' ARG . 39.9 mt -60.76 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 129.295 3.038 . . . . 0.0 116.207 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -71.97 -24.01 61.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.172 2.189 . . . . 0.0 107.38 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.83 166.65 54.28 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 104.596 -3.402 . . . . 0.0 104.596 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.0 m -149.68 143.51 25.52 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 119.169 -2.371 . . . . 0.0 113.219 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.571 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.33 3.1 p -99.78 135.45 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 124.955 2.312 . . . . 0.0 107.992 176.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 5.9 m95 -126.79 132.99 50.91 Favored 'General case' 0 C--N 1.305 -1.366 1 C-N-CA 132.901 4.481 . . . . 0.0 102.149 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.1 m -103.99 157.38 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.495 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.11 -42.25 2.52 Favored Glycine 0 CA--C 1.554 2.513 0 C-N-CA 119.291 -1.433 . . . . 0.0 111.064 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -175.32 166.41 3.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 130.13 3.372 . . . . 0.0 110.469 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.74 159.89 32.31 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.37 2.268 . . . . 0.0 113.435 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.31 134.81 48.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.173 2.189 . . . . 0.0 110.649 177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -23.16 -62.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.864 3.265 . . . . 0.0 118.676 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 11.19 65.12 Favored Glycine 0 N--CA 1.463 0.469 0 C-N-CA 125.829 1.68 . . . . 0.0 116.268 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -104.64 173.76 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.191 0.996 . . . . 0.0 111.213 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -153.0 165.32 35.92 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.755 -1.216 . . . . 0.0 111.814 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 2.1 mptp? -58.95 107.28 0.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.877 2.071 . . . . 0.0 113.912 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.0 p -86.64 4.5 40.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.949 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -154.56 176.43 12.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.956 1.702 . . . . 0.0 110.931 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.15 -52.05 8.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.578 1.151 . . . . 0.0 111.566 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.6 -174.14 4.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.538 1.935 . . . . 0.0 109.343 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.72 -70.22 0.36 Allowed 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.467 -2.02 . . . . 0.0 110.219 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.14 176.23 1.41 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.743 1.617 . . . . 0.0 113.936 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -45.13 -37.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 1 C-N-CA 131.815 4.046 . . . . 0.0 115.316 176.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -149.73 -43.37 0.14 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.48 2.712 . . . . 0.0 112.284 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -78.0 -167.42 1.0 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 131.564 3.946 . . . . 0.0 115.949 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 27.3 mt-10 -150.49 131.21 14.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.157 -1.383 . . . . 0.0 114.013 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 61.7 m -94.66 130.23 41.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.004 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -135.09 174.81 10.19 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.19 2.196 . . . . 0.0 108.755 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.254 0.0 OUTLIER -135.42 169.21 17.85 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.614 1.166 . . . . 0.0 113.244 178.016 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 115.854 -2.022 . . . . 0.0 114.315 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.989 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.503 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.292 51.5 t -101.98 148.74 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.237 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.3 t -151.63 130.62 12.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.704 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -98.25 157.4 16.19 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m -82.17 155.82 24.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 110.501 -3.045 . . . . 0.0 107.511 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.18 -21.36 47.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.745 1.157 . . . . 0.0 113.168 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.2 p -106.96 -10.04 16.08 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.693 2.797 . . . . 0.0 115.519 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.458 1.0 OUTLIER 40.92 2.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 1 C-N-CA 134.705 5.202 . . . . 0.0 119.17 -177.425 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 67.31 0.14 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 126.84 2.162 . . . . 0.0 112.012 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.37 -16.05 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 124.484 3.456 . . . . 0.0 116.743 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -115.57 -20.69 10.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 119.366 0.985 . . . . 0.0 113.444 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.91 147.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.83 1.252 . . . . 0.0 110.921 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.4 111.49 1.25 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.441 1.496 . . . . 0.0 113.179 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -156.96 70.33 0.27 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.84 0.733 . . . . 0.0 113.25 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -49.45 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 1 C-N-CA 134.16 4.984 . . . . 0.0 120.432 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.5 p -131.32 174.0 10.5 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 128.884 2.874 . . . . 0.0 113.905 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.252 27.2 mt -73.0 75.78 1.19 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.775 1.23 . . . . 0.0 112.26 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.3 p -81.38 -17.42 49.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.43 3.492 . . . . 0.0 112.207 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.3 176.58 25.61 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.262 2.363 . . . . 0.0 111.04 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -141.64 137.88 32.13 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.252 3.2 p -97.2 136.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 124.174 1.94 . . . . 0.0 106.178 176.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -123.45 128.75 50.26 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 131.012 3.725 . . . . 0.0 103.059 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.3 m -100.27 158.49 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.353 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.44 -36.81 1.57 Allowed Glycine 0 CA--C 1.556 2.653 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.259 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.8 t 177.43 167.92 0.63 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 130.41 3.484 . . . . 0.0 110.607 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.11 156.78 33.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.574 1.95 . . . . 0.0 113.435 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 132.87 48.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.641 1.976 . . . . 0.0 110.257 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -28.18 -50.84 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.841 3.256 . . . . 0.0 118.15 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.79 5.56 54.0 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -101.41 174.61 5.9 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.436 1.118 . . . . 0.0 111.741 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -150.47 167.35 27.4 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.024 -1.048 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -66.25 114.11 5.08 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 125.092 1.357 . . . . 0.0 113.404 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 23.5 p -94.69 5.54 51.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.663 176.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -151.85 171.39 17.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.135 -0.978 . . . . 0.0 112.944 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.67 -51.9 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.286 1.434 . . . . 0.0 111.066 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.53 -170.57 3.17 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.531 1.532 . . . . 0.0 108.291 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.522 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.32 -62.78 0.37 Allowed 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 119.364 -2.085 . . . . 0.0 109.68 177.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.34 175.2 0.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -48.77 -39.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 131.186 3.794 . . . . 0.0 114.166 176.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -143.89 -49.55 0.3 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.686 3.194 . . . . 0.0 111.846 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.57 -166.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 133.426 4.691 . . . . 0.0 115.989 -177.135 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 25.4 mt-10 -150.89 130.92 13.41 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.25 136.87 33.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.178 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.91 169.22 19.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.521 1.928 . . . . 0.0 107.582 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.257 0.0 OUTLIER -135.81 168.17 19.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.739 -178.901 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 129.231 3.012 . . . . 0.0 110.687 177.449 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 46.5 t -128.96 148.5 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 118.696 -0.669 . . . . 0.0 109.921 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.402 ' CA ' HD22 ' A' ' 18' ' ' LEU . 44.1 t -152.18 132.68 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.714 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.3 ptp180 -98.89 158.55 15.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -177.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -85.22 169.58 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.589 3.156 . . . . 0.0 112.528 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -60.01 -18.82 48.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -123.33 -18.29 6.3 Favored 'General case' 0 C--N 1.32 -0.682 1 C-N-CA 132.162 4.185 . . . . 0.0 114.463 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.503 5.2 p-10 46.23 17.86 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 130.44 3.496 . . . . 0.0 116.105 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.49 66.91 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 129.687 3.517 . . . . 0.0 111.423 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.31 -2.13 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.518 3.479 . . . . 0.0 116.959 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -135.38 -32.75 0.92 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -153.26 -170.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.19 1.796 . . . . 0.0 111.201 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.62 114.89 1.39 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.669 1.988 . . . . 0.0 111.903 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.73 6.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.631 1.586 . . . . 0.0 111.751 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.92 -25.65 1.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.658 1.983 . . . . 0.0 113.255 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.7 p -134.0 167.16 21.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.879 2.072 . . . . 0.0 112.107 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 5' ' ' ARG . 23.5 mt -56.1 66.01 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.244 3.018 . . . . 0.0 117.642 -177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 t -79.38 5.37 12.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.887 1.675 . . . . 0.0 112.743 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.68 171.3 14.94 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.209 2.337 . . . . 0.0 108.776 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -140.39 138.67 34.97 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.9 p -96.99 139.25 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 123.943 1.83 . . . . 0.0 106.405 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.65 112.3 16.63 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 129.724 3.21 . . . . 0.0 103.479 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.711 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.2 t -79.74 143.56 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.103 -177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 -51.48 4.11 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 178.33 164.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 128.943 2.897 . . . . 0.0 113.978 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.8 155.51 22.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.287 2.635 . . . . 0.0 116.66 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.21 135.03 47.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.966 1.706 . . . . 0.0 110.354 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 m -39.18 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 1 C-N-CA 132.174 4.19 . . . . 0.0 120.643 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.21 1.27 7.71 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.971 1.272 . . . . 0.0 114.84 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.39 179.04 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.21 1.404 . . . . 0.0 110.303 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -149.24 165.46 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.09 -1.006 . . . . 0.0 109.864 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.73 114.59 3.39 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.422 1.089 . . . . 0.0 112.205 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 26.5 p -92.96 10.31 31.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.19 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -163.11 170.6 17.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.1 -53.47 17.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.621 1.568 . . . . 0.0 111.959 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -80.0 -177.51 6.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.017 2.927 . . . . 0.0 110.129 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.51 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.8 -65.67 0.36 Allowed 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 119.484 -2.01 . . . . 0.0 109.945 177.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.46 175.0 0.59 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -49.46 -37.02 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 1 C-N-CA 131.713 4.005 . . . . 0.0 114.426 176.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.15 -49.52 0.21 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 129.983 3.313 . . . . 0.0 111.501 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.711 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -73.35 -167.3 0.41 Allowed 'General case' 0 N--CA 1.443 -0.814 1 C-N-CA 131.711 4.004 . . . . 0.0 116.475 -177.193 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.1 mt-10 -148.41 130.8 15.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.06 137.5 32.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.75 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.9 m -149.14 170.26 18.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 108.692 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.89 173.48 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.534 1.534 . . . . 0.0 112.832 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 128.947 2.899 . . . . 0.0 109.896 176.583 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.507 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.272 48.5 t -103.94 147.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.36 0.664 . . . . 0.0 109.468 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' HD22 ' A' ' 18' ' ' LEU . 35.9 t -157.1 111.89 2.76 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.402 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -72.82 175.8 6.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.305 1.442 . . . . 0.0 113.995 -178.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.21 174.32 7.46 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.448 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.57 -47.71 66.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -99.01 -28.2 13.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.832 0.853 . . . . 0.0 112.88 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CB ' ' HD3' ' A' ' 5' ' ' ARG 0.368 0.7 OUTLIER 58.2 -23.84 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 130.975 3.71 . . . . 0.0 117.118 -176.921 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.78 -72.59 0.58 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 127.487 2.47 . . . . 0.0 117.088 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.61 -3.21 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.179 3.253 . . . . 0.0 114.288 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -93.84 -21.54 19.21 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 p -175.07 152.2 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.327 1.051 . . . . 0.0 111.781 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -73.03 79.18 1.2 Allowed 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.584 -1.323 . . . . 0.0 113.312 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.22 143.31 6.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.444 1.973 . . . . 0.0 113.565 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -51.07 8.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 1 C-N-CA 132.632 4.373 . . . . 0.0 120.37 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.3 p -66.82 146.79 54.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 131.008 3.723 . . . . 0.0 115.352 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 4' ' ' CYS 0.269 74.1 mt -78.66 54.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.548 -2.115 . . . . 0.0 114.116 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -71.85 -27.23 62.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.61 155.61 48.65 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 104.467 -3.453 . . . . 0.0 104.467 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.1 m -140.49 143.55 35.54 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 120.766 -1.432 . . . . 0.0 113.35 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.278 3.5 p -97.17 136.28 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 124.577 2.132 . . . . 0.0 107.984 176.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -122.33 122.17 38.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 108.867 -3.788 . . . . 0.0 102.851 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.713 HG22 ' CG ' ' A' ' 42' ' ' TYR . 42.3 t -93.27 139.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.944 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.47 -19.53 10.79 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.544 -1.142 . . . . 0.0 114.402 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 166.35 153.97 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 130.491 3.516 . . . . 0.0 111.884 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -66.49 154.94 38.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.123 2.169 . . . . 0.0 112.198 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 133.54 49.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.358 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -35.7 -28.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 131.185 3.794 . . . . 0.0 120.155 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.32 3.37 12.55 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.17 1.366 . . . . 0.0 114.839 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -99.77 177.64 5.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.976 1.31 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -150.27 163.82 37.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.5 mptm? -61.25 120.04 9.6 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.432 1.093 . . . . 0.0 112.443 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.41 2.47 55.77 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.557 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -151.66 165.56 33.96 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 119.705 1.139 . . . . 0.0 110.767 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -43.34 89.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.459 1.123 . . . . 0.0 112.675 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.36 -173.99 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 109.597 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -68.8 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 119.543 -1.973 . . . . 0.0 111.957 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.06 175.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.24 1.816 . . . . 0.0 114.152 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -47.95 -37.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 1 C-N-CA 132.109 4.163 . . . . 0.0 115.444 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.99 -42.16 0.15 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.463 3.105 . . . . 0.0 112.896 -176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.713 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -82.39 -169.64 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.909 3.284 . . . . 0.0 116.141 -176.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.4 mt-10 -149.46 124.56 10.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.226 177.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.34 110.77 20.47 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.278 1.431 . . . . 0.0 110.096 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -114.91 171.72 7.48 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.306 1.442 . . . . 0.0 108.531 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 168.17 19.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.674 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 129.938 3.295 . . . . 0.0 110.137 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.274 47.3 t -107.36 150.57 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.923 0.889 . . . . 0.0 109.274 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.408 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.1 t -152.89 121.07 6.21 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.1 ptp180 -73.62 172.55 11.19 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.414 1.886 . . . . 0.0 115.6 -177.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.0 m -109.41 169.81 8.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.663 2.385 . . . . 0.0 111.703 -177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -52.86 -33.7 50.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.768 1.627 . . . . 0.0 114.908 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -127.55 64.24 1.35 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.492 2.717 . . . . 0.0 109.196 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.73 -24.01 0.5 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.622 1.969 . . . . 0.0 115.586 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 69.49 0.9 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 122.168 3.627 . . . . 0.0 122.168 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.03 -30.28 47.83 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.512 2.808 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 t -87.95 2.81 50.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -140.87 168.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -176.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.496 ' H ' HG12 ' A' ' 13' ' ' VAL . 3.4 m170 -51.63 -37.19 49.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.121 2.168 . . . . 0.0 114.802 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.49 35.41 3.02 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -65.17 24.48 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 129.944 3.298 . . . . 0.0 117.164 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -134.09 178.0 7.3 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.419 2.288 . . . . 0.0 112.673 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 5' ' ' ARG . 19.7 mt -67.51 65.3 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.108 2.163 . . . . 0.0 114.249 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -73.95 -27.14 60.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.645 2.778 . . . . 0.0 109.375 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.19 165.55 45.22 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -140.72 142.09 34.85 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.301 -1.117 . . . . 0.0 113.527 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.275 3.2 p -100.25 136.12 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 124.465 2.079 . . . . 0.0 106.928 176.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -126.62 124.93 41.03 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 131.634 3.974 . . . . 0.0 102.422 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.534 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.5 m -93.16 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.005 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.77 -61.16 3.7 Favored Glycine 0 CA--C 1.554 2.529 0 C-N-CA 119.241 -1.456 . . . . 0.0 110.76 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 t -158.95 158.77 33.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 128.295 2.638 . . . . 0.0 112.234 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -68.45 158.98 32.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.37 1.868 . . . . 0.0 112.688 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.89 42.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.905 2.482 . . . . 0.0 111.146 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 p -20.84 -63.22 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.552 3.541 . . . . 0.0 118.57 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.05 9.9 67.88 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.035 1.574 . . . . 0.0 117.035 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -101.6 174.11 6.12 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.374 1.087 . . . . 0.0 110.825 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -149.99 168.0 25.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.861 -1.149 . . . . 0.0 110.551 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -60.42 111.45 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.918 1.687 . . . . 0.0 112.496 177.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 16.8 p -93.46 10.69 31.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -159.61 165.95 31.7 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.587 1.155 . . . . 0.0 110.556 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.79 -36.28 80.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.04 1.336 . . . . 0.0 112.657 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -102.2 -175.14 2.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.254 2.622 . . . . 0.0 110.191 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.527 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -136.95 -68.16 0.49 Allowed 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 119.538 -1.976 . . . . 0.0 110.137 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.4 174.22 1.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -46.09 -42.42 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 1 C-N-CA 132.122 4.169 . . . . 0.0 114.338 176.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.01 -44.32 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 130.823 3.649 . . . . 0.0 111.951 -176.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -79.04 -166.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 130.54 3.536 . . . . 0.0 116.087 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 15.9 mt-10 -152.11 127.22 9.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.806 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -91.13 136.07 33.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.995 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -142.18 167.78 21.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.738 2.015 . . . . 0.0 108.849 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.265 0.0 OUTLIER -130.04 165.83 21.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.11 179.82 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 C-N-CA 129.456 3.102 . . . . 0.0 112.234 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.259 56.4 t -121.08 147.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.392 0.596 . . . . 0.0 110.386 -177.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.43 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.9 t -151.74 125.8 9.2 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.546 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.1 ptt180 -95.22 175.61 6.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.851 1.31 . . . . 0.0 113.317 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 26.4 p -123.67 174.84 7.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.09 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.73 -30.9 46.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.495 1.918 . . . . 0.0 115.182 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -96.5 -18.56 19.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.048 2.139 . . . . 0.0 113.709 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.306 0.9 OUTLIER 39.7 27.19 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.247 3.419 . . . . 0.0 115.7 -177.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 14' ' ' HIS . . . -173.83 70.75 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.31 -20.68 26.15 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.289 3.326 . . . . 0.0 115.866 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.1 p -114.33 -34.05 5.42 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.99 2.116 . . . . 0.0 110.835 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -174.43 138.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 127.929 2.492 . . . . 0.0 107.153 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 20.9 p-80 -84.25 161.29 20.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.87 2.468 . . . . 0.0 114.966 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 28.66 0.02 OUTLIER Glycine 0 N--CA 1.473 1.103 0 N-CA-C 117.341 1.696 . . . . 0.0 117.341 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 52.88 48.65 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 129.257 3.023 . . . . 0.0 115.058 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.0 p -121.29 156.53 32.34 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.784 1.754 . . . . 0.0 113.994 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.306 28.4 mt -81.59 53.8 2.21 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.386 1.474 . . . . 0.0 112.918 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -76.93 29.53 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.072 2.149 . . . . 0.0 110.479 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . -142.5 173.05 24.07 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 130.168 3.747 . . . . 0.0 108.381 177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -148.15 139.67 23.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.482 -1.01 . . . . 0.0 111.448 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.275 2.5 p -98.24 131.04 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 124.338 2.018 . . . . 0.0 105.774 176.134 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -115.2 124.29 51.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 109.114 -3.675 . . . . 0.0 103.337 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.624 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.6 m -92.67 161.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.38 -59.67 4.78 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -178.54 166.72 1.8 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.379 3.471 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.85 157.01 35.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.548 2.339 . . . . 0.0 117.258 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 129.66 39.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.96 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -34.71 -31.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 131.28 3.832 . . . . 0.0 119.713 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.14 29.57 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.754 1.169 . . . . 0.0 115.638 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -104.3 174.4 5.89 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.998 1.319 . . . . 0.0 111.463 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -151.56 167.98 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.201 -0.937 . . . . 0.0 111.368 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -69.23 110.54 4.64 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 113.724 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.5 t -84.88 -2.98 58.48 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.196 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -156.72 165.63 35.7 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.863 -1.148 . . . . 0.0 111.205 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -73.97 -26.25 60.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -101.56 175.06 5.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.661 1.584 . . . . 0.0 109.876 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.518 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -139.76 -62.62 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.689 -1.882 . . . . 0.0 110.629 -177.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.62 177.27 0.2 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.953 1.701 . . . . 0.0 115.132 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -51.46 -35.73 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 131.658 3.983 . . . . 0.0 114.092 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -152.55 -44.73 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 130.362 3.465 . . . . 0.0 112.986 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.624 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -73.85 -169.83 0.8 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.909 3.284 . . . . 0.0 113.9 -177.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 17.3 mt-10 -148.42 129.3 14.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.874 1.321 . . . . 0.0 114.498 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.4 132.06 34.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.76 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.6 m -142.34 173.57 11.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.085 1.754 . . . . 0.0 108.262 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -137.91 166.72 23.34 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 129.715 3.206 . . . . 0.0 113.129 177.444 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 22' ' ' VAL . 87.5 t -130.41 132.14 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.446 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' CB ' HG23 ' A' ' 22' ' ' VAL . 48.0 t -153.78 125.55 7.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.5 ptp85 -89.56 164.07 14.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.97 1.367 . . . . 0.0 112.825 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.92 159.64 26.28 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.386 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.4 -12.15 13.19 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.0 p -113.62 -14.09 12.67 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.744 2.018 . . . . 0.0 114.451 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.344 0.5 OUTLIER 43.29 -8.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 1 C-N-CA 135.881 5.672 . . . . 0.0 118.466 -177.474 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.89 70.97 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.97 0 O-C-N 121.155 -0.966 . . . . 0.0 112.9 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.27 -20.03 53.23 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.418 3.412 . . . . 0.0 116.478 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -105.23 -38.08 6.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 127.866 2.466 . . . . 0.0 110.015 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.72 131.97 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.874 1.269 . . . . 0.0 110.093 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -41.16 125.37 2.45 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.318 2.247 . . . . 0.0 114.13 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.53 70.59 0.41 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 117.463 1.745 . . . . 0.0 117.463 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -27.84 62.12 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.676 1.226 . . . . 0.0 112.12 177.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -71.08 118.75 14.24 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 129.049 2.939 . . . . 0.0 111.209 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 3' ' ' HYP 0.296 18.0 mt -60.77 66.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.945 2.898 . . . . 0.0 115.487 -176.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -75.48 -14.53 60.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.763 2.025 . . . . 0.0 110.451 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.26 174.14 33.57 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.8 m -155.74 148.04 23.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 119.553 -2.145 . . . . 0.0 112.581 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -92.57 140.66 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 126.79 2.036 . . . . 0.0 109.368 177.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 11.9 m95 -132.44 109.59 9.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG12 ' CD1' ' A' ' 42' ' ' TYR . 2.4 m -75.02 160.42 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.852 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.44 -62.72 4.28 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -177.96 165.0 1.94 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 130.799 3.64 . . . . 0.0 112.089 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -51.7 151.74 3.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 129.607 3.163 . . . . 0.0 117.786 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.58 135.52 48.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.197 1.799 . . . . 0.0 110.89 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.77 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 131.433 3.893 . . . . 0.0 119.208 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.1 8.63 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 125.954 1.74 . . . . 0.0 116.773 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -101.27 177.26 4.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -151.03 165.48 33.65 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 121.54 -0.725 . . . . 0.0 110.32 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.6 mptm? -64.1 121.7 14.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.26 1.024 . . . . 0.0 113.643 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.35 4.07 53.77 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.403 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -158.48 170.07 23.03 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 120.462 1.483 . . . . 0.0 114.049 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.5 -29.61 56.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -101.85 178.44 4.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 107.942 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.82 -64.4 0.38 Allowed 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 119.719 -1.863 . . . . 0.0 109.452 -177.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.49 171.41 0.44 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.977 2.111 . . . . 0.0 113.862 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -50.7 -38.44 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 131.024 3.73 . . . . 0.0 114.776 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -134.72 -48.0 0.75 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 129.502 3.121 . . . . 0.0 113.309 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.535 ' CD1' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -85.78 -168.17 2.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 129.908 3.283 . . . . 0.0 116.25 -177.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 60.1 mt-10 -142.95 135.6 27.7 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.417 -2.174 . . . . 0.0 112.328 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -93.74 129.03 40.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.15 1.38 . . . . 0.0 109.565 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.3 m -135.27 171.82 13.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.92 1.288 . . . . 0.0 108.237 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -135.05 165.76 24.61 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.53 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.246 1.818 . . . . 0.0 114.079 177.315 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.527 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.301 57.5 t -145.99 152.64 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.066 1.346 . . . . 0.0 110.593 -177.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t -151.38 133.51 15.21 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -83.43 177.84 8.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.065 1.346 . . . . 0.0 113.238 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.5 m -106.88 169.99 8.21 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.507 1.923 . . . . 0.0 108.867 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.75 -54.38 15.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 t -87.08 1.51 52.71 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.4 2.5 p-10 36.27 34.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 130.544 3.538 . . . . 0.0 116.696 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.95 59.56 0.25 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 116.962 1.545 . . . . 0.0 116.962 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.72 -17.32 13.08 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.075 3.183 . . . . 0.0 116.211 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.474 ' C ' HG22 ' A' ' 13' ' ' VAL . 71.4 m 60.68 64.37 1.18 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 131.81 4.044 . . . . 0.0 119.181 177.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -156.92 -47.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -176.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -75.98 -54.97 6.07 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 131.65 3.98 . . . . 0.0 116.29 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.72 -169.34 42.01 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 127.023 2.249 . . . . 0.0 111.834 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.92 4.28 44.92 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -136.4 -172.09 3.06 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.11 2.564 . . . . 0.0 112.149 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt -55.18 53.98 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.65 3.58 . . . . 0.0 116.824 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 t -69.58 -15.11 63.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.785 0.834 . . . . 0.0 111.078 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.3 173.59 55.25 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -153.29 143.66 22.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 118.914 -2.521 . . . . 0.0 113.017 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.527 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.291 2.6 p -99.78 132.3 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-O 124.434 2.064 . . . . 0.0 107.265 176.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -121.26 110.5 16.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 109.134 -3.666 . . . . 0.0 103.739 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.652 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -80.95 160.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.586 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -55.11 4.8 Favored Glycine 0 CA--C 1.552 2.385 0 C-N-CA 118.234 -1.936 . . . . 0.0 109.337 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.2 t 175.52 164.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.133 3.773 . . . . 0.0 113.265 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.35 151.28 44.36 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 127.922 2.489 . . . . 0.0 116.382 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.79 53.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.487 1.915 . . . . 0.0 111.332 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -32.0 -17.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 1 C-N-CA 134.298 5.039 . . . . 0.0 121.253 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.81 10.2 2.6 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 125.466 1.507 . . . . 0.0 115.274 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -99.71 178.6 4.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.105 0.962 . . . . 0.0 110.735 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -147.98 168.13 23.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.325 -0.859 . . . . 0.0 110.83 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -63.35 109.34 1.56 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.58 177.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.21 -3.35 58.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.027 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -150.51 165.43 33.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.084 1.354 . . . . 0.0 110.882 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.4 -47.69 69.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.327 1.051 . . . . 0.0 112.923 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.62 -176.37 6.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 128.509 2.723 . . . . 0.0 109.57 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.496 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.8 -70.43 0.42 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 119.645 -1.909 . . . . 0.0 108.493 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.98 177.12 2.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 114.438 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -44.55 -38.5 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 131.354 3.862 . . . . 0.0 113.349 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.21 -52.67 0.18 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 130.407 3.483 . . . . 0.0 111.321 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.652 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -65.8 -170.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.888 1 C-N-CA 131.859 4.063 . . . . 0.0 113.889 -177.107 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 38' ' ' TYR . 13.6 mt-10 -147.6 125.54 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 87.0 m -89.78 135.17 33.79 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.021 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.3 m -142.86 173.65 11.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.686 2.394 . . . . 0.0 106.829 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 170.3 16.21 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.218 1.007 . . . . 0.0 110.384 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.325 2.25 . . . . 0.0 110.015 176.546 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.471 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 38.2 t -113.01 142.99 23.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.672 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -149.63 132.2 15.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 18' ' ' LEU . 1.7 ptp180 -96.72 158.52 15.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 122.721 1.248 . . . . 0.0 114.322 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m -82.25 -179.83 7.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.723 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -35.16 76.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.053 2.141 . . . . 0.0 111.626 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.2 t -116.2 53.63 0.86 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.011 1.724 . . . . 0.0 109.519 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -57.42 -29.33 64.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.1 66.38 0.03 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.841 1.686 . . . . 0.0 115.328 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.75 -10.53 27.95 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.756 2.971 . . . . 0.0 117.752 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -146.15 22.42 1.37 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 p -161.39 168.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 127.153 2.181 . . . . 0.0 108.304 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -71.47 119.45 15.63 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.536 -1.352 . . . . 0.0 112.787 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.55 138.14 27.0 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -98.0 -74.47 0.58 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.096 0.959 . . . . 0.0 112.752 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.5 p -152.33 170.37 20.22 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.5 mt -73.79 63.93 0.92 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.294 2.638 . . . . 0.0 111.393 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -68.19 -25.78 65.4 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.078 1.351 . . . . 0.0 108.73 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.61 160.09 48.72 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.7 m -141.27 141.38 33.96 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.298 -1.119 . . . . 0.0 111.709 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.4 p -94.72 137.29 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 124.399 2.047 . . . . 0.0 107.01 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -121.32 119.75 33.08 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 110.304 -3.135 . . . . 0.0 103.89 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CG ' ' A' ' 42' ' ' TYR . 41.7 t -90.46 144.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.546 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.46 -35.47 2.23 Favored Glycine 0 CA--C 1.555 2.557 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.301 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t 175.77 152.69 0.15 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.067 2.947 . . . . 0.0 112.503 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.73 160.68 11.29 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.593 1.957 . . . . 0.0 111.385 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.79 132.34 38.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.316 1.446 . . . . 0.0 109.393 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -28.12 -50.33 0.07 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 130.045 3.338 . . . . 0.0 117.732 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 3.59 61.49 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.08 1.592 . . . . 0.0 117.08 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -101.62 -179.23 3.96 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.723 1.262 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -151.84 163.81 38.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 121.149 -0.969 . . . . 0.0 109.41 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.7 mptm? -61.06 118.66 7.06 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 112.973 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -92.29 5.13 51.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.057 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -157.51 168.65 26.69 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-N 120.563 1.529 . . . . 0.0 113.097 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.51 -48.17 73.45 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.489 1.515 . . . . 0.0 112.561 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -88.58 -177.94 5.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.991 2.116 . . . . 0.0 108.14 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.436 ' HD2' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.21 -59.85 0.38 Allowed 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 118.76 -2.462 . . . . 0.0 110.635 -177.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 172.44 175.45 0.09 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.135 2.174 . . . . 0.0 113.959 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -49.05 -38.21 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 130.872 3.669 . . . . 0.0 114.122 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -143.53 -52.64 0.35 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 129.665 3.186 . . . . 0.0 111.936 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -69.85 -169.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.744 1 C-N-CA 132.137 4.175 . . . . 0.0 116.347 -177.223 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 28.1 mt-10 -148.74 128.47 13.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.24 115.39 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.758 1.223 . . . . 0.0 111.112 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.3 m -124.39 167.64 14.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.786 1.279 . . . . 0.0 107.776 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.96 168.88 18.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.098 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 128.212 2.605 . . . . 0.0 113.507 177.246 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.561 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 48.5 t -135.05 148.26 29.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.41 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' HD22 ' A' ' 18' ' ' LEU . 53.9 t -152.64 116.9 4.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.422 ' H ' ' CD2' ' A' ' 18' ' ' LEU 0.294 0.0 OUTLIER -91.12 175.0 7.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.851 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.4 p -115.98 -179.28 3.61 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.925 2.49 . . . . 0.0 112.632 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.11 -53.86 46.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.802 0.811 . . . . 0.0 109.225 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 t -88.63 43.55 1.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.591 1.157 . . . . 0.0 111.142 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -41.71 -41.83 2.39 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.795 1.638 . . . . 0.0 112.681 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.1 60.46 0.03 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 125.61 1.576 . . . . 0.0 116.739 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -63.28 -16.04 52.02 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.386 3.391 . . . . 0.0 117.695 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -69.73 -22.56 63.37 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.99 -157.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.113 2.165 . . . . 0.0 111.02 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.88 82.22 2.16 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 112.1 177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 109.05 2.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.81 -15.14 0.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 117.003 2.224 . . . . 0.0 117.003 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.4 p -130.79 154.14 48.32 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 124.228 1.966 . . . . 0.0 115.652 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 4' ' ' CYS . 25.5 mt -70.82 63.11 0.29 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.558 2.743 . . . . 0.0 116.629 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -68.96 -11.96 61.2 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.231 0.613 . . . . 0.0 111.656 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.92 175.1 41.46 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.353 1.93 . . . . 0.0 110.49 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -149.48 142.72 25.11 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.16 -1.788 . . . . 0.0 113.219 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.561 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.6 p -101.32 137.99 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 124.119 1.914 . . . . 0.0 106.291 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.423 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 7.7 m95 -125.16 119.14 27.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 130.88 3.672 . . . . 0.0 103.181 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -87.18 161.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.455 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.34 -63.45 3.93 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.076 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 p -162.16 161.04 27.85 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.188 2.595 . . . . 0.0 113.05 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -61.57 160.99 10.35 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.787 1.279 . . . . 0.0 113.653 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -77.07 133.08 39.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.945 2.098 . . . . 0.0 110.153 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.7 p -18.87 -65.77 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 130.716 3.607 . . . . 0.0 117.894 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 9.48 70.6 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.802 1.668 . . . . 0.0 116.896 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -99.25 174.8 6.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.433 1.116 . . . . 0.0 111.024 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -149.95 168.72 23.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.805 -1.184 . . . . 0.0 111.034 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -67.77 112.8 5.05 Favored 'General case' 0 CA--C 1.511 -0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 113.053 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 22.2 t -88.02 -1.71 58.16 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.862 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -157.79 167.69 29.31 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.093 -1.004 . . . . 0.0 111.498 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.63 -33.48 68.98 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.6 177.21 5.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 110.627 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.541 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.24 -64.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 119.708 -1.87 . . . . 0.0 110.487 -177.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 174.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.154 1.781 . . . . 0.0 115.046 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.59 -42.35 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 131.026 3.73 . . . . 0.0 113.884 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -141.91 -46.55 0.35 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 130.708 3.603 . . . . 0.0 112.827 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.585 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -74.4 -169.16 0.77 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 130.024 3.329 . . . . 0.0 115.447 -177.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.4 mt-10 -148.04 126.34 12.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 123.309 1.528 . . . . 0.0 114.263 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.76 132.25 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.467 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.4 m -143.42 170.79 15.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.517 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -136.0 167.83 20.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.784 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 129.059 2.944 . . . . 0.0 112.328 177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.317 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.297 66.2 t -148.32 151.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 110.471 -177.176 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.495 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.1 t -155.42 116.13 3.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.872 ' HG3' HD23 ' A' ' 18' ' ' LEU . 12.9 mtm180 -69.5 -175.6 0.86 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.922 2.296 . . . . 0.0 111.884 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 8.5 p -142.31 170.32 15.93 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 129.69 3.196 . . . . 0.0 110.309 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.14 -38.81 91.78 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.338 1.055 . . . . 0.0 109.064 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -93.35 25.53 3.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.617 2.767 . . . . 0.0 112.153 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -53.71 -20.15 5.1 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 121.036 1.744 . . . . 0.0 113.609 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.07 71.68 0.01 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.1 -16.87 48.71 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.114 2.543 . . . . 0.0 117.651 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.3 m -87.24 -16.94 33.75 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.85 137.42 5.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -38.01 106.23 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.888 1.675 . . . . 0.0 115.472 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.99 67.74 2.04 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.746 1.641 . . . . 0.0 114.091 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -61.5 -33.64 74.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.653 2.781 . . . . 0.0 112.296 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.1 p -140.16 155.75 46.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 124.03 1.871 . . . . 0.0 113.428 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' A' ' 5' ' ' ARG . 5.5 mt -61.87 83.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.749 3.62 . . . . 0.0 114.716 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -75.8 0.95 16.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.685 0.794 . . . . 0.0 111.448 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.36 162.83 12.27 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.235 2.826 . . . . 0.0 107.818 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.1 m -146.91 141.56 26.68 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.377 -1.661 . . . . 0.0 110.506 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.323 2.5 p -96.34 133.23 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 124.91 2.291 . . . . 0.0 108.541 176.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -121.46 112.71 18.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 109.343 -3.571 . . . . 0.0 104.213 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.2 m -86.63 158.11 3.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 112.959 -1.928 . . . . 0.0 107.497 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.72 -50.5 3.28 Favored Glycine 0 CA--C 1.553 2.439 0 C-N-CA 119.127 -1.511 . . . . 0.0 112.071 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -178.32 160.61 1.34 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.294 3.438 . . . . 0.0 111.768 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.07 161.84 7.99 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.909 2.484 . . . . 0.0 114.664 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 145.57 40.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.735 2.014 . . . . 0.0 110.647 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -32.37 -54.72 0.33 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 119.482 3.142 . . . . 0.0 119.482 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.28 14.05 30.8 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 124.692 1.139 . . . . 0.0 115.204 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -96.95 173.31 7.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.66 0.743 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -151.0 166.83 29.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 43' ' ' GLU . 4.3 mptp? -63.38 124.97 22.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.613 0.765 . . . . 0.0 111.487 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 37.8 t -96.59 1.27 51.1 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.838 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.66 168.22 26.55 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 121.238 -0.914 . . . . 0.0 109.724 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -16.59 56.25 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -105.36 175.43 5.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.973 1.309 . . . . 0.0 108.181 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 119.901 -1.749 . . . . 0.0 109.972 -176.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.68 -178.57 0.16 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.707 2.003 . . . . 0.0 113.626 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -52.94 -38.16 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 131.501 3.921 . . . . 0.0 113.341 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -149.51 -50.93 0.15 Allowed 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 130.505 3.522 . . . . 0.0 111.204 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.612 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -69.92 -172.38 0.52 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.33 3.452 . . . . 0.0 112.772 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 7.2 mm-40 -146.4 128.67 15.77 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 72.8 m -86.91 123.68 32.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.64 173.94 10.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.799 2.04 . . . . 0.0 107.562 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.287 0.0 OUTLIER -138.12 172.67 12.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.793 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.871 2.869 . . . . 0.0 110.447 176.922 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.302 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.281 56.0 t -100.41 150.09 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.728 1.211 . . . . 0.0 109.73 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HYP . . . . . 0.434 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.4 t -159.16 112.69 2.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.886 ' HG3' HD23 ' A' ' 18' ' ' LEU . 59.1 mtm180 -69.91 -176.77 1.16 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 113.465 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p -133.87 177.29 7.84 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 129.888 3.275 . . . . 0.0 112.264 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.22 -48.77 77.96 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.689 1.196 . . . . 0.0 111.623 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -70.65 -30.43 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.38 1.472 . . . . 0.0 114.907 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' A' ' 5' ' ' ARG 0.442 0.0 OUTLIER 43.0 -11.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 1 C-N-CA 136.66 5.984 . . . . 0.0 119.685 -177.447 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.87 67.26 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 127.232 2.349 . . . . 0.0 112.623 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.93 -29.32 41.32 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.362 2.708 . . . . 0.0 114.86 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -130.39 10.96 5.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -159.1 155.76 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 126.472 1.909 . . . . 0.0 109.914 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -58.36 109.68 0.82 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.524 2.33 . . . . 0.0 113.56 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.53 89.79 1.03 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.04 0.828 . . . . 0.0 114.162 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -110.68 -34.3 6.32 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.68 1.192 . . . . 0.0 112.719 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.6 p -146.84 -177.92 5.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.45 2.7 . . . . 0.0 111.995 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' A' ' 5' ' ' ARG 0.252 17.2 mt -63.54 69.97 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 128.58 2.752 . . . . 0.0 117.216 -177.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.2 t -64.73 -30.68 71.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.426 1.49 . . . . 0.0 109.158 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.33 157.72 38.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.2 m -140.22 138.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 122.003 -0.704 . . . . 0.0 111.915 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.308 3.3 p -96.77 134.27 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-O 124.807 2.241 . . . . 0.0 108.103 176.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -119.64 122.02 40.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 108.994 -3.73 . . . . 0.0 103.73 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.3 m -96.74 156.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.6 -12.6 7.75 Favored Glycine 0 CA--C 1.557 2.695 0 C-N-CA 118.769 -1.681 . . . . 0.0 115.48 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 142.91 162.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 1 C-N-CA 135.985 5.714 . . . . 0.0 113.946 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -70.45 154.46 41.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.894 2.477 . . . . 0.0 115.35 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 131.78 46.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.251 1.82 . . . . 0.0 108.551 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -28.96 -63.62 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.296 2.638 . . . . 0.0 116.87 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.2 5.33 84.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -97.44 177.68 5.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.753 1.277 . . . . 0.0 111.074 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -152.3 166.07 32.97 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.2 mptm? -64.46 121.83 15.31 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.327 1.051 . . . . 0.0 113.103 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.7 t -91.25 0.03 57.6 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.157 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -160.73 166.89 27.94 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 119.83 1.196 . . . . 0.0 109.302 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -22.26 59.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.16 171.48 7.3 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.936 1.695 . . . . 0.0 108.832 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.32 -67.7 0.47 Allowed 'General case' 0 C--O 1.223 -0.32 0 O-C-N 120.187 -1.571 . . . . 0.0 110.161 -177.215 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.14 174.71 0.71 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 112.906 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -48.13 -35.98 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 130.924 3.69 . . . . 0.0 115.046 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -150.27 -44.54 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 113.136 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.562 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -76.96 -171.22 1.9 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.07 2.948 . . . . 0.0 113.55 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mt-10 -148.85 120.69 8.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 81.0 m -83.66 104.14 13.54 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.594 1.558 . . . . 0.0 109.445 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.9 m -111.52 175.73 5.31 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.54 1.162 . . . . 0.0 108.937 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -139.46 173.89 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.246 0.904 0 C-N-CA 128.799 2.84 . . . . 0.0 109.622 176.82 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.302 55.1 t -125.9 151.81 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.052 1.341 . . . . 0.0 111.128 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -157.15 127.75 6.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.758 ' HG3' HD23 ' A' ' 18' ' ' LEU . 44.6 mtm180 -75.75 154.7 36.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 123.973 1.844 . . . . 0.0 114.369 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.1 m -89.13 166.53 13.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 110.047 -3.251 . . . . 0.0 108.995 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.0 -46.1 92.14 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.609 -1.307 . . . . 0.0 112.228 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -95.79 43.75 1.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.94 1.696 . . . . 0.0 110.529 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -38.34 -35.68 0.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.677 2.791 . . . . 0.0 116.511 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.34 -84.63 0.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.39 -7.4 0.78 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.149 3.233 . . . . 0.0 115.041 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.98 -24.92 52.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.124 0.874 . . . . 0.0 111.293 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.08 143.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 122.992 1.377 . . . . 0.0 113.059 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -2.42 0.41 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 128.069 2.548 . . . . 0.0 116.486 -177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.89 117.83 0.91 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.08 2.752 . . . . 0.0 109.629 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -53.98 -11.53 0.45 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.8 t -58.5 162.62 3.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.488 1.515 . . . . 0.0 113.092 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.758 HD23 ' HG3' ' A' ' 5' ' ' ARG . 37.6 mt -66.73 61.2 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.819 2.447 . . . . 0.0 116.972 -177.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t -66.52 -37.19 84.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.504 1.922 . . . . 0.0 109.57 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.07 46.88 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 m -135.92 134.51 38.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 120.745 -1.444 . . . . 0.0 113.098 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.481 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 3.5 p -93.37 137.37 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 124.316 2.008 . . . . 0.0 106.228 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -122.58 119.73 31.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 109.997 -3.274 . . . . 0.0 103.127 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 ' CG ' ' A' ' 42' ' ' TYR . 51.2 t -93.3 138.83 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.279 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -48.24 3.68 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -170.18 158.2 6.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.269 1.828 . . . . 0.0 114.251 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.0 161.42 18.72 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.327 1.537 . . . . 0.0 112.688 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 133.89 40.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.488 1.915 . . . . 0.0 109.346 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -34.96 -40.81 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.653 3.181 . . . . 0.0 118.801 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.61 4.14 39.79 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -100.41 177.59 4.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.012 1.325 . . . . 0.0 111.653 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -151.2 166.97 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.294 -0.879 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.75 118.7 7.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.632 1.573 . . . . 0.0 112.882 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.3 p -99.03 11.75 38.06 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.303 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -158.66 158.36 33.63 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 110.091 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -25.25 59.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.588 0.709 . . . . 0.0 112.321 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.24 -169.86 1.75 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.108 2.563 . . . . 0.0 109.485 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.83 -65.26 0.37 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 119.114 -2.241 . . . . 0.0 112.436 177.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.68 176.8 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -51.24 -40.03 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 1 C-N-CA 131.701 4.001 . . . . 0.0 113.977 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.17 -48.4 0.27 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.074 3.35 . . . . 0.0 111.405 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.674 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.52 -164.73 0.43 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.014 4.126 . . . . 0.0 116.484 -177.027 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.2 mt-10 -148.62 129.73 14.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.506 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.55 134.43 34.13 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.981 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.32 169.81 16.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.941 1.696 . . . . 0.0 108.929 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.311 0.0 OUTLIER -134.62 168.27 19.29 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.722 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.084 1 C-N-CA 132.406 4.282 . . . . 0.0 109.447 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.293 67.4 t -142.61 151.19 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.947 1.699 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.1 t -154.92 122.1 5.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.882 ' HG3' HD23 ' A' ' 18' ' ' LEU . 40.0 mtm180 -73.31 -171.83 1.03 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.249 1.82 . . . . 0.0 113.568 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.2 p -151.35 -178.87 6.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.886 2.474 . . . . 0.0 114.072 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' H ' ' HB3' ' A' ' 35' ' ' ASN . 15.5 t70 -52.72 -47.24 67.45 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.383 2.273 . . . . 0.0 112.451 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -91.69 -6.36 52.17 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.897 1.279 . . . . 0.0 113.908 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 5' ' ' ARG 0.484 0.2 OUTLIER 46.52 -14.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 136.149 5.78 . . . . 0.0 119.974 -177.436 . . . . . . . . 5 4 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.67 65.35 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 127.221 2.343 . . . . 0.0 110.989 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -53.31 -16.2 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.594 4.196 . . . . 0.0 118.159 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 m -77.68 -21.87 51.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 125.488 1.515 . . . . 0.0 113.942 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.45 -151.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.468 1.507 . . . . 0.0 112.85 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -119.1 -11.48 9.62 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 129.231 3.012 . . . . 0.0 114.707 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.22 90.22 1.11 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.592 1.568 . . . . 0.0 116.445 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -56.76 69.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.522 3.529 . . . . 0.0 114.752 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.7 p -134.85 170.67 15.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.168 2.187 . . . . 0.0 115.175 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.882 HD23 ' HG3' ' A' ' 5' ' ' ARG . 32.2 mt -71.42 52.73 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.459 1.904 . . . . 0.0 114.152 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 m -69.88 -25.79 63.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.941 1.296 . . . . 0.0 108.373 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.75 170.66 55.04 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.8 m -148.99 142.82 25.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 119.534 -2.156 . . . . 0.0 112.148 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.257 2.8 p -98.33 135.64 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.535 2.112 . . . . 0.0 106.46 176.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -126.17 127.07 45.14 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.021 4.128 . . . . 0.0 102.403 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.479 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -97.61 159.72 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.46 -49.5 3.03 Favored Glycine 0 CA--C 1.557 2.71 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.3 t -169.33 169.02 9.34 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 129.741 3.216 . . . . 0.0 111.34 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.08 165.94 24.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.404 2.282 . . . . 0.0 113.632 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.7 142.82 35.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.881 1.672 . . . . 0.0 112.544 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -35.07 -8.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 C-N-CA 134.697 5.199 . . . . 0.0 122.236 -177.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.22 9.96 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.005 1.764 . . . . 0.0 114.807 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.75 177.92 5.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.044 1.338 . . . . 0.0 110.863 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -152.81 167.67 28.27 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.12 -0.987 . . . . 0.0 110.787 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -64.16 113.51 3.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.387 1.875 . . . . 0.0 111.557 177.174 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 38.9 t -87.84 1.7 53.28 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.31 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' ' 7' ' ' ASP . 16.3 p-10 -158.9 167.25 29.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.622 1.569 . . . . 0.0 110.637 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.28 -42.51 79.44 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -89.37 177.73 6.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.378 2.271 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.27 -68.67 0.45 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 119.879 -1.763 . . . . 0.0 111.191 -177.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.43 170.72 0.78 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.07 1.748 . . . . 0.0 115.164 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.5 tp -44.32 -44.22 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 1 C-N-CA 131.768 4.027 . . . . 0.0 115.214 176.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -136.68 -48.19 0.62 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.989 3.315 . . . . 0.0 111.938 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -76.71 -165.25 0.51 Allowed 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.084 4.154 . . . . 0.0 116.54 -177.337 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 16.5 mt-10 -152.58 127.58 9.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.12 -1.855 . . . . 0.0 113.664 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.41 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.5 m -91.66 129.02 37.7 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -135.41 175.32 9.69 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.287 1.835 . . . . 0.0 108.303 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.273 0.0 OUTLIER -138.96 173.17 11.84 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 177.586 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.101 4.56 . . . . 0.0 109.069 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.303 57.2 t -93.16 151.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.776 1.63 . . . . 0.0 110.07 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.2 t -148.83 137.36 21.18 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.474 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 43.6 mtm180 -66.49 178.67 1.19 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.325 2.25 . . . . 0.0 111.052 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.72 178.57 7.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.789 2.036 . . . . 0.0 112.357 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.65 -32.94 73.13 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 126.074 1.75 . . . . 0.0 113.113 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 t -118.05 48.01 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.156 1.782 . . . . 0.0 108.392 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.57 -27.19 57.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.99 64.91 0.03 OUTLIER Glycine 0 C--N 1.338 0.672 0 C-N-CA 124.919 1.247 . . . . 0.0 115.876 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.96 -24.33 53.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.321 2.681 . . . . 0.0 117.425 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -94.83 -22.95 17.71 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 119.781 1.173 . . . . 0.0 113.683 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.28 138.31 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.05 0.94 . . . . 0.0 111.944 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -57.75 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.813 2.045 . . . . 0.0 114.349 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.0 103.59 0.27 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.098 0.856 . . . . 0.0 113.267 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 54.37 2.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 124.462 2.077 . . . . 0.0 110.889 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 p -82.67 101.7 11.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 68.4 mt -77.15 44.89 0.42 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.278 2.231 . . . . 0.0 113.779 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -66.77 -29.91 69.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.02 0.928 . . . . 0.0 108.765 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.36 176.3 34.91 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.734 2.112 . . . . 0.0 108.102 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.0 m -151.34 139.24 19.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 119.046 -2.444 . . . . 0.0 112.92 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 5.0 p -96.1 135.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 124.247 1.975 . . . . 0.0 106.935 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -122.47 108.94 13.75 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 109.97 -3.286 . . . . 0.0 104.15 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -79.14 160.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 112.653 -2.067 . . . . 0.0 106.695 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.11 -49.15 4.06 Favored Glycine 0 CA--C 1.567 3.339 0 C-N-CA 118.672 -1.728 . . . . 0.0 109.766 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t 165.29 164.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 1 C-N-CA 134.011 4.924 . . . . 0.0 113.271 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.89 154.87 3.7 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 129.626 3.17 . . . . 0.0 117.119 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.36 43.13 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.864 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -29.91 -44.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.999 3.719 . . . . 0.0 118.571 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.74 8.72 34.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.439 1.495 . . . . 0.0 116.576 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -102.54 179.39 4.31 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.772 1.229 . . . . 0.0 111.048 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -149.1 160.82 42.99 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.069 -1.019 . . . . 0.0 109.777 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -57.77 112.75 1.57 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.471 1.509 . . . . 0.0 112.26 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.2 p -85.1 5.08 31.21 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.246 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -159.09 165.46 33.81 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.275 0.943 . . . . 0.0 110.416 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.8 -35.85 75.2 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.893 0.746 . . . . 0.0 112.982 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.98 -175.77 4.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.069 2.148 . . . . 0.0 107.527 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.532 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.31 -67.2 0.33 Allowed 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 119.091 -2.256 . . . . 0.0 111.168 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.57 174.55 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.392 1.877 . . . . 0.0 112.354 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -47.38 -32.38 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 130.765 3.626 . . . . 0.0 115.589 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -155.42 -42.45 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 128.797 2.839 . . . . 0.0 113.863 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.646 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -78.22 -169.26 1.55 Allowed 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.939 3.296 . . . . 0.0 113.894 -176.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 53.1 mt-10 -150.65 123.45 8.64 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.3 m -86.38 117.41 25.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 123.403 1.573 . . . . 0.0 110.789 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.45 174.69 7.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.231 1.813 . . . . 0.0 109.514 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.334 0.0 OUTLIER -137.28 170.56 15.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 177.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.249 1.031 1 C-N-CA 132.651 4.38 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.0 t . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.56 174.0 11.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 113.854 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 127.262 2.225 . . . . 0.0 111.834 -177.175 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 4' ' ' CYS . 36.7 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -78.47 -13.5 59.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.123 1.769 . . . . 0.0 109.493 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.35 166.61 32.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 129.057 3.218 . . . . 0.0 106.89 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.5 m -145.82 145.9 30.95 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.194 -1.18 . . . . 0.0 113.347 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG21 ' HD2' ' A' ' 42' ' ' TYR . 3.2 p -100.23 136.2 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 124.341 2.019 . . . . 0.0 107.122 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -127.59 113.23 15.82 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 130.594 3.558 . . . . 0.0 102.563 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 42' ' ' TYR . 2.4 m -80.25 163.94 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.265 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -56.85 4.87 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t 177.09 170.04 0.54 Allowed 'General case' 0 N--CA 1.485 1.316 1 C-N-CA 131.922 4.089 . . . . 0.0 112.247 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.45 172.87 0.2 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 129.471 3.108 . . . . 0.0 116.927 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.7 140.81 29.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.547 1.939 . . . . 0.0 110.723 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -44.02 -12.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 1 C-N-CA 132.199 4.2 . . . . 0.0 120.915 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.12 2.87 5.16 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.063 1.316 . . . . 0.0 114.63 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -104.95 177.51 4.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.493 1.117 . . . . 0.0 110.983 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -150.37 169.53 21.21 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.618 -0.676 . . . . 0.0 110.87 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -64.44 118.16 8.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 113.461 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 30.3 p -95.53 7.18 47.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.58 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -159.26 167.1 29.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.502 1.121 . . . . 0.0 111.429 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -76.94 -32.8 57.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 122.13 0.967 . . . . 0.0 112.877 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -96.73 -175.88 3.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.053 1.741 . . . . 0.0 108.059 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.548 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.03 -66.82 0.37 Allowed 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 118.821 -2.424 . . . . 0.0 109.681 -178.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.98 171.7 0.84 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -45.39 -41.72 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 130.514 3.526 . . . . 0.0 114.756 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -140.42 -49.37 0.45 Allowed 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 129.924 3.29 . . . . 0.0 112.298 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.586 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.39 -166.67 0.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 130.775 3.63 . . . . 0.0 116.613 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.6 mt-10 -150.63 129.96 12.86 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.979 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 74.6 m -92.71 138.87 31.12 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.102 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.5 m -144.88 170.58 15.86 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 126.77 2.028 . . . . 0.0 108.466 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.98 168.03 19.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.245 0.864 0 C-N-CA 127.353 2.261 . . . . 0.0 113.493 177.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.6 t . . . . . 0 N--CA 1.442 -0.856 0 CA-C-O 120.8 0.333 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -75.77 -172.7 1.99 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 122.28 1.038 . . . . 0.0 113.463 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.8 m . . . . . 0 CA--C 1.544 0.741 0 C-N-CA 126.58 1.952 . . . . 0.0 112.079 -177.22 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 4' ' ' CYS . 87.2 mt . . . . . 0 CA--C 1.548 0.875 0 CA-C-O 120.628 0.251 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -74.18 52.24 0.45 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.355 2.662 . . . . 0.0 110.355 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.26 -173.99 37.35 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 129.092 3.234 . . . . 0.0 108.464 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.7 m -157.23 137.9 13.16 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.011 -1.876 . . . . 0.0 109.657 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 42' ' ' TYR . 4.4 p -93.67 137.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-O 124.414 2.054 . . . . 0.0 107.913 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.19 116.03 22.73 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 130.845 3.658 . . . . 0.0 103.509 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.682 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.9 t -87.09 143.38 11.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.463 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.06 -53.45 4.81 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 p -167.54 154.5 8.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.756 2.022 . . . . 0.0 115.179 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -59.63 151.34 25.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.491 1.916 . . . . 0.0 112.534 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.86 136.87 53.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.077 1.351 . . . . 0.0 109.745 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 p -24.53 -68.29 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.919 3.288 . . . . 0.0 117.191 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.42 9.84 75.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.12 1.819 . . . . 0.0 116.319 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.416 ' CD2' ' HB2' ' A' ' 47' ' ' GLN . 7.3 m95 -98.32 177.87 5.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.897 1.348 . . . . 0.0 110.798 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -148.9 161.85 41.03 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.254 -0.904 . . . . 0.0 109.108 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.0 mptm? -62.64 123.05 17.37 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 124.412 1.085 . . . . 0.0 112.399 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 28.4 p -98.27 9.57 42.7 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.764 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -158.8 169.58 24.05 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.277 0.944 . . . . 0.0 112.378 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.56 -52.08 24.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.331 1.052 . . . . 0.0 111.074 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -167.91 1.92 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -147.56 -57.95 0.25 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 119.506 -1.996 . . . . 0.0 110.575 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.91 175.87 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.359 2.664 . . . . 0.0 114.157 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.62 -39.43 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 1 C-N-CA 132.588 4.355 . . . . 0.0 115.97 176.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.47 -47.54 0.26 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 129.121 2.968 . . . . 0.0 112.191 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.682 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -77.25 -167.46 0.91 Allowed 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 131.708 4.003 . . . . 0.0 116.746 -177.034 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 84.1 mt-10 -149.8 124.01 9.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 65.5 m -88.46 114.45 25.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.426 1.091 . . . . 0.0 109.967 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.4 m -118.78 170.62 8.84 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.277 0.0 OUTLIER -132.18 168.75 17.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.975 177.882 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 31' ' ' TRP . 1.1 tt0 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 125.997 1.719 . . . . 0.0 112.949 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 121.266 0.555 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.541 ' HB3' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -94.28 161.34 14.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 123.403 1.573 . . . . 0.0 113.665 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . 0.315 57.2 m . . . . . 0 CA--C 1.553 1.073 0 CA-C-N 111.955 -2.384 . . . . 0.0 107.358 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.0 mt . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -69.39 -11.06 60.51 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.292 1.037 . . . . 0.0 111.82 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.64 -179.19 47.88 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -152.77 134.76 14.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 119.202 -2.352 . . . . 0.0 112.502 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.284 2.7 p -95.15 133.51 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 124.428 2.061 . . . . 0.0 105.691 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -121.0 130.22 53.71 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 130.859 3.664 . . . . 0.0 102.215 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -103.72 155.6 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.014 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.6 -35.32 2.26 Favored Glycine 0 CA--C 1.552 2.366 0 C-N-CA 118.406 -1.854 . . . . 0.0 113.567 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.6 p 175.95 167.71 0.41 Allowed 'General case' 0 CA--C 1.548 0.883 1 C-N-CA 132.073 4.149 . . . . 0.0 112.975 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -75.2 166.45 23.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.284 1.434 . . . . 0.0 110.222 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 136.74 36.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.784 2.034 . . . . 0.0 110.581 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -29.39 -55.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 129.739 3.216 . . . . 0.0 118.557 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.49 7.98 61.91 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -99.73 175.94 5.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.226 1.013 . . . . 0.0 111.298 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -147.86 167.1 25.65 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.756 -1.215 . . . . 0.0 109.229 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -63.36 115.3 4.47 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.404 1.082 . . . . 0.0 110.959 177.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.436 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 21.1 p -90.53 3.51 53.79 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.574 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -159.16 164.62 35.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.379 0.671 . . . . 0.0 112.293 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.58 -32.04 63.92 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -97.91 -176.05 3.33 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.562 1.945 . . . . 0.0 108.125 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.479 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.62 -65.43 0.37 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 118.717 -2.49 . . . . 0.0 111.289 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.24 177.39 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.723 1.725 . . . . 0.0 115.59 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -49.44 -40.49 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 131.1 3.76 . . . . 0.0 114.233 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.51 -47.1 0.19 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.263 3.425 . . . . 0.0 112.112 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -72.4 -167.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 131.684 3.994 . . . . 0.0 114.959 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -151.06 135.16 16.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.467 . . . . 0.0 114.916 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.5 138.99 30.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.348 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.1 m -145.12 168.38 20.48 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.323 2.249 . . . . 0.0 108.179 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.436 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.53 166.37 23.36 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.611 1.164 . . . . 0.0 112.375 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.944 0 C-N-CA 129.09 2.956 . . . . 0.0 113.07 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 CA--C 1.528 0.131 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.297 7.7 ptp180 -79.38 176.41 9.72 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.2 m . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 128.008 2.523 . . . . 0.0 111.532 -176.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 5' ' ' ARG . 15.2 mt . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -65.78 -30.6 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 110.07 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.22 54.54 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -145.61 143.99 30.19 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 119.809 -1.994 . . . . 0.0 110.768 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.5 p -95.1 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 123.483 1.611 . . . . 0.0 109.309 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.75 102.61 7.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 129.532 3.133 . . . . 0.0 106.73 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 42' ' ' TYR . 47.6 t -76.29 133.37 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 109.959 -3.291 . . . . 0.0 107.69 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.13 -9.92 75.0 Favored Glycine 0 CA--C 1.556 2.612 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.849 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 129.41 162.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 1 C-N-CA 135.949 5.7 . . . . 0.0 115.434 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.51 153.98 2.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.843 3.257 . . . . 0.0 118.209 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 131.19 41.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.64 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 m -39.61 -4.78 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 1 C-N-CA 132.945 4.498 . . . . 0.0 120.809 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.29 4.18 2.0 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 125.581 1.562 . . . . 0.0 115.431 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -99.68 -179.39 4.17 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.884 1.274 . . . . 0.0 111.288 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -149.74 159.69 44.15 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.646 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.1 mptm? -59.14 124.31 19.55 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.005 1.322 . . . . 0.0 112.539 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 31.0 p -97.26 6.73 47.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.507 1.754 . . . . 0.0 110.749 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -157.63 171.5 20.21 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 118.953 0.797 . . . . 0.0 110.369 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.61 -48.78 53.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.949 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.52 -177.88 6.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.142 2.977 . . . . 0.0 109.498 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.65 -68.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 119.405 -2.059 . . . . 0.0 112.431 -177.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.81 174.51 1.77 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.989 1.376 . . . . 0.0 114.55 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 1 C-N-CA 131.818 4.047 . . . . 0.0 115.321 176.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.24 -46.74 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.35 3.06 . . . . 0.0 112.291 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -79.82 -168.62 1.66 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.639 3.976 . . . . 0.0 115.714 -176.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.1 mt-10 -147.21 126.89 13.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.873 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -89.33 122.13 32.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.024 0.916 . . . . 0.0 109.718 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -128.17 170.3 13.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.144 1.378 . . . . 0.0 107.707 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.274 0.0 OUTLIER -133.65 169.1 17.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.505 -179.78 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 127.618 2.367 . . . . 0.0 111.073 176.608 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HB3' HD23 ' A' ' 18' ' ' LEU . 10.1 ptp85 -53.41 173.72 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 131.653 3.981 . . . . 0.0 115.847 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.442 -0.838 0 CA-C-N 112.189 -2.278 . . . . 0.0 106.074 176.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 5' ' ' ARG . 5.0 mt . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 p -69.08 -23.13 63.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.42 0.688 . . . . 0.0 110.326 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 163.19 41.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -144.63 142.26 30.0 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.4 -1.647 . . . . 0.0 110.444 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.456 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.267 3.0 p -99.03 138.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 124.394 2.045 . . . . 0.0 108.22 176.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -130.45 113.8 14.75 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 131.583 3.953 . . . . 0.0 102.34 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.9 m -79.64 160.84 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.206 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.36 -66.75 3.43 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.58 164.52 12.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.463 2.305 . . . . 0.0 114.187 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.02 154.27 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.972 2.909 . . . . 0.0 116.465 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.04 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.637 1.975 . . . . 0.0 109.452 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -38.81 -30.7 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.01 5.32 30.51 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.719 1.152 . . . . 0.0 115.755 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -106.9 177.39 4.87 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.367 1.084 . . . . 0.0 111.789 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -147.26 167.23 24.77 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.5 mptp? -66.2 114.21 5.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.052 0.93 . . . . 0.0 111.774 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -86.87 2.35 49.42 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.349 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -159.56 170.69 21.11 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.468 -0.77 . . . . 0.0 113.005 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -73.37 -42.05 62.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.577 1.551 . . . . 0.0 112.99 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 11.8 pt-20 -87.87 -178.55 6.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.738 2.015 . . . . 0.0 109.944 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -142.99 -68.31 0.35 Allowed 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 119.391 -2.068 . . . . 0.0 109.674 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.43 175.71 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.487 1.515 . . . . 0.0 114.685 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -48.92 -39.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 1 C-N-CA 132.338 4.255 . . . . 0.0 114.652 176.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.72 -45.73 0.18 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 130.315 3.446 . . . . 0.0 111.959 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.554 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -76.5 -167.38 0.79 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 130.083 3.353 . . . . 0.0 115.925 -177.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -151.08 127.17 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.586 -1.643 . . . . 0.0 113.259 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 66.7 m -91.47 138.4 31.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.203 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.5 m -141.95 170.22 16.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.406 2.282 . . . . 0.0 107.468 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 169.5 16.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.121 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 127.138 2.175 . . . . 0.0 111.595 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB2' HG12 ' A' ' 22' ' ' VAL . 45.7 t . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HG3' HD23 ' A' ' 18' ' ' LEU . 15.1 mtm180 -67.12 177.21 1.85 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 130.058 3.343 . . . . 0.0 109.72 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.664 HD23 ' HG3' ' A' ' 5' ' ' ARG . 39.9 mt . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -71.97 -24.01 61.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.172 2.189 . . . . 0.0 107.38 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.83 166.65 54.28 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 104.596 -3.402 . . . . 0.0 104.596 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.0 m -149.68 143.51 25.52 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 119.169 -2.371 . . . . 0.0 113.219 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 4' ' ' CYS 0.33 3.1 p -99.78 135.45 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 124.955 2.312 . . . . 0.0 107.992 176.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 5.9 m95 -126.79 132.99 50.91 Favored 'General case' 0 C--N 1.305 -1.366 1 C-N-CA 132.901 4.481 . . . . 0.0 102.149 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.1 m -103.99 157.38 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.495 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.11 -42.25 2.52 Favored Glycine 0 CA--C 1.554 2.513 0 C-N-CA 119.291 -1.433 . . . . 0.0 111.064 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -175.32 166.41 3.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 130.13 3.372 . . . . 0.0 110.469 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.74 159.89 32.31 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.37 2.268 . . . . 0.0 113.435 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.31 134.81 48.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.173 2.189 . . . . 0.0 110.649 177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -23.16 -62.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.864 3.265 . . . . 0.0 118.676 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 11.19 65.12 Favored Glycine 0 N--CA 1.463 0.469 0 C-N-CA 125.829 1.68 . . . . 0.0 116.268 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -104.64 173.76 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.191 0.996 . . . . 0.0 111.213 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -153.0 165.32 35.92 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.755 -1.216 . . . . 0.0 111.814 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 2.1 mptp? -58.95 107.28 0.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.877 2.071 . . . . 0.0 113.912 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.0 p -86.64 4.5 40.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.949 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -154.56 176.43 12.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.956 1.702 . . . . 0.0 110.931 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.15 -52.05 8.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.578 1.151 . . . . 0.0 111.566 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.6 -174.14 4.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.538 1.935 . . . . 0.0 109.343 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.72 -70.22 0.36 Allowed 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.467 -2.02 . . . . 0.0 110.219 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.14 176.23 1.41 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.743 1.617 . . . . 0.0 113.936 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -45.13 -37.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 1 C-N-CA 131.815 4.046 . . . . 0.0 115.316 176.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -149.73 -43.37 0.14 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.48 2.712 . . . . 0.0 112.284 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -78.0 -167.42 1.0 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 131.564 3.946 . . . . 0.0 115.949 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 27.3 mt-10 -150.49 131.21 14.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.157 -1.383 . . . . 0.0 114.013 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 61.7 m -94.66 130.23 41.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.004 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -135.09 174.81 10.19 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.19 2.196 . . . . 0.0 108.755 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.254 0.0 OUTLIER -135.42 169.21 17.85 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.614 1.166 . . . . 0.0 113.244 178.016 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 115.854 -2.022 . . . . 0.0 114.315 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.704 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -98.25 157.4 16.19 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.547 0.845 0 CA-C-N 110.501 -3.045 . . . . 0.0 107.511 177.42 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.252 27.2 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.696 0.76 . . . . 0.0 112.26 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.3 p -81.38 -17.42 49.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.43 3.492 . . . . 0.0 112.207 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.3 176.58 25.61 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.262 2.363 . . . . 0.0 111.04 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -141.64 137.88 32.13 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.252 3.2 p -97.2 136.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 124.174 1.94 . . . . 0.0 106.178 176.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -123.45 128.75 50.26 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 131.012 3.725 . . . . 0.0 103.059 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.3 m -100.27 158.49 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.353 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.44 -36.81 1.57 Allowed Glycine 0 CA--C 1.556 2.653 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.259 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.8 t 177.43 167.92 0.63 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 130.41 3.484 . . . . 0.0 110.607 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.11 156.78 33.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.574 1.95 . . . . 0.0 113.435 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 132.87 48.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.641 1.976 . . . . 0.0 110.257 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -28.18 -50.84 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.841 3.256 . . . . 0.0 118.15 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.79 5.56 54.0 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -101.41 174.61 5.9 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.436 1.118 . . . . 0.0 111.741 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -150.47 167.35 27.4 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.024 -1.048 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -66.25 114.11 5.08 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 125.092 1.357 . . . . 0.0 113.404 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 23.5 p -94.69 5.54 51.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.663 176.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -151.85 171.39 17.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.135 -0.978 . . . . 0.0 112.944 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.67 -51.9 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.286 1.434 . . . . 0.0 111.066 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.53 -170.57 3.17 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.531 1.532 . . . . 0.0 108.291 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.522 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.32 -62.78 0.37 Allowed 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 119.364 -2.085 . . . . 0.0 109.68 177.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.34 175.2 0.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -48.77 -39.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 131.186 3.794 . . . . 0.0 114.166 176.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -143.89 -49.55 0.3 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.686 3.194 . . . . 0.0 111.846 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.57 -166.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 133.426 4.691 . . . . 0.0 115.989 -177.135 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 25.4 mt-10 -150.89 130.92 13.41 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.25 136.87 33.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.178 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.91 169.22 19.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.521 1.928 . . . . 0.0 107.582 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.257 0.0 OUTLIER -135.81 168.17 19.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.739 -178.901 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 129.231 3.012 . . . . 0.0 110.687 177.449 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.402 ' CA ' HD22 ' A' ' 18' ' ' LEU . 44.1 t . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.714 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.3 ptp180 -98.89 158.55 15.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -177.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 129.589 3.156 . . . . 0.0 112.528 -177.335 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 5' ' ' ARG . 23.5 mt . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 t -79.38 5.37 12.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.887 1.675 . . . . 0.0 112.743 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.68 171.3 14.94 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.209 2.337 . . . . 0.0 108.776 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -140.39 138.67 34.97 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.9 p -96.99 139.25 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 123.943 1.83 . . . . 0.0 106.405 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.65 112.3 16.63 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 129.724 3.21 . . . . 0.0 103.479 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.711 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.2 t -79.74 143.56 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.103 -177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 -51.48 4.11 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 178.33 164.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 128.943 2.897 . . . . 0.0 113.978 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.8 155.51 22.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.287 2.635 . . . . 0.0 116.66 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.21 135.03 47.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.966 1.706 . . . . 0.0 110.354 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 m -39.18 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 1 C-N-CA 132.174 4.19 . . . . 0.0 120.643 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.21 1.27 7.71 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.971 1.272 . . . . 0.0 114.84 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.39 179.04 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.21 1.404 . . . . 0.0 110.303 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -149.24 165.46 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.09 -1.006 . . . . 0.0 109.864 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.73 114.59 3.39 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.422 1.089 . . . . 0.0 112.205 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 26.5 p -92.96 10.31 31.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.19 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -163.11 170.6 17.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.1 -53.47 17.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.621 1.568 . . . . 0.0 111.959 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -80.0 -177.51 6.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.017 2.927 . . . . 0.0 110.129 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.51 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.8 -65.67 0.36 Allowed 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 119.484 -2.01 . . . . 0.0 109.945 177.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.46 175.0 0.59 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -49.46 -37.02 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 1 C-N-CA 131.713 4.005 . . . . 0.0 114.426 176.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.15 -49.52 0.21 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 129.983 3.313 . . . . 0.0 111.501 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.711 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -73.35 -167.3 0.41 Allowed 'General case' 0 N--CA 1.443 -0.814 1 C-N-CA 131.711 4.004 . . . . 0.0 116.475 -177.193 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.1 mt-10 -148.41 130.8 15.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.06 137.5 32.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.75 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.9 m -149.14 170.26 18.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 108.692 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.89 173.48 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.534 1.534 . . . . 0.0 112.832 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 128.947 2.899 . . . . 0.0 109.896 176.583 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' HD22 ' A' ' 18' ' ' LEU . 35.9 t . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.402 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -72.82 175.8 6.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.305 1.442 . . . . 0.0 113.995 -178.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.448 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 4' ' ' CYS 0.269 74.1 mt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -71.85 -27.23 62.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.61 155.61 48.65 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 104.467 -3.453 . . . . 0.0 104.467 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.1 m -140.49 143.55 35.54 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 120.766 -1.432 . . . . 0.0 113.35 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 42' ' ' TYR 0.278 3.5 p -97.17 136.28 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 124.577 2.132 . . . . 0.0 107.984 176.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -122.33 122.17 38.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 108.867 -3.788 . . . . 0.0 102.851 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.713 HG22 ' CG ' ' A' ' 42' ' ' TYR . 42.3 t -93.27 139.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.944 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.47 -19.53 10.79 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.544 -1.142 . . . . 0.0 114.402 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 166.35 153.97 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 130.491 3.516 . . . . 0.0 111.884 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -66.49 154.94 38.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.123 2.169 . . . . 0.0 112.198 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 133.54 49.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.358 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -35.7 -28.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 131.185 3.794 . . . . 0.0 120.155 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.32 3.37 12.55 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.17 1.366 . . . . 0.0 114.839 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -99.77 177.64 5.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.976 1.31 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -150.27 163.82 37.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.5 mptm? -61.25 120.04 9.6 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.432 1.093 . . . . 0.0 112.443 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.41 2.47 55.77 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.557 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -151.66 165.56 33.96 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 119.705 1.139 . . . . 0.0 110.767 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -43.34 89.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.459 1.123 . . . . 0.0 112.675 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.36 -173.99 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 109.597 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -68.8 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 119.543 -1.973 . . . . 0.0 111.957 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.06 175.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.24 1.816 . . . . 0.0 114.152 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -47.95 -37.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 1 C-N-CA 132.109 4.163 . . . . 0.0 115.444 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.99 -42.16 0.15 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.463 3.105 . . . . 0.0 112.896 -176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.713 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -82.39 -169.64 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.909 3.284 . . . . 0.0 116.141 -176.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.4 mt-10 -149.46 124.56 10.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.226 177.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.34 110.77 20.47 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.278 1.431 . . . . 0.0 110.096 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -114.91 171.72 7.48 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.306 1.442 . . . . 0.0 108.531 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 168.17 19.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.674 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 129.938 3.295 . . . . 0.0 110.137 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.226 -0.168 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.1 ptp180 -73.62 172.55 11.19 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.414 1.886 . . . . 0.0 115.6 -177.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 127.663 2.385 . . . . 0.0 111.703 -177.173 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 5' ' ' ARG . 19.7 mt . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -73.95 -27.14 60.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.645 2.778 . . . . 0.0 109.375 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.19 165.55 45.22 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -140.72 142.09 34.85 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.301 -1.117 . . . . 0.0 113.527 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.275 3.2 p -100.25 136.12 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 124.465 2.079 . . . . 0.0 106.928 176.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -126.62 124.93 41.03 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 131.634 3.974 . . . . 0.0 102.422 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.534 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.5 m -93.16 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.005 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.77 -61.16 3.7 Favored Glycine 0 CA--C 1.554 2.529 0 C-N-CA 119.241 -1.456 . . . . 0.0 110.76 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 t -158.95 158.77 33.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 128.295 2.638 . . . . 0.0 112.234 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -68.45 158.98 32.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.37 1.868 . . . . 0.0 112.688 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.89 42.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.905 2.482 . . . . 0.0 111.146 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 p -20.84 -63.22 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.552 3.541 . . . . 0.0 118.57 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.05 9.9 67.88 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.035 1.574 . . . . 0.0 117.035 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -101.6 174.11 6.12 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.374 1.087 . . . . 0.0 110.825 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -149.99 168.0 25.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.861 -1.149 . . . . 0.0 110.551 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -60.42 111.45 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.918 1.687 . . . . 0.0 112.496 177.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 16.8 p -93.46 10.69 31.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -159.61 165.95 31.7 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.587 1.155 . . . . 0.0 110.556 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.79 -36.28 80.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.04 1.336 . . . . 0.0 112.657 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -102.2 -175.14 2.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.254 2.622 . . . . 0.0 110.191 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.527 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -136.95 -68.16 0.49 Allowed 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 119.538 -1.976 . . . . 0.0 110.137 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.4 174.22 1.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -46.09 -42.42 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 1 C-N-CA 132.122 4.169 . . . . 0.0 114.338 176.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.01 -44.32 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 130.823 3.649 . . . . 0.0 111.951 -176.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -79.04 -166.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 130.54 3.536 . . . . 0.0 116.087 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 15.9 mt-10 -152.11 127.22 9.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.806 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -91.13 136.07 33.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.995 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -142.18 167.78 21.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.738 2.015 . . . . 0.0 108.849 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.443 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.265 0.0 OUTLIER -130.04 165.83 21.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.11 179.82 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 C-N-CA 129.456 3.102 . . . . 0.0 112.234 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.546 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.1 ptt180 -95.22 175.61 6.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.851 1.31 . . . . 0.0 113.317 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 26.4 p . . . . . 0 C--N 1.316 -0.883 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.09 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.306 28.4 mt . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -76.93 29.53 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.072 2.149 . . . . 0.0 110.479 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . -142.5 173.05 24.07 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 130.168 3.747 . . . . 0.0 108.381 177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -148.15 139.67 23.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.482 -1.01 . . . . 0.0 111.448 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.275 2.5 p -98.24 131.04 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 124.338 2.018 . . . . 0.0 105.774 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -115.2 124.29 51.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 109.114 -3.675 . . . . 0.0 103.337 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.624 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.6 m -92.67 161.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.38 -59.67 4.78 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -178.54 166.72 1.8 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.379 3.471 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.85 157.01 35.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.548 2.339 . . . . 0.0 117.258 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 129.66 39.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.96 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -34.71 -31.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 131.28 3.832 . . . . 0.0 119.713 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.14 29.57 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.754 1.169 . . . . 0.0 115.638 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -104.3 174.4 5.89 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.998 1.319 . . . . 0.0 111.463 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -151.56 167.98 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.201 -0.937 . . . . 0.0 111.368 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -69.23 110.54 4.64 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 113.724 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.5 t -84.88 -2.98 58.48 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.196 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -156.72 165.63 35.7 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.863 -1.148 . . . . 0.0 111.205 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -73.97 -26.25 60.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -101.56 175.06 5.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.661 1.584 . . . . 0.0 109.876 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.518 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -139.76 -62.62 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.689 -1.882 . . . . 0.0 110.629 -177.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.62 177.27 0.2 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.953 1.701 . . . . 0.0 115.132 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -51.46 -35.73 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 131.658 3.983 . . . . 0.0 114.092 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -152.55 -44.73 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 130.362 3.465 . . . . 0.0 112.986 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.624 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -73.85 -169.83 0.8 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.909 3.284 . . . . 0.0 113.9 -177.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 17.3 mt-10 -148.42 129.3 14.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.874 1.321 . . . . 0.0 114.498 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.4 132.06 34.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.76 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.6 m -142.34 173.57 11.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.085 1.754 . . . . 0.0 108.262 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -137.91 166.72 23.34 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 129.715 3.206 . . . . 0.0 113.129 177.444 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' CB ' HG23 ' A' ' 22' ' ' VAL . 48.0 t . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.5 ptp85 -89.56 164.07 14.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.97 1.367 . . . . 0.0 112.825 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.546 0.792 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.386 177.184 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.296 18.0 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -75.48 -14.53 60.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.763 2.025 . . . . 0.0 110.451 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.26 174.14 33.57 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.8 m -155.74 148.04 23.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 119.553 -2.145 . . . . 0.0 112.581 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -92.57 140.66 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 126.79 2.036 . . . . 0.0 109.368 177.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 11.9 m95 -132.44 109.59 9.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG12 ' CD1' ' A' ' 42' ' ' TYR . 2.4 m -75.02 160.42 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.852 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.44 -62.72 4.28 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -177.96 165.0 1.94 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 130.799 3.64 . . . . 0.0 112.089 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -51.7 151.74 3.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 129.607 3.163 . . . . 0.0 117.786 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.58 135.52 48.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.197 1.799 . . . . 0.0 110.89 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.77 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 131.433 3.893 . . . . 0.0 119.208 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.1 8.63 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 125.954 1.74 . . . . 0.0 116.773 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -101.27 177.26 4.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -151.03 165.48 33.65 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 121.54 -0.725 . . . . 0.0 110.32 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.6 mptm? -64.1 121.7 14.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.26 1.024 . . . . 0.0 113.643 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.35 4.07 53.77 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.403 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -158.48 170.07 23.03 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 120.462 1.483 . . . . 0.0 114.049 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.5 -29.61 56.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -101.85 178.44 4.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 107.942 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.82 -64.4 0.38 Allowed 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 119.719 -1.863 . . . . 0.0 109.452 -177.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.49 171.41 0.44 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.977 2.111 . . . . 0.0 113.862 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -50.7 -38.44 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 131.024 3.73 . . . . 0.0 114.776 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -134.72 -48.0 0.75 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 129.502 3.121 . . . . 0.0 113.309 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.535 ' CD1' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -85.78 -168.17 2.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 129.908 3.283 . . . . 0.0 116.25 -177.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 60.1 mt-10 -142.95 135.6 27.7 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.417 -2.174 . . . . 0.0 112.328 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -93.74 129.03 40.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.15 1.38 . . . . 0.0 109.565 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.3 m -135.27 171.82 13.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.92 1.288 . . . . 0.0 108.237 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -135.05 165.76 24.61 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.53 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.246 1.818 . . . . 0.0 114.079 177.315 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 C--O 1.225 -0.186 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -83.43 177.84 8.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.065 1.346 . . . . 0.0 113.238 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 126.507 1.923 . . . . 0.0 108.867 177.574 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 t -69.58 -15.11 63.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.785 0.834 . . . . 0.0 111.078 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.3 173.59 55.25 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -153.29 143.66 22.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 118.914 -2.521 . . . . 0.0 113.017 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.291 2.6 p -99.78 132.3 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-O 124.434 2.064 . . . . 0.0 107.265 176.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -121.26 110.5 16.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 109.134 -3.666 . . . . 0.0 103.739 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.652 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -80.95 160.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.586 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -55.11 4.8 Favored Glycine 0 CA--C 1.552 2.385 0 C-N-CA 118.234 -1.936 . . . . 0.0 109.337 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.2 t 175.52 164.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.133 3.773 . . . . 0.0 113.265 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.35 151.28 44.36 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 127.922 2.489 . . . . 0.0 116.382 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.79 53.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.487 1.915 . . . . 0.0 111.332 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -32.0 -17.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 1 C-N-CA 134.298 5.039 . . . . 0.0 121.253 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.81 10.2 2.6 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 125.466 1.507 . . . . 0.0 115.274 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -99.71 178.6 4.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.105 0.962 . . . . 0.0 110.735 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -147.98 168.13 23.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.325 -0.859 . . . . 0.0 110.83 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -63.35 109.34 1.56 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.58 177.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.21 -3.35 58.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.027 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -150.51 165.43 33.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.084 1.354 . . . . 0.0 110.882 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.4 -47.69 69.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.327 1.051 . . . . 0.0 112.923 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.62 -176.37 6.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 128.509 2.723 . . . . 0.0 109.57 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.496 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.8 -70.43 0.42 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 119.645 -1.909 . . . . 0.0 108.493 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.98 177.12 2.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 114.438 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -44.55 -38.5 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 131.354 3.862 . . . . 0.0 113.349 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.21 -52.67 0.18 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 130.407 3.483 . . . . 0.0 111.321 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.652 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -65.8 -170.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.888 1 C-N-CA 131.859 4.063 . . . . 0.0 113.889 -177.107 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 38' ' ' TYR . 13.6 mt-10 -147.6 125.54 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 87.0 m -89.78 135.17 33.79 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.021 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.3 m -142.86 173.65 11.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.686 2.394 . . . . 0.0 106.829 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 170.3 16.21 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.218 1.007 . . . . 0.0 110.384 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.325 2.25 . . . . 0.0 110.015 176.546 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 18' ' ' LEU . 1.7 ptp180 -96.72 158.52 15.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 122.721 1.248 . . . . 0.0 114.322 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.723 -177.291 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.5 mt . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.187 0.517 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -68.19 -25.78 65.4 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.078 1.351 . . . . 0.0 108.73 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.61 160.09 48.72 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.7 m -141.27 141.38 33.96 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.298 -1.119 . . . . 0.0 111.709 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.4 p -94.72 137.29 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 124.399 2.047 . . . . 0.0 107.01 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -121.32 119.75 33.08 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 110.304 -3.135 . . . . 0.0 103.89 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CG ' ' A' ' 42' ' ' TYR . 41.7 t -90.46 144.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.546 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.46 -35.47 2.23 Favored Glycine 0 CA--C 1.555 2.557 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.301 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t 175.77 152.69 0.15 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.067 2.947 . . . . 0.0 112.503 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.73 160.68 11.29 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.593 1.957 . . . . 0.0 111.385 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.79 132.34 38.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.316 1.446 . . . . 0.0 109.393 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -28.12 -50.33 0.07 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 130.045 3.338 . . . . 0.0 117.732 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 3.59 61.49 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.08 1.592 . . . . 0.0 117.08 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -101.62 -179.23 3.96 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.723 1.262 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -151.84 163.81 38.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 121.149 -0.969 . . . . 0.0 109.41 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.7 mptm? -61.06 118.66 7.06 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 112.973 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -92.29 5.13 51.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.057 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -157.51 168.65 26.69 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-N 120.563 1.529 . . . . 0.0 113.097 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.51 -48.17 73.45 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.489 1.515 . . . . 0.0 112.561 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -88.58 -177.94 5.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.991 2.116 . . . . 0.0 108.14 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.436 ' HD2' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.21 -59.85 0.38 Allowed 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 118.76 -2.462 . . . . 0.0 110.635 -177.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 172.44 175.45 0.09 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.135 2.174 . . . . 0.0 113.959 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -49.05 -38.21 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 130.872 3.669 . . . . 0.0 114.122 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -143.53 -52.64 0.35 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 129.665 3.186 . . . . 0.0 111.936 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -69.85 -169.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.744 1 C-N-CA 132.137 4.175 . . . . 0.0 116.347 -177.223 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 28.1 mt-10 -148.74 128.47 13.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.24 115.39 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.758 1.223 . . . . 0.0 111.112 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.3 m -124.39 167.64 14.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.786 1.279 . . . . 0.0 107.776 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.96 168.88 18.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.098 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 128.212 2.605 . . . . 0.0 113.507 177.246 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' HD22 ' A' ' 18' ' ' LEU . 53.9 t . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.422 ' H ' ' CD2' ' A' ' 18' ' ' LEU 0.294 0.0 OUTLIER -91.12 175.0 7.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.851 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.4 p . . . . . 0 C--N 1.31 -1.134 0 C-N-CA 127.925 2.49 . . . . 0.0 112.632 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 4' ' ' CYS . 25.5 mt . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -68.96 -11.96 61.2 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.231 0.613 . . . . 0.0 111.656 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.92 175.1 41.46 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.353 1.93 . . . . 0.0 110.49 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -149.48 142.72 25.11 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.16 -1.788 . . . . 0.0 113.219 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 42' ' ' TYR . 2.6 p -101.32 137.99 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 124.119 1.914 . . . . 0.0 106.291 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.423 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 7.7 m95 -125.16 119.14 27.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 130.88 3.672 . . . . 0.0 103.181 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -87.18 161.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.455 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.34 -63.45 3.93 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.076 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 p -162.16 161.04 27.85 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.188 2.595 . . . . 0.0 113.05 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -61.57 160.99 10.35 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.787 1.279 . . . . 0.0 113.653 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -77.07 133.08 39.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.945 2.098 . . . . 0.0 110.153 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.7 p -18.87 -65.77 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 130.716 3.607 . . . . 0.0 117.894 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 9.48 70.6 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.802 1.668 . . . . 0.0 116.896 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -99.25 174.8 6.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.433 1.116 . . . . 0.0 111.024 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -149.95 168.72 23.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.805 -1.184 . . . . 0.0 111.034 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -67.77 112.8 5.05 Favored 'General case' 0 CA--C 1.511 -0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 113.053 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 22.2 t -88.02 -1.71 58.16 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.862 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -157.79 167.69 29.31 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.093 -1.004 . . . . 0.0 111.498 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.63 -33.48 68.98 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.6 177.21 5.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 110.627 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.541 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.24 -64.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 119.708 -1.87 . . . . 0.0 110.487 -177.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 174.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.154 1.781 . . . . 0.0 115.046 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.59 -42.35 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 131.026 3.73 . . . . 0.0 113.884 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -141.91 -46.55 0.35 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 130.708 3.603 . . . . 0.0 112.827 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.585 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -74.4 -169.16 0.77 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 130.024 3.329 . . . . 0.0 115.447 -177.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.4 mt-10 -148.04 126.34 12.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 123.309 1.528 . . . . 0.0 114.263 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.76 132.25 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.467 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.4 m -143.42 170.79 15.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.517 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -136.0 167.83 20.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.784 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 129.059 2.944 . . . . 0.0 112.328 177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.1 t . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.872 ' HG3' HD23 ' A' ' 18' ' ' LEU . 12.9 mtm180 -69.5 -175.6 0.86 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.922 2.296 . . . . 0.0 111.884 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 8.5 p . . . . . 0 N--CA 1.437 -1.111 0 C-N-CA 129.69 3.196 . . . . 0.0 110.309 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' A' ' 5' ' ' ARG . 5.5 mt . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -75.8 0.95 16.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.685 0.794 . . . . 0.0 111.448 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.36 162.83 12.27 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.235 2.826 . . . . 0.0 107.818 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.1 m -146.91 141.56 26.68 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.377 -1.661 . . . . 0.0 110.506 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.323 2.5 p -96.34 133.23 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 124.91 2.291 . . . . 0.0 108.541 176.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -121.46 112.71 18.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 109.343 -3.571 . . . . 0.0 104.213 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.2 m -86.63 158.11 3.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 112.959 -1.928 . . . . 0.0 107.497 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.72 -50.5 3.28 Favored Glycine 0 CA--C 1.553 2.439 0 C-N-CA 119.127 -1.511 . . . . 0.0 112.071 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -178.32 160.61 1.34 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.294 3.438 . . . . 0.0 111.768 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.07 161.84 7.99 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.909 2.484 . . . . 0.0 114.664 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 145.57 40.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.735 2.014 . . . . 0.0 110.647 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -32.37 -54.72 0.33 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 119.482 3.142 . . . . 0.0 119.482 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.28 14.05 30.8 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 124.692 1.139 . . . . 0.0 115.204 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -96.95 173.31 7.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.66 0.743 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -151.0 166.83 29.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 43' ' ' GLU . 4.3 mptp? -63.38 124.97 22.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.613 0.765 . . . . 0.0 111.487 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 37.8 t -96.59 1.27 51.1 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.838 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.66 168.22 26.55 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 121.238 -0.914 . . . . 0.0 109.724 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -16.59 56.25 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -105.36 175.43 5.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.973 1.309 . . . . 0.0 108.181 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 119.901 -1.749 . . . . 0.0 109.972 -176.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.68 -178.57 0.16 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.707 2.003 . . . . 0.0 113.626 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -52.94 -38.16 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 131.501 3.921 . . . . 0.0 113.341 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -149.51 -50.93 0.15 Allowed 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 130.505 3.522 . . . . 0.0 111.204 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.612 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -69.92 -172.38 0.52 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.33 3.452 . . . . 0.0 112.772 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 7.2 mm-40 -146.4 128.67 15.77 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 72.8 m -86.91 123.68 32.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.64 173.94 10.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.799 2.04 . . . . 0.0 107.562 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.287 0.0 OUTLIER -138.12 172.67 12.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.793 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.871 2.869 . . . . 0.0 110.447 176.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.4 t . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.886 ' HG3' HD23 ' A' ' 18' ' ' LEU . 59.1 mtm180 -69.91 -176.77 1.16 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 113.465 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p . . . . . 0 C--N 1.319 -0.73 0 C-N-CA 129.888 3.275 . . . . 0.0 112.264 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' A' ' 5' ' ' ARG 0.252 17.2 mt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.2 t -64.73 -30.68 71.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.426 1.49 . . . . 0.0 109.158 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.33 157.72 38.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.2 m -140.22 138.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 122.003 -0.704 . . . . 0.0 111.915 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.428 ' HB ' ' SG ' ' A' ' 44' ' ' CYS 0.308 3.3 p -96.77 134.27 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-O 124.807 2.241 . . . . 0.0 108.103 176.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -119.64 122.02 40.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 108.994 -3.73 . . . . 0.0 103.73 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.3 m -96.74 156.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.6 -12.6 7.75 Favored Glycine 0 CA--C 1.557 2.695 0 C-N-CA 118.769 -1.681 . . . . 0.0 115.48 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 142.91 162.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 1 C-N-CA 135.985 5.714 . . . . 0.0 113.946 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -70.45 154.46 41.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.894 2.477 . . . . 0.0 115.35 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 131.78 46.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.251 1.82 . . . . 0.0 108.551 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -28.96 -63.62 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.296 2.638 . . . . 0.0 116.87 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.2 5.33 84.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -97.44 177.68 5.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.753 1.277 . . . . 0.0 111.074 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -152.3 166.07 32.97 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.2 mptm? -64.46 121.83 15.31 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.327 1.051 . . . . 0.0 113.103 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.7 t -91.25 0.03 57.6 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.157 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -160.73 166.89 27.94 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 119.83 1.196 . . . . 0.0 109.302 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -22.26 59.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.16 171.48 7.3 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.936 1.695 . . . . 0.0 108.832 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.32 -67.7 0.47 Allowed 'General case' 0 C--O 1.223 -0.32 0 O-C-N 120.187 -1.571 . . . . 0.0 110.161 -177.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.14 174.71 0.71 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 112.906 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -48.13 -35.98 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 130.924 3.69 . . . . 0.0 115.046 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -150.27 -44.54 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 113.136 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.562 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -76.96 -171.22 1.9 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.07 2.948 . . . . 0.0 113.55 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mt-10 -148.85 120.69 8.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 81.0 m -83.66 104.14 13.54 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.594 1.558 . . . . 0.0 109.445 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.9 m -111.52 175.73 5.31 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.54 1.162 . . . . 0.0 108.937 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -139.46 173.89 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.246 0.904 0 C-N-CA 128.799 2.84 . . . . 0.0 109.622 176.82 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.758 ' HG3' HD23 ' A' ' 18' ' ' LEU . 44.6 mtm180 -75.75 154.7 36.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 123.973 1.844 . . . . 0.0 114.369 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 110.047 -3.251 . . . . 0.0 108.995 177.378 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.758 HD23 ' HG3' ' A' ' 5' ' ' ARG . 37.6 mt . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t -66.52 -37.19 84.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.504 1.922 . . . . 0.0 109.57 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.07 46.88 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 m -135.92 134.51 38.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 120.745 -1.444 . . . . 0.0 113.098 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.45 HG21 ' HD2' ' A' ' 42' ' ' TYR . 3.5 p -93.37 137.37 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 124.316 2.008 . . . . 0.0 106.228 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -122.58 119.73 31.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 109.997 -3.274 . . . . 0.0 103.127 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 ' CG ' ' A' ' 42' ' ' TYR . 51.2 t -93.3 138.83 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.279 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -48.24 3.68 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -170.18 158.2 6.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.269 1.828 . . . . 0.0 114.251 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.0 161.42 18.72 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.327 1.537 . . . . 0.0 112.688 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 133.89 40.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.488 1.915 . . . . 0.0 109.346 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -34.96 -40.81 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.653 3.181 . . . . 0.0 118.801 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.61 4.14 39.79 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -100.41 177.59 4.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.012 1.325 . . . . 0.0 111.653 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -151.2 166.97 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.294 -0.879 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.75 118.7 7.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.632 1.573 . . . . 0.0 112.882 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.3 p -99.03 11.75 38.06 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.303 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.66 158.36 33.63 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 110.091 -177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -25.25 59.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.588 0.709 . . . . 0.0 112.321 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.24 -169.86 1.75 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.108 2.563 . . . . 0.0 109.485 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.83 -65.26 0.37 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 119.114 -2.241 . . . . 0.0 112.436 177.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.68 176.8 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -51.24 -40.03 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 1 C-N-CA 131.701 4.001 . . . . 0.0 113.977 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.17 -48.4 0.27 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.074 3.35 . . . . 0.0 111.405 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.674 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.52 -164.73 0.43 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.014 4.126 . . . . 0.0 116.484 -177.027 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.2 mt-10 -148.62 129.73 14.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.506 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.55 134.43 34.13 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.981 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.32 169.81 16.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.941 1.696 . . . . 0.0 108.929 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.311 0.0 OUTLIER -134.62 168.27 19.29 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.722 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.084 1 C-N-CA 132.406 4.282 . . . . 0.0 109.447 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.1 t . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.882 ' HG3' HD23 ' A' ' 18' ' ' LEU . 40.0 mtm180 -73.31 -171.83 1.03 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.249 1.82 . . . . 0.0 113.568 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 C--N 1.32 -0.683 0 C-N-CA 127.886 2.474 . . . . 0.0 114.072 -179.821 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.882 HD23 ' HG3' ' A' ' 5' ' ' ARG . 32.2 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 m -69.88 -25.79 63.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.941 1.296 . . . . 0.0 108.373 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.75 170.66 55.04 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.8 m -148.99 142.82 25.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 119.534 -2.156 . . . . 0.0 112.148 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 42' ' ' TYR 0.257 2.8 p -98.33 135.64 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.535 2.112 . . . . 0.0 106.46 176.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -126.17 127.07 45.14 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.021 4.128 . . . . 0.0 102.403 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.479 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -97.61 159.72 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.46 -49.5 3.03 Favored Glycine 0 CA--C 1.557 2.71 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.3 t -169.33 169.02 9.34 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 129.741 3.216 . . . . 0.0 111.34 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.08 165.94 24.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.404 2.282 . . . . 0.0 113.632 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.7 142.82 35.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.881 1.672 . . . . 0.0 112.544 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -35.07 -8.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 C-N-CA 134.697 5.199 . . . . 0.0 122.236 -177.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.22 9.96 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.005 1.764 . . . . 0.0 114.807 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.75 177.92 5.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.044 1.338 . . . . 0.0 110.863 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -152.81 167.67 28.27 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.12 -0.987 . . . . 0.0 110.787 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -64.16 113.51 3.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.387 1.875 . . . . 0.0 111.557 177.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 38.9 t -87.84 1.7 53.28 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.31 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -158.9 167.25 29.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.622 1.569 . . . . 0.0 110.637 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.28 -42.51 79.44 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -89.37 177.73 6.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.378 2.271 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.27 -68.67 0.45 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 119.879 -1.763 . . . . 0.0 111.191 -177.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.43 170.72 0.78 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.07 1.748 . . . . 0.0 115.164 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.5 tp -44.32 -44.22 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 1 C-N-CA 131.768 4.027 . . . . 0.0 115.214 176.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -136.68 -48.19 0.62 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.989 3.315 . . . . 0.0 111.938 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -76.71 -165.25 0.51 Allowed 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.084 4.154 . . . . 0.0 116.54 -177.337 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 16.5 mt-10 -152.58 127.58 9.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.12 -1.855 . . . . 0.0 113.664 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.41 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.5 m -91.66 129.02 37.7 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -135.41 175.32 9.69 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.287 1.835 . . . . 0.0 108.303 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.273 0.0 OUTLIER -138.96 173.17 11.84 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 177.586 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.101 4.56 . . . . 0.0 109.069 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.2 t . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.474 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 43.6 mtm180 -66.49 178.67 1.19 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.325 2.25 . . . . 0.0 111.052 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 126.789 2.036 . . . . 0.0 112.357 -178.332 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 68.4 mt . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -66.77 -29.91 69.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.02 0.928 . . . . 0.0 108.765 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.36 176.3 34.91 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.734 2.112 . . . . 0.0 108.102 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.0 m -151.34 139.24 19.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 119.046 -2.444 . . . . 0.0 112.92 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' SG ' ' A' ' 44' ' ' CYS . 5.0 p -96.1 135.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 124.247 1.975 . . . . 0.0 106.935 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -122.47 108.94 13.75 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 109.97 -3.286 . . . . 0.0 104.15 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -79.14 160.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 112.653 -2.067 . . . . 0.0 106.695 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.11 -49.15 4.06 Favored Glycine 0 CA--C 1.567 3.339 0 C-N-CA 118.672 -1.728 . . . . 0.0 109.766 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t 165.29 164.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 1 C-N-CA 134.011 4.924 . . . . 0.0 113.271 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.89 154.87 3.7 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 129.626 3.17 . . . . 0.0 117.119 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.36 43.13 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.864 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -29.91 -44.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.999 3.719 . . . . 0.0 118.571 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.74 8.72 34.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.439 1.495 . . . . 0.0 116.576 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -102.54 179.39 4.31 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.772 1.229 . . . . 0.0 111.048 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -149.1 160.82 42.99 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.069 -1.019 . . . . 0.0 109.777 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -57.77 112.75 1.57 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.471 1.509 . . . . 0.0 112.26 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.2 p -85.1 5.08 31.21 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.246 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -159.09 165.46 33.81 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.275 0.943 . . . . 0.0 110.416 177.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.8 -35.85 75.2 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.893 0.746 . . . . 0.0 112.982 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.98 -175.77 4.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.069 2.148 . . . . 0.0 107.527 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.532 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.31 -67.2 0.33 Allowed 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 119.091 -2.256 . . . . 0.0 111.168 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.57 174.55 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.392 1.877 . . . . 0.0 112.354 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -47.38 -32.38 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 130.765 3.626 . . . . 0.0 115.589 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -155.42 -42.45 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 128.797 2.839 . . . . 0.0 113.863 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.646 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -78.22 -169.26 1.55 Allowed 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.939 3.296 . . . . 0.0 113.894 -176.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 53.1 mt-10 -150.65 123.45 8.64 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.3 m -86.38 117.41 25.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 123.403 1.573 . . . . 0.0 110.789 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.45 174.69 7.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.231 1.813 . . . . 0.0 109.514 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.334 0.0 OUTLIER -137.28 170.56 15.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 177.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.249 1.031 1 C-N-CA 132.651 4.38 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.331 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.251 59.1 t -145.49 149.33 16.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.0 t -149.57 128.71 12.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.56 174.0 11.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 113.854 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.1 m -111.65 174.71 5.74 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.262 2.225 . . . . 0.0 111.834 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.77 -42.73 84.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.384 1.074 . . . . 0.0 111.727 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.1 t -108.06 54.65 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.25 1.82 . . . . 0.0 109.155 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -45.63 -42.53 11.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.857 0.863 . . . . 0.0 113.257 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 67.5 0.17 Allowed Glycine 0 N--CA 1.463 0.458 0 C-N-CA 125.713 1.625 . . . . 0.0 114.645 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -57.2 -22.35 47.99 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.444 2.763 . . . . 0.0 117.216 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -148.51 34.11 0.79 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.322 1.449 . . . . 0.0 113.568 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 162.91 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.82 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -71.45 150.76 44.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 113.027 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.97 32.5 84.29 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -73.24 -10.07 59.37 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.46 2.704 . . . . 0.0 116.477 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -60.92 173.71 0.73 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.637 1.975 . . . . 0.0 112.222 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 4' ' ' CYS . 36.7 mt -67.49 60.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.86 2.064 . . . . 0.0 114.756 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -78.47 -13.5 59.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.123 1.769 . . . . 0.0 109.493 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.35 166.61 32.08 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 129.057 3.218 . . . . 0.0 106.89 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.5 m -145.82 145.9 30.95 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.194 -1.18 . . . . 0.0 113.347 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 3.2 p -100.23 136.2 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 124.341 2.019 . . . . 0.0 107.122 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -127.59 113.23 15.82 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 130.594 3.558 . . . . 0.0 102.563 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 42' ' ' TYR . 2.4 m -80.25 163.94 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.265 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -56.85 4.87 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t 177.09 170.04 0.54 Allowed 'General case' 0 N--CA 1.485 1.316 1 C-N-CA 131.922 4.089 . . . . 0.0 112.247 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -56.45 172.87 0.2 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 129.471 3.108 . . . . 0.0 116.927 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.7 140.81 29.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.547 1.939 . . . . 0.0 110.723 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -44.02 -12.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 1 C-N-CA 132.199 4.2 . . . . 0.0 120.915 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.12 2.87 5.16 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.063 1.316 . . . . 0.0 114.63 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -104.95 177.51 4.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.493 1.117 . . . . 0.0 110.983 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -150.37 169.53 21.21 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.618 -0.676 . . . . 0.0 110.87 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -64.44 118.16 8.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 113.461 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 30.3 p -95.53 7.18 47.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.58 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -159.26 167.1 29.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.502 1.121 . . . . 0.0 111.429 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -76.94 -32.8 57.58 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 122.13 0.967 . . . . 0.0 112.877 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -96.73 -175.88 3.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.053 1.741 . . . . 0.0 108.059 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.548 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.03 -66.82 0.37 Allowed 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 118.821 -2.424 . . . . 0.0 109.681 -178.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.98 171.7 0.84 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -45.39 -41.72 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 130.514 3.526 . . . . 0.0 114.756 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -140.42 -49.37 0.45 Allowed 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 129.924 3.29 . . . . 0.0 112.298 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.586 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.39 -166.67 0.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 130.775 3.63 . . . . 0.0 116.613 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.6 mt-10 -150.63 129.96 12.86 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.979 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 74.6 m -92.71 138.87 31.12 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.102 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.5 m -144.88 170.58 15.86 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 126.77 2.028 . . . . 0.0 108.466 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.98 168.03 19.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.245 0.864 0 C-N-CA 127.353 2.261 . . . . 0.0 113.493 177.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.258 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.504 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.32 72.3 t -149.24 153.62 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.937 0.895 . . . . 0.0 111.792 -177.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.505 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.6 t -152.56 128.67 10.42 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.077 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -75.77 -172.7 1.99 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 122.28 1.038 . . . . 0.0 113.463 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.8 m -124.07 -177.87 3.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.58 1.952 . . . . 0.0 112.079 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -54.87 -64.52 0.81 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.963 1.305 . . . . 0.0 109.035 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -88.11 50.92 2.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.156 2.582 . . . . 0.0 110.843 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -59.27 -13.95 9.52 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.8 59.71 8.3 Favored Glycine 0 CA--C 1.508 -0.346 0 N-CA-C 118.225 2.05 . . . . 0.0 118.225 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.64 -0.32 2.41 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 124.289 3.326 . . . . 0.0 115.526 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.3 m -135.33 7.68 3.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.243 1.817 . . . . 0.0 115.054 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.81 -163.81 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.077 0.951 . . . . 0.0 112.784 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -60.69 135.74 57.86 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.68 1.592 . . . . 0.0 114.239 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.2 26.85 71.78 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.424 2.13 . . . . 0.0 118.424 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -47.8 49.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 135.261 5.424 . . . . 0.0 117.523 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 p -144.81 -170.23 3.36 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 128.041 2.536 . . . . 0.0 113.746 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 3' ' ' HYP . 87.2 mt -69.76 52.73 0.11 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.828 2.851 . . . . 0.0 111.429 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -74.18 52.24 0.45 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 128.355 2.662 . . . . 0.0 110.355 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -169.26 -173.99 37.35 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 129.092 3.234 . . . . 0.0 108.464 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.7 m -157.23 137.9 13.16 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 120.011 -1.876 . . . . 0.0 109.657 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 4.4 p -93.67 137.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-O 124.414 2.054 . . . . 0.0 107.913 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.19 116.03 22.73 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 130.845 3.658 . . . . 0.0 103.509 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.682 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.9 t -87.09 143.38 11.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 112.201 -2.272 . . . . 0.0 109.463 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.06 -53.45 4.81 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 p -167.54 154.5 8.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.756 2.022 . . . . 0.0 115.179 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -59.63 151.34 25.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.491 1.916 . . . . 0.0 112.534 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.86 136.87 53.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.077 1.351 . . . . 0.0 109.745 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 p -24.53 -68.29 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 129.919 3.288 . . . . 0.0 117.191 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.42 9.84 75.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 126.12 1.819 . . . . 0.0 116.319 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.416 ' CD2' ' HB2' ' A' ' 47' ' ' GLN . 7.3 m95 -98.32 177.87 5.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.897 1.348 . . . . 0.0 110.798 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -148.9 161.85 41.03 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.254 -0.904 . . . . 0.0 109.108 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.0 mptm? -62.64 123.05 17.37 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 124.412 1.085 . . . . 0.0 112.399 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 28.4 p -98.27 9.57 42.7 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.764 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -158.8 169.58 24.05 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.277 0.944 . . . . 0.0 112.378 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.56 -52.08 24.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.331 1.052 . . . . 0.0 111.074 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -167.91 1.92 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -147.56 -57.95 0.25 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 119.506 -1.996 . . . . 0.0 110.575 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.91 175.87 0.1 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.359 2.664 . . . . 0.0 114.157 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.62 -39.43 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 1 C-N-CA 132.588 4.355 . . . . 0.0 115.97 176.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.47 -47.54 0.26 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 129.121 2.968 . . . . 0.0 112.191 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.682 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -77.25 -167.46 0.91 Allowed 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 131.708 4.003 . . . . 0.0 116.746 -177.034 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 84.1 mt-10 -149.8 124.01 9.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 65.5 m -88.46 114.45 25.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.426 1.091 . . . . 0.0 109.967 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.4 m -118.78 170.62 8.84 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.277 0.0 OUTLIER -132.18 168.75 17.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.975 177.882 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 31' ' ' TRP . 1.1 tt0 . . . . . 0 C--O 1.247 0.943 0 C-N-CA 125.997 1.719 . . . . 0.0 112.949 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.217 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.305 59.6 t -143.77 152.67 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 110.133 -177.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.1 t -153.39 135.67 14.92 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.236 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.541 ' HB3' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -94.28 161.34 14.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 123.403 1.573 . . . . 0.0 113.665 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . 0.315 57.2 m -87.06 169.66 12.21 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 111.955 -2.384 . . . . 0.0 107.358 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' A' ' 35' ' ' ASN . 17.1 p30 -66.64 -37.23 84.39 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.318 -1.489 . . . . 0.0 112.517 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -105.5 47.7 0.87 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.528 2.331 . . . . 0.0 110.071 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.13 -30.7 2.02 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.96 -84.62 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 125.119 1.342 . . . . 0.0 116.282 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -57.08 -2.2 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.851 3.701 . . . . 0.0 115.085 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 t -85.96 -28.67 24.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.875 1.27 . . . . 0.0 111.659 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.58 -172.91 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.25 -1.23 1.52 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.79 147.62 15.28 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.23 16.3 1.61 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 129.678 3.191 . . . . 0.0 116.692 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.8 p -135.98 134.51 38.67 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.0 mt -73.17 61.34 0.61 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.633 3.173 . . . . 0.0 112.475 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -69.39 -11.06 60.51 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.292 1.037 . . . . 0.0 111.82 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.64 -179.19 47.88 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -152.77 134.76 14.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 119.202 -2.352 . . . . 0.0 112.502 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.284 2.7 p -95.15 133.51 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 124.428 2.061 . . . . 0.0 105.691 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -121.0 130.22 53.71 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 130.859 3.664 . . . . 0.0 102.215 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 42' ' ' TYR . 1.0 OUTLIER -103.72 155.6 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.014 -177.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.6 -35.32 2.26 Favored Glycine 0 CA--C 1.552 2.366 0 C-N-CA 118.406 -1.854 . . . . 0.0 113.567 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.6 p 175.95 167.71 0.41 Allowed 'General case' 0 CA--C 1.548 0.883 1 C-N-CA 132.073 4.149 . . . . 0.0 112.975 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -75.2 166.45 23.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.284 1.434 . . . . 0.0 110.222 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 136.74 36.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.784 2.034 . . . . 0.0 110.581 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -29.39 -55.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 129.739 3.216 . . . . 0.0 118.557 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.49 7.98 61.91 Favored Glycine 0 N--CA 1.471 1.032 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -99.73 175.94 5.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.226 1.013 . . . . 0.0 111.298 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -147.86 167.1 25.65 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.756 -1.215 . . . . 0.0 109.229 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -63.36 115.3 4.47 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.404 1.082 . . . . 0.0 110.959 177.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.436 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 21.1 p -90.53 3.51 53.79 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.574 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 7' ' ' ASP . 19.7 p-10 -159.16 164.62 35.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.379 0.671 . . . . 0.0 112.293 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.58 -32.04 63.92 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -97.91 -176.05 3.33 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.562 1.945 . . . . 0.0 108.125 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.479 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.62 -65.43 0.37 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 118.717 -2.49 . . . . 0.0 111.289 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.24 177.39 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.723 1.725 . . . . 0.0 115.59 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -49.44 -40.49 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 131.1 3.76 . . . . 0.0 114.233 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.51 -47.1 0.19 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.263 3.425 . . . . 0.0 112.112 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CD1' ' HB ' ' A' ' 24' ' ' VAL . 0.5 OUTLIER -72.4 -167.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 131.684 3.994 . . . . 0.0 114.959 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -151.06 135.16 16.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.467 . . . . 0.0 114.916 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.5 138.99 30.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.348 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.1 m -145.12 168.38 20.48 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.323 2.249 . . . . 0.0 108.179 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.436 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.53 166.37 23.36 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.611 1.164 . . . . 0.0 112.375 178.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.944 0 C-N-CA 129.09 2.956 . . . . 0.0 113.07 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.572 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 24.5 t -113.69 141.85 28.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 t -148.31 127.57 12.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.297 7.7 ptp180 -79.38 176.41 9.72 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.2 m -118.46 173.66 6.7 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.008 2.523 . . . . 0.0 111.532 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.87 -57.76 6.78 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.162 1.385 . . . . 0.0 110.917 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.9 t -99.04 55.06 1.0 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.425 1.89 . . . . 0.0 109.935 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -48.02 -40.9 24.12 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.09 62.48 0.06 OUTLIER Glycine 0 C--N 1.33 0.216 0 N-CA-C 117.463 1.745 . . . . 0.0 117.463 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.32 -16.9 57.59 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.965 2.443 . . . . 0.0 116.548 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -130.88 34.27 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 123.516 1.627 . . . . 0.0 114.849 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.51 164.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.185 -1.37 . . . . 0.0 114.644 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.58 65.91 1.35 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.146 1.778 . . . . 0.0 113.149 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.35 55.96 0.2 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.89 -4.77 17.71 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -96.99 146.73 24.69 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.53 2.332 . . . . 0.0 117.04 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 5' ' ' ARG . 15.2 mt -65.36 66.4 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 129.511 3.124 . . . . 0.0 115.797 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.9 p -65.78 -30.6 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 110.07 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.22 54.54 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -145.61 143.99 30.19 Favored 'General case' 0 CA--C 1.503 -0.827 0 O-C-N 119.809 -1.994 . . . . 0.0 110.768 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.5 p -95.1 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 123.483 1.611 . . . . 0.0 109.309 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.75 102.61 7.4 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 129.532 3.133 . . . . 0.0 106.73 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 42' ' ' TYR . 47.6 t -76.29 133.37 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 109.959 -3.291 . . . . 0.0 107.69 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.13 -9.92 75.0 Favored Glycine 0 CA--C 1.556 2.612 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.849 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 129.41 162.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 1 C-N-CA 135.949 5.7 . . . . 0.0 115.434 176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -52.51 153.98 2.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 129.843 3.257 . . . . 0.0 118.209 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.4 131.19 41.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.64 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 m -39.61 -4.78 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 1 C-N-CA 132.945 4.498 . . . . 0.0 120.809 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.29 4.18 2.0 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 125.581 1.562 . . . . 0.0 115.431 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -99.68 -179.39 4.17 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.884 1.274 . . . . 0.0 111.288 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -149.74 159.69 44.15 Favored 'General case' 0 C--O 1.243 0.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.646 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.1 mptm? -59.14 124.31 19.55 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.005 1.322 . . . . 0.0 112.539 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 31.0 p -97.26 6.73 47.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.507 1.754 . . . . 0.0 110.749 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -157.63 171.5 20.21 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 118.953 0.797 . . . . 0.0 110.369 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.61 -48.78 53.37 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.468 0.651 . . . . 0.0 111.949 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.52 -177.88 6.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.142 2.977 . . . . 0.0 109.498 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -141.65 -68.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 119.405 -2.059 . . . . 0.0 112.431 -177.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.81 174.51 1.77 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.989 1.376 . . . . 0.0 114.55 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 1 C-N-CA 131.818 4.047 . . . . 0.0 115.321 176.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.24 -46.74 0.2 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.35 3.06 . . . . 0.0 112.291 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -79.82 -168.62 1.66 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.639 3.976 . . . . 0.0 115.714 -176.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.1 mt-10 -147.21 126.89 13.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.873 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -89.33 122.13 32.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.024 0.916 . . . . 0.0 109.718 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -128.17 170.3 13.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.144 1.378 . . . . 0.0 107.707 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.274 0.0 OUTLIER -133.65 169.1 17.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.505 -179.78 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 127.618 2.367 . . . . 0.0 111.073 176.608 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.266 59.5 t -112.91 149.17 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 123.793 0.837 . . . . 0.0 108.868 178.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.8 t -155.88 108.83 2.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HB3' HD23 ' A' ' 18' ' ' LEU . 10.1 ptp85 -53.41 173.72 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 131.653 3.981 . . . . 0.0 115.847 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.6 m -97.9 -174.25 2.82 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 112.189 -2.278 . . . . 0.0 106.074 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -72.99 -55.09 7.03 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.304 -1.498 . . . . 0.0 107.546 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -78.26 32.04 0.18 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.412 2.285 . . . . 0.0 113.306 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 27.5 t70 -53.85 -10.83 0.34 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.0 -89.3 1.11 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 124.592 1.091 . . . . 0.0 113.742 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -54.78 -7.13 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 125.266 3.977 . . . . 0.0 115.963 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -92.48 -7.82 46.35 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -176.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 124.507 1.123 . . . . 0.0 112.14 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.458 ' CD2' ' H ' ' A' ' 14' ' ' HIS . 2.7 p80 -71.16 -11.56 61.01 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.306 -1.496 . . . . 0.0 112.655 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.94 69.94 1.18 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.36 1.304 . . . . 0.0 116.36 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -133.55 -54.56 0.89 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.781 1.232 . . . . 0.0 109.569 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.4 p -140.42 151.24 44.75 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 5' ' ' ARG . 5.0 mt -52.97 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.778 1 C-N-CA 131.756 4.022 . . . . 0.0 114.426 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 p -69.08 -23.13 63.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.42 0.688 . . . . 0.0 110.326 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.04 163.19 41.36 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -144.63 142.26 30.0 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.4 -1.647 . . . . 0.0 110.444 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.267 3.0 p -99.03 138.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 124.394 2.045 . . . . 0.0 108.22 176.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -130.45 113.8 14.75 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 131.583 3.953 . . . . 0.0 102.34 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.9 m -79.64 160.84 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.206 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.36 -66.75 3.43 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.58 164.52 12.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.463 2.305 . . . . 0.0 114.187 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.02 154.27 19.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.972 2.909 . . . . 0.0 116.465 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.04 51.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.637 1.975 . . . . 0.0 109.452 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -38.81 -30.7 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.01 5.32 30.51 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.719 1.152 . . . . 0.0 115.755 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -106.9 177.39 4.87 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.367 1.084 . . . . 0.0 111.789 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -147.26 167.23 24.77 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.5 mptp? -66.2 114.21 5.13 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.052 0.93 . . . . 0.0 111.774 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -86.87 2.35 49.42 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.349 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -159.56 170.69 21.11 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.468 -0.77 . . . . 0.0 113.005 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -73.37 -42.05 62.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.577 1.551 . . . . 0.0 112.99 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 11.8 pt-20 -87.87 -178.55 6.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.738 2.015 . . . . 0.0 109.944 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -142.99 -68.31 0.35 Allowed 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 119.391 -2.068 . . . . 0.0 109.674 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.43 175.71 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.487 1.515 . . . . 0.0 114.685 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.3 tp -48.92 -39.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 1 C-N-CA 132.338 4.255 . . . . 0.0 114.652 176.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.72 -45.73 0.18 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 130.315 3.446 . . . . 0.0 111.959 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.554 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -76.5 -167.38 0.79 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 130.083 3.353 . . . . 0.0 115.925 -177.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -151.08 127.17 10.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.586 -1.643 . . . . 0.0 113.259 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 66.7 m -91.47 138.4 31.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.203 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.5 m -141.95 170.22 16.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.406 2.282 . . . . 0.0 107.468 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 169.5 16.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.121 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 127.138 2.175 . . . . 0.0 111.595 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.433 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.571 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.278 46.5 t -100.03 148.36 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.921 0.888 . . . . 0.0 110.011 -177.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HB2' HG12 ' A' ' 22' ' ' VAL . 45.7 t -155.84 131.49 9.72 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HG3' HD23 ' A' ' 18' ' ' LEU . 15.1 mtm180 -67.12 177.21 1.85 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.1 m -122.95 165.27 17.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 130.058 3.343 . . . . 0.0 109.72 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -48.89 -47.13 43.4 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 127.529 2.332 . . . . 0.0 113.156 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -79.35 -18.37 52.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.53 1.932 . . . . 0.0 116.086 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CD ' ' A' ' 5' ' ' ARG 0.464 0.0 OUTLIER 30.08 46.59 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 131.455 3.902 . . . . 0.0 113.837 -177.235 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.85 71.81 0.04 OUTLIER Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.906 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -61.4 -7.82 9.38 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.591 3.528 . . . . 0.0 117.294 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t 72.05 32.41 1.81 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 127.8 2.44 . . . . 0.0 116.532 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.8 -162.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.31 -1.768 . . . . 0.0 113.407 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -64.21 87.59 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.773 2.029 . . . . 0.0 113.717 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.69 93.22 2.19 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.888 1.709 . . . . 0.0 115.366 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -67.16 -26.79 66.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -54.69 -171.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 130.67 3.588 . . . . 0.0 113.255 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.664 HD23 ' HG3' ' A' ' 5' ' ' ARG . 39.9 mt -60.76 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 129.295 3.038 . . . . 0.0 116.207 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -71.97 -24.01 61.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.172 2.189 . . . . 0.0 107.38 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.83 166.65 54.28 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 104.596 -3.402 . . . . 0.0 104.596 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.0 m -149.68 143.51 25.52 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 119.169 -2.371 . . . . 0.0 113.219 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.571 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.33 3.1 p -99.78 135.45 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 124.955 2.312 . . . . 0.0 107.992 176.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 5.9 m95 -126.79 132.99 50.91 Favored 'General case' 0 C--N 1.305 -1.366 1 C-N-CA 132.901 4.481 . . . . 0.0 102.149 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.1 m -103.99 157.38 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.495 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.11 -42.25 2.52 Favored Glycine 0 CA--C 1.554 2.513 0 C-N-CA 119.291 -1.433 . . . . 0.0 111.064 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -175.32 166.41 3.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 130.13 3.372 . . . . 0.0 110.469 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.74 159.89 32.31 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.37 2.268 . . . . 0.0 113.435 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.31 134.81 48.3 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.173 2.189 . . . . 0.0 110.649 177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -23.16 -62.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.864 3.265 . . . . 0.0 118.676 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 11.19 65.12 Favored Glycine 0 N--CA 1.463 0.469 0 C-N-CA 125.829 1.68 . . . . 0.0 116.268 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -104.64 173.76 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.191 0.996 . . . . 0.0 111.213 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -153.0 165.32 35.92 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 120.755 -1.216 . . . . 0.0 111.814 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 2.1 mptp? -58.95 107.28 0.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.877 2.071 . . . . 0.0 113.912 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.0 p -86.64 4.5 40.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.949 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -154.56 176.43 12.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.956 1.702 . . . . 0.0 110.931 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.15 -52.05 8.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.578 1.151 . . . . 0.0 111.566 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.6 -174.14 4.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.538 1.935 . . . . 0.0 109.343 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.72 -70.22 0.36 Allowed 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.467 -2.02 . . . . 0.0 110.219 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.14 176.23 1.41 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.743 1.617 . . . . 0.0 113.936 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -45.13 -37.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 1 C-N-CA 131.815 4.046 . . . . 0.0 115.316 176.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -149.73 -43.37 0.14 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.48 2.712 . . . . 0.0 112.284 -176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -78.0 -167.42 1.0 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 131.564 3.946 . . . . 0.0 115.949 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 27.3 mt-10 -150.49 131.21 14.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.157 -1.383 . . . . 0.0 114.013 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 61.7 m -94.66 130.23 41.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.004 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -135.09 174.81 10.19 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.19 2.196 . . . . 0.0 108.755 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.254 0.0 OUTLIER -135.42 169.21 17.85 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.614 1.166 . . . . 0.0 113.244 178.016 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 115.854 -2.022 . . . . 0.0 114.315 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.989 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.503 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.292 51.5 t -101.98 148.74 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.237 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.3 t -151.63 130.62 12.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.704 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.2 ptp180 -98.25 157.4 16.19 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m -82.17 155.82 24.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 110.501 -3.045 . . . . 0.0 107.511 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.18 -21.36 47.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.745 1.157 . . . . 0.0 113.168 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.2 p -106.96 -10.04 16.08 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.693 2.797 . . . . 0.0 115.519 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.458 1.0 OUTLIER 40.92 2.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 1 C-N-CA 134.705 5.202 . . . . 0.0 119.17 -177.425 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.18 67.31 0.14 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 126.84 2.162 . . . . 0.0 112.012 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.37 -16.05 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 124.484 3.456 . . . . 0.0 116.743 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -115.57 -20.69 10.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 119.366 0.985 . . . . 0.0 113.444 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.91 147.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.83 1.252 . . . . 0.0 110.921 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.4 111.49 1.25 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.441 1.496 . . . . 0.0 113.179 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -156.96 70.33 0.27 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.84 0.733 . . . . 0.0 113.25 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -49.45 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 1 C-N-CA 134.16 4.984 . . . . 0.0 120.432 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.5 p -131.32 174.0 10.5 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 128.884 2.874 . . . . 0.0 113.905 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.252 27.2 mt -73.0 75.78 1.19 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.775 1.23 . . . . 0.0 112.26 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.3 p -81.38 -17.42 49.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.43 3.492 . . . . 0.0 112.207 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.3 176.58 25.61 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.262 2.363 . . . . 0.0 111.04 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -141.64 137.88 32.13 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.252 3.2 p -97.2 136.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 124.174 1.94 . . . . 0.0 106.178 176.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -123.45 128.75 50.26 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 131.012 3.725 . . . . 0.0 103.059 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.3 m -100.27 158.49 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.353 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.44 -36.81 1.57 Allowed Glycine 0 CA--C 1.556 2.653 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.259 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.8 t 177.43 167.92 0.63 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 130.41 3.484 . . . . 0.0 110.607 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.11 156.78 33.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.574 1.95 . . . . 0.0 113.435 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 132.87 48.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.641 1.976 . . . . 0.0 110.257 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -28.18 -50.84 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.841 3.256 . . . . 0.0 118.15 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.79 5.56 54.0 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -101.41 174.61 5.9 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.436 1.118 . . . . 0.0 111.741 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -150.47 167.35 27.4 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.024 -1.048 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -66.25 114.11 5.08 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 125.092 1.357 . . . . 0.0 113.404 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 23.5 p -94.69 5.54 51.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.663 176.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -151.85 171.39 17.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.135 -0.978 . . . . 0.0 112.944 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.67 -51.9 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.286 1.434 . . . . 0.0 111.066 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.53 -170.57 3.17 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.531 1.532 . . . . 0.0 108.291 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.522 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.32 -62.78 0.37 Allowed 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 119.364 -2.085 . . . . 0.0 109.68 177.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.34 175.2 0.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -48.77 -39.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 131.186 3.794 . . . . 0.0 114.166 176.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . . . -143.89 -49.55 0.3 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 129.686 3.194 . . . . 0.0 111.846 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -74.57 -166.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 133.426 4.691 . . . . 0.0 115.989 -177.135 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 25.4 mt-10 -150.89 130.92 13.41 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.25 136.87 33.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.178 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.91 169.22 19.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.521 1.928 . . . . 0.0 107.582 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.257 0.0 OUTLIER -135.81 168.17 19.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.739 -178.901 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 129.231 3.012 . . . . 0.0 110.687 177.449 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.324 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 46.5 t -128.96 148.5 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 118.696 -0.669 . . . . 0.0 109.921 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.402 ' CA ' HD22 ' A' ' 18' ' ' LEU . 44.1 t -152.18 132.68 13.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.714 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.3 ptp180 -98.89 158.55 15.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -177.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -85.22 169.58 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.589 3.156 . . . . 0.0 112.528 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -60.01 -18.82 48.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -123.33 -18.29 6.3 Favored 'General case' 0 C--N 1.32 -0.682 1 C-N-CA 132.162 4.185 . . . . 0.0 114.463 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.503 5.2 p-10 46.23 17.86 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 130.44 3.496 . . . . 0.0 116.105 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.49 66.91 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 129.687 3.517 . . . . 0.0 111.423 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -65.31 -2.13 5.51 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.518 3.479 . . . . 0.0 116.959 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -135.38 -32.75 0.92 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -153.26 -170.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 126.19 1.796 . . . . 0.0 111.201 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.62 114.89 1.39 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.669 1.988 . . . . 0.0 111.903 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.73 6.17 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.631 1.586 . . . . 0.0 111.751 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.92 -25.65 1.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.658 1.983 . . . . 0.0 113.255 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.7 p -134.0 167.16 21.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.879 2.072 . . . . 0.0 112.107 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 5' ' ' ARG . 23.5 mt -56.1 66.01 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.244 3.018 . . . . 0.0 117.642 -177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 t -79.38 5.37 12.79 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.887 1.675 . . . . 0.0 112.743 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.68 171.3 14.94 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.209 2.337 . . . . 0.0 108.776 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.5 m -140.39 138.67 34.97 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.9 p -96.99 139.25 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-O 123.943 1.83 . . . . 0.0 106.405 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.65 112.3 16.63 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 129.724 3.21 . . . . 0.0 103.479 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.711 HG22 ' CG ' ' A' ' 42' ' ' TYR . 40.2 t -79.74 143.56 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.103 -177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 -51.48 4.11 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 t 178.33 164.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 128.943 2.897 . . . . 0.0 113.978 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.8 155.51 22.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 128.287 2.635 . . . . 0.0 116.66 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.21 135.03 47.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.966 1.706 . . . . 0.0 110.354 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 m -39.18 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 1 C-N-CA 132.174 4.19 . . . . 0.0 120.643 -177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.21 1.27 7.71 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.971 1.272 . . . . 0.0 114.84 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.39 179.04 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.21 1.404 . . . . 0.0 110.303 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -149.24 165.46 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.09 -1.006 . . . . 0.0 109.864 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.73 114.59 3.39 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.422 1.089 . . . . 0.0 112.205 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 26.5 p -92.96 10.31 31.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.19 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -163.11 170.6 17.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.1 -53.47 17.23 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.621 1.568 . . . . 0.0 111.959 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -80.0 -177.51 6.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.017 2.927 . . . . 0.0 110.129 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.51 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -143.8 -65.67 0.36 Allowed 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 119.484 -2.01 . . . . 0.0 109.945 177.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.46 175.0 0.59 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -49.46 -37.02 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 1 C-N-CA 131.713 4.005 . . . . 0.0 114.426 176.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -146.15 -49.52 0.21 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 129.983 3.313 . . . . 0.0 111.501 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.711 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -73.35 -167.3 0.41 Allowed 'General case' 0 N--CA 1.443 -0.814 1 C-N-CA 131.711 4.004 . . . . 0.0 116.475 -177.193 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 20.1 mt-10 -148.41 130.8 15.68 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.06 137.5 32.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.75 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.9 m -149.14 170.26 18.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 108.692 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.89 173.48 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.534 1.534 . . . . 0.0 112.832 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 128.947 2.899 . . . . 0.0 109.896 176.583 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.507 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.272 48.5 t -103.94 147.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.36 0.664 . . . . 0.0 109.468 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' HD22 ' A' ' 18' ' ' LEU . 35.9 t -157.1 111.89 2.76 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.402 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -72.82 175.8 6.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.305 1.442 . . . . 0.0 113.995 -178.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.21 174.32 7.46 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 112.565 -2.107 . . . . 0.0 110.448 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.57 -47.71 66.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -99.01 -28.2 13.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.832 0.853 . . . . 0.0 112.88 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CB ' ' HD3' ' A' ' 5' ' ' ARG 0.368 0.7 OUTLIER 58.2 -23.84 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 130.975 3.71 . . . . 0.0 117.118 -176.921 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.78 -72.59 0.58 Allowed Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 127.487 2.47 . . . . 0.0 117.088 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.61 -3.21 1.3 Allowed 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.179 3.253 . . . . 0.0 114.288 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -93.84 -21.54 19.21 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 p -175.07 152.2 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.327 1.051 . . . . 0.0 111.781 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -73.03 79.18 1.2 Allowed 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.584 -1.323 . . . . 0.0 113.312 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.22 143.31 6.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.444 1.973 . . . . 0.0 113.565 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -51.07 8.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 1 C-N-CA 132.632 4.373 . . . . 0.0 120.37 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.3 p -66.82 146.79 54.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 131.008 3.723 . . . . 0.0 115.352 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 4' ' ' CYS 0.269 74.1 mt -78.66 54.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.548 -2.115 . . . . 0.0 114.116 177.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.8 m -71.85 -27.23 62.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.61 155.61 48.65 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 104.467 -3.453 . . . . 0.0 104.467 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.1 m -140.49 143.55 35.54 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 120.766 -1.432 . . . . 0.0 113.35 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.278 3.5 p -97.17 136.28 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 124.577 2.132 . . . . 0.0 107.984 176.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -122.33 122.17 38.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 108.867 -3.788 . . . . 0.0 102.851 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.713 HG22 ' CG ' ' A' ' 42' ' ' TYR . 42.3 t -93.27 139.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 112.505 -2.134 . . . . 0.0 109.944 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.47 -19.53 10.79 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.544 -1.142 . . . . 0.0 114.402 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 166.35 153.97 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 130.491 3.516 . . . . 0.0 111.884 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -66.49 154.94 38.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.123 2.169 . . . . 0.0 112.198 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 133.54 49.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.358 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -35.7 -28.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 131.185 3.794 . . . . 0.0 120.155 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.32 3.37 12.55 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.17 1.366 . . . . 0.0 114.839 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -99.77 177.64 5.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.976 1.31 . . . . 0.0 109.908 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -150.27 163.82 37.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.5 mptm? -61.25 120.04 9.6 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.432 1.093 . . . . 0.0 112.443 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.41 2.47 55.77 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.557 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -151.66 165.56 33.96 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 119.705 1.139 . . . . 0.0 110.767 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -43.34 89.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.459 1.123 . . . . 0.0 112.675 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.36 -173.99 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 109.597 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -68.8 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 119.543 -1.973 . . . . 0.0 111.957 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.06 175.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.24 1.816 . . . . 0.0 114.152 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -47.95 -37.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 1 C-N-CA 132.109 4.163 . . . . 0.0 115.444 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.99 -42.16 0.15 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.463 3.105 . . . . 0.0 112.896 -176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.713 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -82.39 -169.64 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.909 3.284 . . . . 0.0 116.141 -176.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 32.4 mt-10 -149.46 124.56 10.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.226 177.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.34 110.77 20.47 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.278 1.431 . . . . 0.0 110.096 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -114.91 171.72 7.48 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.306 1.442 . . . . 0.0 108.531 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 168.17 19.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.674 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 129.938 3.295 . . . . 0.0 110.137 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.274 47.3 t -107.36 150.57 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.923 0.889 . . . . 0.0 109.274 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.408 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.1 t -152.89 121.07 6.21 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.25 2.1 ptp180 -73.62 172.55 11.19 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.414 1.886 . . . . 0.0 115.6 -177.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.0 m -109.41 169.81 8.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.663 2.385 . . . . 0.0 111.703 -177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -52.86 -33.7 50.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.768 1.627 . . . . 0.0 114.908 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -127.55 64.24 1.35 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.492 2.717 . . . . 0.0 109.196 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.73 -24.01 0.5 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.622 1.969 . . . . 0.0 115.586 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 69.49 0.9 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 122.168 3.627 . . . . 0.0 122.168 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.03 -30.28 47.83 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.512 2.808 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 t -87.95 2.81 50.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -140.87 168.92 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -176.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.496 ' H ' HG12 ' A' ' 13' ' ' VAL . 3.4 m170 -51.63 -37.19 49.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.121 2.168 . . . . 0.0 114.802 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.49 35.41 3.02 Favored Glycine 0 N--CA 1.469 0.854 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -65.17 24.48 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 129.944 3.298 . . . . 0.0 117.164 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -134.09 178.0 7.3 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.419 2.288 . . . . 0.0 112.673 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 5' ' ' ARG . 19.7 mt -67.51 65.3 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.108 2.163 . . . . 0.0 114.249 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -73.95 -27.14 60.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.645 2.778 . . . . 0.0 109.375 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.19 165.55 45.22 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -140.72 142.09 34.85 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.301 -1.117 . . . . 0.0 113.527 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.275 3.2 p -100.25 136.12 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 124.465 2.079 . . . . 0.0 106.928 176.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -126.62 124.93 41.03 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 131.634 3.974 . . . . 0.0 102.422 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.534 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.5 m -93.16 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.005 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.77 -61.16 3.7 Favored Glycine 0 CA--C 1.554 2.529 0 C-N-CA 119.241 -1.456 . . . . 0.0 110.76 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 t -158.95 158.77 33.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 128.295 2.638 . . . . 0.0 112.234 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -68.45 158.98 32.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.37 1.868 . . . . 0.0 112.688 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.89 42.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.905 2.482 . . . . 0.0 111.146 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 p -20.84 -63.22 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 130.552 3.541 . . . . 0.0 118.57 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.05 9.9 67.88 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 117.035 1.574 . . . . 0.0 117.035 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -101.6 174.11 6.12 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.374 1.087 . . . . 0.0 110.825 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -149.99 168.0 25.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.861 -1.149 . . . . 0.0 110.551 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -60.42 111.45 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.918 1.687 . . . . 0.0 112.496 177.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 16.8 p -93.46 10.69 31.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -159.61 165.95 31.7 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.587 1.155 . . . . 0.0 110.556 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.79 -36.28 80.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.04 1.336 . . . . 0.0 112.657 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -102.2 -175.14 2.75 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.254 2.622 . . . . 0.0 110.191 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.527 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -136.95 -68.16 0.49 Allowed 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 119.538 -1.976 . . . . 0.0 110.137 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.4 174.22 1.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.4 tp -46.09 -42.42 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 1 C-N-CA 132.122 4.169 . . . . 0.0 114.338 176.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.01 -44.32 0.26 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 130.823 3.649 . . . . 0.0 111.951 -176.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -79.04 -166.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 130.54 3.536 . . . . 0.0 116.087 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 15.9 mt-10 -152.11 127.22 9.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.806 177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.0 m -91.13 136.07 33.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.995 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -142.18 167.78 21.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.738 2.015 . . . . 0.0 108.849 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.265 0.0 OUTLIER -130.04 165.83 21.38 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.11 179.82 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 C-N-CA 129.456 3.102 . . . . 0.0 112.234 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.259 56.4 t -121.08 147.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.392 0.596 . . . . 0.0 110.386 -177.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.43 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.9 t -151.74 125.8 9.2 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.546 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.1 ptt180 -95.22 175.61 6.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.851 1.31 . . . . 0.0 113.317 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 26.4 p -123.67 174.84 7.2 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.09 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.73 -30.9 46.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.495 1.918 . . . . 0.0 115.182 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 t -96.5 -18.56 19.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.048 2.139 . . . . 0.0 113.709 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.306 0.9 OUTLIER 39.7 27.19 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.247 3.419 . . . . 0.0 115.7 -177.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 14' ' ' HIS . . . -173.83 70.75 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.31 -20.68 26.15 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.289 3.326 . . . . 0.0 115.866 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.1 p -114.33 -34.05 5.42 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 126.99 2.116 . . . . 0.0 110.835 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -174.43 138.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 127.929 2.492 . . . . 0.0 107.153 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.479 ' CD2' ' H ' ' A' ' 14' ' ' HIS . 19.0 p80 -84.25 161.29 20.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.87 2.468 . . . . 0.0 114.966 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 28.66 0.02 OUTLIER Glycine 0 N--CA 1.473 1.103 0 N-CA-C 117.341 1.696 . . . . 0.0 117.341 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 52.88 48.65 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 129.257 3.023 . . . . 0.0 115.058 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.0 p -121.29 156.53 32.34 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.784 1.754 . . . . 0.0 113.994 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 5' ' ' ARG 0.306 28.4 mt -81.59 53.8 2.21 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.386 1.474 . . . . 0.0 112.918 178.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -76.93 29.53 0.13 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.072 2.149 . . . . 0.0 110.479 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . -142.5 173.05 24.07 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 130.168 3.747 . . . . 0.0 108.381 177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.3 m -148.15 139.67 23.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.482 -1.01 . . . . 0.0 111.448 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.275 2.5 p -98.24 131.04 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 124.338 2.018 . . . . 0.0 105.774 176.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -115.2 124.29 51.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 109.114 -3.675 . . . . 0.0 103.337 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.624 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.6 m -92.67 161.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.38 -59.67 4.78 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 107.818 -2.113 . . . . 0.0 107.818 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -178.54 166.72 1.8 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.379 3.471 . . . . 0.0 112.685 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -67.85 157.01 35.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.548 2.339 . . . . 0.0 117.258 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 129.66 39.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.96 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -34.71 -31.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 131.28 3.832 . . . . 0.0 119.713 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.14 29.57 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.754 1.169 . . . . 0.0 115.638 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -104.3 174.4 5.89 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.998 1.319 . . . . 0.0 111.463 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -151.56 167.98 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.201 -0.937 . . . . 0.0 111.368 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -69.23 110.54 4.64 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 113.724 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.5 t -84.88 -2.98 58.48 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.196 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -156.72 165.63 35.7 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.863 -1.148 . . . . 0.0 111.205 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -73.97 -26.25 60.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -101.56 175.06 5.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.661 1.584 . . . . 0.0 109.876 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.518 ' CD1' ' HE3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -139.76 -62.62 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.689 -1.882 . . . . 0.0 110.629 -177.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.62 177.27 0.2 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.953 1.701 . . . . 0.0 115.132 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -51.46 -35.73 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 131.658 3.983 . . . . 0.0 114.092 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -152.55 -44.73 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 130.362 3.465 . . . . 0.0 112.986 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.624 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -73.85 -169.83 0.8 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.909 3.284 . . . . 0.0 113.9 -177.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 17.3 mt-10 -148.42 129.3 14.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.874 1.321 . . . . 0.0 114.498 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.4 132.06 34.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.76 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.6 m -142.34 173.57 11.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.085 1.754 . . . . 0.0 108.262 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -137.91 166.72 23.34 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 129.715 3.206 . . . . 0.0 113.129 177.444 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 22' ' ' VAL . 87.5 t -130.41 132.14 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.446 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' CB ' HG23 ' A' ' 22' ' ' VAL . 48.0 t -153.78 125.55 7.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 18' ' ' LEU . 4.5 ptp85 -89.56 164.07 14.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.97 1.367 . . . . 0.0 112.825 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.92 159.64 26.28 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.386 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.4 -12.15 13.19 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.0 p -113.62 -14.09 12.67 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.744 2.018 . . . . 0.0 114.451 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.344 0.5 OUTLIER 43.29 -8.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 1 C-N-CA 135.881 5.672 . . . . 0.0 118.466 -177.474 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.89 70.97 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.97 0 O-C-N 121.155 -0.966 . . . . 0.0 112.9 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.27 -20.03 53.23 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.418 3.412 . . . . 0.0 116.478 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -105.23 -38.08 6.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 127.866 2.466 . . . . 0.0 110.015 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.72 131.97 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.874 1.269 . . . . 0.0 110.093 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -41.16 125.37 2.45 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.318 2.247 . . . . 0.0 114.13 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.53 70.59 0.41 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 117.463 1.745 . . . . 0.0 117.463 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.1 -27.84 62.12 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.676 1.226 . . . . 0.0 112.12 177.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.5 p -71.08 118.75 14.24 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 129.049 2.939 . . . . 0.0 111.209 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 3' ' ' HYP 0.296 18.0 mt -60.77 66.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.945 2.898 . . . . 0.0 115.487 -176.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -75.48 -14.53 60.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.763 2.025 . . . . 0.0 110.451 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.26 174.14 33.57 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.8 m -155.74 148.04 23.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 119.553 -2.145 . . . . 0.0 112.581 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -92.57 140.66 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 126.79 2.036 . . . . 0.0 109.368 177.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 11.9 m95 -132.44 109.59 9.93 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG12 ' CD1' ' A' ' 42' ' ' TYR . 2.4 m -75.02 160.42 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 112.359 -2.201 . . . . 0.0 107.852 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.44 -62.72 4.28 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -177.96 165.0 1.94 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 130.799 3.64 . . . . 0.0 112.089 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -51.7 151.74 3.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 129.607 3.163 . . . . 0.0 117.786 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -70.58 135.52 48.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.197 1.799 . . . . 0.0 110.89 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.77 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 131.433 3.893 . . . . 0.0 119.208 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.1 8.63 27.13 Favored Glycine 0 N--CA 1.468 0.781 0 C-N-CA 125.954 1.74 . . . . 0.0 116.773 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -101.27 177.26 4.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -151.03 165.48 33.65 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 121.54 -0.725 . . . . 0.0 110.32 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.6 mptm? -64.1 121.7 14.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.26 1.024 . . . . 0.0 113.643 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.35 4.07 53.77 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.403 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -158.48 170.07 23.03 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-N 120.462 1.483 . . . . 0.0 114.049 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.5 -29.61 56.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -101.85 178.44 4.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 107.942 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -143.82 -64.4 0.38 Allowed 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 119.719 -1.863 . . . . 0.0 109.452 -177.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.49 171.41 0.44 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.977 2.111 . . . . 0.0 113.862 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -50.7 -38.44 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 131.024 3.73 . . . . 0.0 114.776 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -134.72 -48.0 0.75 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 129.502 3.121 . . . . 0.0 113.309 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.535 ' CD1' HG12 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -85.78 -168.17 2.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 129.908 3.283 . . . . 0.0 116.25 -177.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 60.1 mt-10 -142.95 135.6 27.7 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.417 -2.174 . . . . 0.0 112.328 176.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -93.74 129.03 40.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.15 1.38 . . . . 0.0 109.565 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.3 m -135.27 171.82 13.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.92 1.288 . . . . 0.0 108.237 177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -135.05 165.76 24.61 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.53 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 126.246 1.818 . . . . 0.0 114.079 177.315 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.527 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.301 57.5 t -145.99 152.64 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.066 1.346 . . . . 0.0 110.593 -177.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.1 t -151.38 133.51 15.21 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -83.43 177.84 8.29 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.065 1.346 . . . . 0.0 113.238 -177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.5 m -106.88 169.99 8.21 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.507 1.923 . . . . 0.0 108.867 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.75 -54.38 15.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 t -87.08 1.51 52.71 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.4 2.5 p-10 36.27 34.85 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 130.544 3.538 . . . . 0.0 116.696 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.95 59.56 0.25 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 116.962 1.545 . . . . 0.0 116.962 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.72 -17.32 13.08 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 124.075 3.183 . . . . 0.0 116.211 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.474 ' C ' HG22 ' A' ' 13' ' ' VAL . 71.4 m 60.68 64.37 1.18 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 131.81 4.044 . . . . 0.0 119.181 177.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -156.92 -47.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -176.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -75.98 -54.97 6.07 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 131.65 3.98 . . . . 0.0 116.29 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.72 -169.34 42.01 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 127.023 2.249 . . . . 0.0 111.834 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.92 4.28 44.92 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -136.4 -172.09 3.06 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 128.11 2.564 . . . . 0.0 112.149 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt -55.18 53.98 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.65 3.58 . . . . 0.0 116.824 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 t -69.58 -15.11 63.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.785 0.834 . . . . 0.0 111.078 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.3 173.59 55.25 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -153.29 143.66 22.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 118.914 -2.521 . . . . 0.0 113.017 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.527 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.291 2.6 p -99.78 132.3 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-O 124.434 2.064 . . . . 0.0 107.265 176.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -121.26 110.5 16.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 109.134 -3.666 . . . . 0.0 103.739 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.652 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -80.95 160.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 113.046 -1.888 . . . . 0.0 106.586 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.19 -55.11 4.8 Favored Glycine 0 CA--C 1.552 2.385 0 C-N-CA 118.234 -1.936 . . . . 0.0 109.337 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.2 t 175.52 164.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 131.133 3.773 . . . . 0.0 113.265 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.35 151.28 44.36 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 127.922 2.489 . . . . 0.0 116.382 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.79 53.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.487 1.915 . . . . 0.0 111.332 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -32.0 -17.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 1 C-N-CA 134.298 5.039 . . . . 0.0 121.253 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.81 10.2 2.6 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 125.466 1.507 . . . . 0.0 115.274 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -99.71 178.6 4.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.105 0.962 . . . . 0.0 110.735 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -147.98 168.13 23.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.325 -0.859 . . . . 0.0 110.83 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -63.35 109.34 1.56 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.58 177.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.21 -3.35 58.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.027 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -150.51 165.43 33.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.084 1.354 . . . . 0.0 110.882 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -67.4 -47.69 69.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.327 1.051 . . . . 0.0 112.923 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.62 -176.37 6.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 128.509 2.723 . . . . 0.0 109.57 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.496 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.8 -70.43 0.42 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 119.645 -1.909 . . . . 0.0 108.493 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.98 177.12 2.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 114.438 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -44.55 -38.5 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 131.354 3.862 . . . . 0.0 113.349 176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -148.21 -52.67 0.18 Allowed 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 130.407 3.483 . . . . 0.0 111.321 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.652 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -65.8 -170.16 0.07 Allowed 'General case' 0 N--CA 1.441 -0.888 1 C-N-CA 131.859 4.063 . . . . 0.0 113.889 -177.107 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 38' ' ' TYR . 13.6 mt-10 -147.6 125.54 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 87.0 m -89.78 135.17 33.79 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.021 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.3 m -142.86 173.65 11.36 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.686 2.394 . . . . 0.0 106.829 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.11 170.3 16.21 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.218 1.007 . . . . 0.0 110.384 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 127.325 2.25 . . . . 0.0 110.015 176.546 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.471 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 38.2 t -113.01 142.99 23.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.672 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -149.63 132.2 15.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 18' ' ' LEU . 1.7 ptp180 -96.72 158.52 15.39 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 122.721 1.248 . . . . 0.0 114.322 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.4 m -82.25 -179.83 7.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.723 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -35.16 76.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 127.053 2.141 . . . . 0.0 111.626 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.2 t -116.2 53.63 0.86 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.011 1.724 . . . . 0.0 109.519 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -57.42 -29.33 64.05 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.1 66.38 0.03 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.841 1.686 . . . . 0.0 115.328 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.75 -10.53 27.95 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.756 2.971 . . . . 0.0 117.752 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -146.15 22.42 1.37 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 p -161.39 168.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 127.153 2.181 . . . . 0.0 108.304 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -71.47 119.45 15.63 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 120.536 -1.352 . . . . 0.0 112.787 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.55 138.14 27.0 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -98.0 -74.47 0.58 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.096 0.959 . . . . 0.0 112.752 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.5 p -152.33 170.37 20.22 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 5' ' ' ARG . 43.5 mt -73.79 63.93 0.92 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.294 2.638 . . . . 0.0 111.393 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -68.19 -25.78 65.4 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.078 1.351 . . . . 0.0 108.73 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.61 160.09 48.72 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 106.993 -2.443 . . . . 0.0 106.993 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.7 m -141.27 141.38 33.96 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 121.298 -1.119 . . . . 0.0 111.709 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.4 p -94.72 137.29 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 124.399 2.047 . . . . 0.0 107.01 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -121.32 119.75 33.08 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 110.304 -3.135 . . . . 0.0 103.89 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.737 HG22 ' CG ' ' A' ' 42' ' ' TYR . 41.7 t -90.46 144.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.032 -2.349 . . . . 0.0 108.546 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.46 -35.47 2.23 Favored Glycine 0 CA--C 1.555 2.557 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.301 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t 175.77 152.69 0.15 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 129.067 2.947 . . . . 0.0 112.503 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.73 160.68 11.29 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.593 1.957 . . . . 0.0 111.385 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.79 132.34 38.02 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.316 1.446 . . . . 0.0 109.393 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -28.12 -50.33 0.07 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 130.045 3.338 . . . . 0.0 117.732 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.46 3.59 61.49 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.08 1.592 . . . . 0.0 117.08 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -101.62 -179.23 3.96 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.723 1.262 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -151.84 163.81 38.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 121.149 -0.969 . . . . 0.0 109.41 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.7 mptm? -61.06 118.66 7.06 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.955 1.302 . . . . 0.0 112.973 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -92.29 5.13 51.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.057 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -157.51 168.65 26.69 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-N 120.563 1.529 . . . . 0.0 113.097 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -65.51 -48.17 73.45 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.489 1.515 . . . . 0.0 112.561 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -88.58 -177.94 5.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.991 2.116 . . . . 0.0 108.14 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.436 ' HD2' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.21 -59.85 0.38 Allowed 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 118.76 -2.462 . . . . 0.0 110.635 -177.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 172.44 175.45 0.09 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.135 2.174 . . . . 0.0 113.959 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -49.05 -38.21 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 130.872 3.669 . . . . 0.0 114.122 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -143.53 -52.64 0.35 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 129.665 3.186 . . . . 0.0 111.936 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -69.85 -169.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.744 1 C-N-CA 132.137 4.175 . . . . 0.0 116.347 -177.223 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 28.1 mt-10 -148.74 128.47 13.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.24 115.39 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.758 1.223 . . . . 0.0 111.112 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.3 m -124.39 167.64 14.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.786 1.279 . . . . 0.0 107.776 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.96 168.88 18.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.098 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 128.212 2.605 . . . . 0.0 113.507 177.246 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.561 ' HB ' ' CG1' ' A' ' 22' ' ' VAL . 48.5 t -135.05 148.26 29.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.41 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' HD22 ' A' ' 18' ' ' LEU . 53.9 t -152.64 116.9 4.92 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.422 ' H ' ' CD2' ' A' ' 18' ' ' LEU 0.294 0.0 OUTLIER -91.12 175.0 7.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.851 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.4 p -115.98 -179.28 3.61 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 127.925 2.49 . . . . 0.0 112.632 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.11 -53.86 46.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.802 0.811 . . . . 0.0 109.225 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 t -88.63 43.55 1.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.591 1.157 . . . . 0.0 111.142 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -41.71 -41.83 2.39 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.795 1.638 . . . . 0.0 112.681 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.1 60.46 0.03 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 125.61 1.576 . . . . 0.0 116.739 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -63.28 -16.04 52.02 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.386 3.391 . . . . 0.0 117.695 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -69.73 -22.56 63.37 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.99 -157.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.113 2.165 . . . . 0.0 111.02 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.88 82.22 2.16 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.407 1.483 . . . . 0.0 112.1 177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 109.05 2.67 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.81 -15.14 0.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 117.003 2.224 . . . . 0.0 117.003 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.4 p -130.79 154.14 48.32 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 124.228 1.966 . . . . 0.0 115.652 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 4' ' ' CYS . 25.5 mt -70.82 63.11 0.29 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.558 2.743 . . . . 0.0 116.629 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -68.96 -11.96 61.2 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.231 0.613 . . . . 0.0 111.656 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.92 175.1 41.46 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.353 1.93 . . . . 0.0 110.49 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -149.48 142.72 25.11 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.16 -1.788 . . . . 0.0 113.219 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.561 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 2.6 p -101.32 137.99 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 124.119 1.914 . . . . 0.0 106.291 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.423 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 7.7 m95 -125.16 119.14 27.72 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 130.88 3.672 . . . . 0.0 103.181 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -87.18 161.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.455 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.34 -63.45 3.93 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.076 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 p -162.16 161.04 27.85 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.188 2.595 . . . . 0.0 113.05 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -61.57 160.99 10.35 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.787 1.279 . . . . 0.0 113.653 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . . . -77.07 133.08 39.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.945 2.098 . . . . 0.0 110.153 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.7 p -18.87 -65.77 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 130.716 3.607 . . . . 0.0 117.894 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 9.48 70.6 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.802 1.668 . . . . 0.0 116.896 -177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -99.25 174.8 6.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.433 1.116 . . . . 0.0 111.024 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -149.95 168.72 23.0 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.805 -1.184 . . . . 0.0 111.034 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HE3' ' HD2' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -67.77 112.8 5.05 Favored 'General case' 0 CA--C 1.511 -0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 113.053 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 22.2 t -88.02 -1.71 58.16 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.862 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -157.79 167.69 29.31 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.093 -1.004 . . . . 0.0 111.498 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.63 -33.48 68.98 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.6 177.21 5.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 110.627 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.541 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -141.24 -64.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 119.708 -1.87 . . . . 0.0 110.487 -177.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 174.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.154 1.781 . . . . 0.0 115.046 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -47.59 -42.35 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 131.026 3.73 . . . . 0.0 113.884 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -141.91 -46.55 0.35 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 130.708 3.603 . . . . 0.0 112.827 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.585 ' CG ' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -74.4 -169.16 0.77 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 130.024 3.329 . . . . 0.0 115.447 -177.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.4 mt-10 -148.04 126.34 12.27 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 123.309 1.528 . . . . 0.0 114.263 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.76 132.25 34.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.467 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.4 m -143.42 170.79 15.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.949 1.7 . . . . 0.0 108.517 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -136.0 167.83 20.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.784 178.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 129.059 2.944 . . . . 0.0 112.328 177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.317 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.297 66.2 t -148.32 151.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.392 1.477 . . . . 0.0 110.471 -177.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.495 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.1 t -155.42 116.13 3.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.872 ' HG3' HD23 ' A' ' 18' ' ' LEU . 12.9 mtm180 -69.5 -175.6 0.86 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.922 2.296 . . . . 0.0 111.884 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 8.5 p -142.31 170.32 15.93 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 129.69 3.196 . . . . 0.0 110.309 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.14 -38.81 91.78 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.338 1.055 . . . . 0.0 109.064 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -93.35 25.53 3.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.617 2.767 . . . . 0.0 112.153 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -53.71 -20.15 5.1 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 121.036 1.744 . . . . 0.0 113.609 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.07 71.68 0.01 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 116.049 1.18 . . . . 0.0 116.049 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.1 -16.87 48.71 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.114 2.543 . . . . 0.0 117.651 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.3 m -87.24 -16.94 33.75 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.85 137.42 5.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -38.01 106.23 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.888 1.675 . . . . 0.0 115.472 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.99 67.74 2.04 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.746 1.641 . . . . 0.0 114.091 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -61.5 -33.64 74.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.653 2.781 . . . . 0.0 112.296 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.1 p -140.16 155.75 46.82 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 124.03 1.871 . . . . 0.0 113.428 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' A' ' 5' ' ' ARG . 5.5 mt -61.87 83.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.749 3.62 . . . . 0.0 114.716 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -75.8 0.95 16.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.685 0.794 . . . . 0.0 111.448 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.36 162.83 12.27 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.235 2.826 . . . . 0.0 107.818 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.1 m -146.91 141.56 26.68 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.377 -1.661 . . . . 0.0 110.506 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.323 2.5 p -96.34 133.23 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 124.91 2.291 . . . . 0.0 108.541 176.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -121.46 112.71 18.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 109.343 -3.571 . . . . 0.0 104.213 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.2 m -86.63 158.11 3.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 112.959 -1.928 . . . . 0.0 107.497 -177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.72 -50.5 3.28 Favored Glycine 0 CA--C 1.553 2.439 0 C-N-CA 119.127 -1.511 . . . . 0.0 112.071 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -178.32 160.61 1.34 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 130.294 3.438 . . . . 0.0 111.768 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.07 161.84 7.99 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.909 2.484 . . . . 0.0 114.664 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 145.57 40.76 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.735 2.014 . . . . 0.0 110.647 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 p -32.37 -54.72 0.33 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 119.482 3.142 . . . . 0.0 119.482 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.28 14.05 30.8 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 124.692 1.139 . . . . 0.0 115.204 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -96.95 173.31 7.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.66 0.743 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -151.0 166.83 29.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.145 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 43' ' ' GLU . 4.3 mptp? -63.38 124.97 22.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.613 0.765 . . . . 0.0 111.487 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 37.8 t -96.59 1.27 51.1 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.838 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.66 168.22 26.55 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 121.238 -0.914 . . . . 0.0 109.724 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.24 -16.59 56.25 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -105.36 175.43 5.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.973 1.309 . . . . 0.0 108.181 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 119.901 -1.749 . . . . 0.0 109.972 -176.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.68 -178.57 0.16 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.707 2.003 . . . . 0.0 113.626 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 41' ' ' ALA . 5.9 tp -52.94 -38.16 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 131.501 3.921 . . . . 0.0 113.341 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -149.51 -50.93 0.15 Allowed 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 130.505 3.522 . . . . 0.0 111.204 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.612 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -69.92 -172.38 0.52 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.33 3.452 . . . . 0.0 112.772 -177.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 7.2 mm-40 -146.4 128.67 15.77 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 72.8 m -86.91 123.68 32.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.9 m -129.64 173.94 10.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.799 2.04 . . . . 0.0 107.562 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.287 0.0 OUTLIER -138.12 172.67 12.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 177.793 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.871 2.869 . . . . 0.0 110.447 176.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.302 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 22' ' ' VAL 0.281 56.0 t -100.41 150.09 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.728 1.211 . . . . 0.0 109.73 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . 0.434 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.4 t -159.16 112.69 2.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.886 ' HG3' HD23 ' A' ' 18' ' ' LEU . 59.1 mtm180 -69.91 -176.77 1.16 Allowed 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 113.465 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 3.8 p -133.87 177.29 7.84 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 129.888 3.275 . . . . 0.0 112.264 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.22 -48.77 77.96 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.689 1.196 . . . . 0.0 111.623 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -70.65 -30.43 67.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.38 1.472 . . . . 0.0 114.907 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' A' ' 5' ' ' ARG 0.442 0.0 OUTLIER 43.0 -11.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 1 C-N-CA 136.66 5.984 . . . . 0.0 119.685 -177.447 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.87 67.26 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 127.232 2.349 . . . . 0.0 112.623 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.93 -29.32 41.32 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.362 2.708 . . . . 0.0 114.86 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -130.39 10.96 5.33 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -159.1 155.76 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 126.472 1.909 . . . . 0.0 109.914 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -58.36 109.68 0.82 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.524 2.33 . . . . 0.0 113.56 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.53 89.79 1.03 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.04 0.828 . . . . 0.0 114.162 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -110.68 -34.3 6.32 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.68 1.192 . . . . 0.0 112.719 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.6 p -146.84 -177.92 5.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.45 2.7 . . . . 0.0 111.995 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' A' ' 5' ' ' ARG 0.252 17.2 mt -63.54 69.97 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 128.58 2.752 . . . . 0.0 117.216 -177.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.2 t -64.73 -30.68 71.7 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.426 1.49 . . . . 0.0 109.158 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.33 157.72 38.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.2 m -140.22 138.07 34.79 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 122.003 -0.704 . . . . 0.0 111.915 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG13 ' HB ' ' A' ' 2' ' ' VAL 0.308 3.3 p -96.77 134.27 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-O 124.807 2.241 . . . . 0.0 108.103 176.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -119.64 122.02 40.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 108.994 -3.73 . . . . 0.0 103.73 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.3 m -96.74 156.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.6 -12.6 7.75 Favored Glycine 0 CA--C 1.557 2.695 0 C-N-CA 118.769 -1.681 . . . . 0.0 115.48 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t 142.91 162.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 1 C-N-CA 135.985 5.714 . . . . 0.0 113.946 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -70.45 154.46 41.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.894 2.477 . . . . 0.0 115.35 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.93 131.78 46.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.251 1.82 . . . . 0.0 108.551 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -28.96 -63.62 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.296 2.638 . . . . 0.0 116.87 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.2 5.33 84.53 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -97.44 177.68 5.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.753 1.277 . . . . 0.0 111.074 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -152.3 166.07 32.97 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 2.2 mptm? -64.46 121.83 15.31 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 124.327 1.051 . . . . 0.0 113.103 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 19.7 t -91.25 0.03 57.6 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.157 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -160.73 166.89 27.94 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 119.83 1.196 . . . . 0.0 109.302 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -22.26 59.07 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.16 171.48 7.3 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.936 1.695 . . . . 0.0 108.832 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -138.32 -67.7 0.47 Allowed 'General case' 0 C--O 1.223 -0.32 0 O-C-N 120.187 -1.571 . . . . 0.0 110.161 -177.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.14 174.71 0.71 Allowed 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.402 1.881 . . . . 0.0 112.906 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.2 tp -48.13 -35.98 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 130.924 3.69 . . . . 0.0 115.046 177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -150.27 -44.54 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 113.136 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.562 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -76.96 -171.22 1.9 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.07 2.948 . . . . 0.0 113.55 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mt-10 -148.85 120.69 8.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 81.0 m -83.66 104.14 13.54 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.594 1.558 . . . . 0.0 109.445 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.9 m -111.52 175.73 5.31 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.54 1.162 . . . . 0.0 108.937 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER -139.46 173.89 11.08 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 177.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.246 0.904 0 C-N-CA 128.799 2.84 . . . . 0.0 109.622 176.82 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.302 55.1 t -125.9 151.81 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.052 1.341 . . . . 0.0 111.128 -177.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -157.15 127.75 6.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.758 ' HG3' HD23 ' A' ' 18' ' ' LEU . 44.6 mtm180 -75.75 154.7 36.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 123.973 1.844 . . . . 0.0 114.369 177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.1 m -89.13 166.53 13.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 110.047 -3.251 . . . . 0.0 108.995 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.0 -46.1 92.14 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.609 -1.307 . . . . 0.0 112.228 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -95.79 43.75 1.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.94 1.696 . . . . 0.0 110.529 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -38.34 -35.68 0.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.677 2.791 . . . . 0.0 116.511 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.34 -84.63 0.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.39 -7.4 0.78 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.149 3.233 . . . . 0.0 115.041 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -76.98 -24.92 52.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.124 0.874 . . . . 0.0 111.293 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.08 143.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 122.992 1.377 . . . . 0.0 113.059 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.0 -2.42 0.41 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 128.069 2.548 . . . . 0.0 116.486 -177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.89 117.83 0.91 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 128.08 2.752 . . . . 0.0 109.629 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -53.98 -11.53 0.45 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.8 t -58.5 162.62 3.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.488 1.515 . . . . 0.0 113.092 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.758 HD23 ' HG3' ' A' ' 5' ' ' ARG . 37.6 mt -66.73 61.2 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.819 2.447 . . . . 0.0 116.972 -177.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t -66.52 -37.19 84.49 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.504 1.922 . . . . 0.0 109.57 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.07 46.88 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 m -135.92 134.51 38.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 120.745 -1.444 . . . . 0.0 113.098 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.481 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 3.5 p -93.37 137.37 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 124.316 2.008 . . . . 0.0 106.228 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -122.58 119.73 31.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 109.997 -3.274 . . . . 0.0 103.127 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 ' CG ' ' A' ' 42' ' ' TYR . 51.2 t -93.3 138.83 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 112.103 -2.317 . . . . 0.0 109.279 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -48.24 3.68 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -170.18 158.2 6.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.269 1.828 . . . . 0.0 114.251 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -65.0 161.42 18.72 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.327 1.537 . . . . 0.0 112.688 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 133.89 40.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.488 1.915 . . . . 0.0 109.346 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -34.96 -40.81 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 129.653 3.181 . . . . 0.0 118.801 -177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.61 4.14 39.79 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -100.41 177.59 4.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.012 1.325 . . . . 0.0 111.653 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -151.2 166.97 29.24 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.294 -0.879 . . . . 0.0 110.666 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 1.1 mptp? -61.75 118.7 7.49 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.632 1.573 . . . . 0.0 112.882 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 46' ' ' LYS . 29.3 p -99.03 11.75 38.06 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.303 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.66 158.36 33.63 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 110.091 -177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -25.25 59.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.588 0.709 . . . . 0.0 112.321 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -101.24 -169.86 1.75 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.108 2.563 . . . . 0.0 109.485 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -143.83 -65.26 0.37 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 119.114 -2.241 . . . . 0.0 112.436 177.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.68 176.8 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.1 tp -51.24 -40.03 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 1 C-N-CA 131.701 4.001 . . . . 0.0 113.977 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -144.17 -48.4 0.27 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.074 3.35 . . . . 0.0 111.405 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.674 ' CG ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -76.52 -164.73 0.43 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.014 4.126 . . . . 0.0 116.484 -177.027 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 18.2 mt-10 -148.62 129.73 14.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.842 -1.526 . . . . 0.0 113.506 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.55 134.43 34.13 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.981 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.8 m -143.32 169.81 16.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.941 1.696 . . . . 0.0 108.929 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 34' ' ' CYS 0.311 0.0 OUTLIER -134.62 168.27 19.29 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.722 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.25 1.084 1 C-N-CA 132.406 4.282 . . . . 0.0 109.447 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.293 67.4 t -142.61 151.19 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.947 1.699 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' HD22 ' A' ' 18' ' ' LEU . 49.1 t -154.92 122.1 5.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.882 ' HG3' HD23 ' A' ' 18' ' ' LEU . 40.0 mtm180 -73.31 -171.83 1.03 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.249 1.82 . . . . 0.0 113.568 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.2 p -151.35 -178.87 6.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 127.886 2.474 . . . . 0.0 114.072 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' H ' ' HB3' ' A' ' 35' ' ' ASN . 15.5 t70 -52.72 -47.24 67.45 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.383 2.273 . . . . 0.0 112.451 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -91.69 -6.36 52.17 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.897 1.279 . . . . 0.0 113.908 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 5' ' ' ARG 0.484 0.2 OUTLIER 46.52 -14.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 136.149 5.78 . . . . 0.0 119.974 -177.436 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.67 65.35 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 127.221 2.343 . . . . 0.0 110.989 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -53.31 -16.2 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.594 4.196 . . . . 0.0 118.159 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.7 m -77.68 -21.87 51.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 125.488 1.515 . . . . 0.0 113.942 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 m -148.45 -151.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.468 1.507 . . . . 0.0 112.85 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -119.1 -11.48 9.62 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 129.231 3.012 . . . . 0.0 114.707 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.22 90.22 1.11 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.592 1.568 . . . . 0.0 116.445 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -56.76 69.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.522 3.529 . . . . 0.0 114.752 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.7 p -134.85 170.67 15.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.168 2.187 . . . . 0.0 115.175 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.882 HD23 ' HG3' ' A' ' 5' ' ' ARG . 32.2 mt -71.42 52.73 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.459 1.904 . . . . 0.0 114.152 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.6 m -69.88 -25.79 63.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.941 1.296 . . . . 0.0 108.373 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.75 170.66 55.04 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.8 m -148.99 142.82 25.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 119.534 -2.156 . . . . 0.0 112.148 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 2' ' ' VAL 0.257 2.8 p -98.33 135.64 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.535 2.112 . . . . 0.0 106.46 176.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -126.17 127.07 45.14 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.021 4.128 . . . . 0.0 102.403 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.479 HG12 ' CG ' ' A' ' 42' ' ' TYR . 1.6 m -97.61 159.72 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.46 -49.5 3.03 Favored Glycine 0 CA--C 1.557 2.71 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.3 t -169.33 169.02 9.34 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 129.741 3.216 . . . . 0.0 111.34 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.08 165.94 24.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.404 2.282 . . . . 0.0 113.632 177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.7 142.82 35.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.881 1.672 . . . . 0.0 112.544 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -35.07 -8.45 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.085 2 C-N-CA 134.697 5.199 . . . . 0.0 122.236 -177.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.22 9.96 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.005 1.764 . . . . 0.0 114.807 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -96.75 177.92 5.48 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.044 1.338 . . . . 0.0 110.863 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -152.81 167.67 28.27 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.12 -0.987 . . . . 0.0 110.787 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HE3' ' HD1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -64.16 113.51 3.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.387 1.875 . . . . 0.0 111.557 177.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 38.9 t -87.84 1.7 53.28 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.31 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' ' 7' ' ' ASP . 16.3 p-10 -158.9 167.25 29.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.622 1.569 . . . . 0.0 110.637 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.28 -42.51 79.44 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -89.37 177.73 6.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.378 2.271 . . . . 0.0 111.581 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -138.27 -68.67 0.45 Allowed 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 119.879 -1.763 . . . . 0.0 111.191 -177.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.43 170.72 0.78 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.07 1.748 . . . . 0.0 115.164 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.5 tp -44.32 -44.22 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 1 C-N-CA 131.768 4.027 . . . . 0.0 115.214 176.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -136.68 -48.19 0.62 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.989 3.315 . . . . 0.0 111.938 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -76.71 -165.25 0.51 Allowed 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.084 4.154 . . . . 0.0 116.54 -177.337 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' CB ' ' A' ' 38' ' ' TYR . 16.5 mt-10 -152.58 127.58 9.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.12 -1.855 . . . . 0.0 113.664 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.41 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.5 m -91.66 129.02 37.7 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -135.41 175.32 9.69 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.287 1.835 . . . . 0.0 108.303 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 34' ' ' CYS 0.273 0.0 OUTLIER -138.96 173.17 11.84 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 177.586 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.101 4.56 . . . . 0.0 109.069 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 22' ' ' VAL 0.303 57.2 t -93.16 151.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.776 1.63 . . . . 0.0 110.07 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' HD22 ' A' ' 18' ' ' LEU . 43.2 t -148.83 137.36 21.18 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.474 ' HG3' ' CD2' ' A' ' 18' ' ' LEU . 43.6 mtm180 -66.49 178.67 1.19 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.325 2.25 . . . . 0.0 111.052 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.72 178.57 7.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.789 2.036 . . . . 0.0 112.357 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.65 -32.94 73.13 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 126.074 1.75 . . . . 0.0 113.113 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 t -118.05 48.01 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.156 1.782 . . . . 0.0 108.392 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.57 -27.19 57.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.99 64.91 0.03 OUTLIER Glycine 0 C--N 1.338 0.672 0 C-N-CA 124.919 1.247 . . . . 0.0 115.876 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.96 -24.33 53.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.321 2.681 . . . . 0.0 117.425 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -94.83 -22.95 17.71 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 119.781 1.173 . . . . 0.0 113.683 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.28 138.31 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.05 0.94 . . . . 0.0 111.944 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -57.75 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.813 2.045 . . . . 0.0 114.349 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -148.0 103.59 0.27 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.098 0.856 . . . . 0.0 113.267 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.26 54.37 2.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 124.462 2.077 . . . . 0.0 110.889 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 p -82.67 101.7 11.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 68.4 mt -77.15 44.89 0.42 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.278 2.231 . . . . 0.0 113.779 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -66.77 -29.91 69.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.02 0.928 . . . . 0.0 108.765 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.36 176.3 34.91 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.734 2.112 . . . . 0.0 108.102 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.0 m -151.34 139.24 19.92 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 119.046 -2.444 . . . . 0.0 112.92 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 2' ' ' VAL . 5.0 p -96.1 135.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 124.247 1.975 . . . . 0.0 106.935 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -122.47 108.94 13.75 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 109.97 -3.286 . . . . 0.0 104.15 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG12 ' CD2' ' A' ' 42' ' ' TYR . 1.5 m -79.14 160.23 4.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 112.653 -2.067 . . . . 0.0 106.695 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.11 -49.15 4.06 Favored Glycine 0 CA--C 1.567 3.339 0 C-N-CA 118.672 -1.728 . . . . 0.0 109.766 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.0 t 165.29 164.04 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 1 C-N-CA 134.011 4.924 . . . . 0.0 113.271 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.89 154.87 3.7 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 129.626 3.17 . . . . 0.0 117.119 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.36 43.13 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.864 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -29.91 -44.53 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.999 3.719 . . . . 0.0 118.571 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.74 8.72 34.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.439 1.495 . . . . 0.0 116.576 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -102.54 179.39 4.31 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.772 1.229 . . . . 0.0 111.048 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -149.1 160.82 42.99 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.069 -1.019 . . . . 0.0 109.777 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HZ3' ' HD1' ' A' ' 38' ' ' TYR . 2.5 mptm? -57.77 112.75 1.57 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.471 1.509 . . . . 0.0 112.26 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.2 p -85.1 5.08 31.21 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.246 176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -159.09 165.46 33.81 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 119.275 0.943 . . . . 0.0 110.416 177.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.8 -35.85 75.2 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.893 0.746 . . . . 0.0 112.982 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.98 -175.77 4.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.069 2.148 . . . . 0.0 107.527 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.532 ' HD1' ' HZ3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -144.31 -67.2 0.33 Allowed 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 119.091 -2.256 . . . . 0.0 111.168 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.57 174.55 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.392 1.877 . . . . 0.0 112.354 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 41' ' ' ALA . 6.0 tp -47.38 -32.38 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 130.765 3.626 . . . . 0.0 115.589 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -155.42 -42.45 0.08 Allowed 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 128.797 2.839 . . . . 0.0 113.863 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.646 ' CD2' HG12 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -78.22 -169.26 1.55 Allowed 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.939 3.296 . . . . 0.0 113.894 -176.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 33' ' ' LYS . 53.1 mt-10 -150.65 123.45 8.64 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 22' ' ' VAL . 71.3 m -86.38 117.41 25.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 123.403 1.573 . . . . 0.0 110.789 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.45 174.69 7.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.231 1.813 . . . . 0.0 109.514 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.334 0.0 OUTLIER -137.28 170.56 15.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 177.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.249 1.031 1 C-N-CA 132.651 4.38 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 stop_ save_